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CHAPTER 1 
VARIATIONS IN THE SUSCEPTIBILITY OF ARTICULAR CARTILAGE TO ANTIRHEUMA­
TIC DRUGS 
Bernard J de Vries, Wim В van den Berg and Levinus BA van de Putte 

VARIATIONS IN THE SUSCEPTIBILITY OF ARTICULAR CARTILAGE TO ANTIRHEUMA-
TIC DRUGS 
1.1 INTRODUCTION 
Joint diseases, especially the chronic ones, are often associated with 
pathology of the articular cartilage. Basically there are two types of 
joint disease: a. Inflammation of the synovial tissue, which secundari-
ly leads to pathological changes of the cartilage; the prototype of 
this condition is rheumatoid arthritis (RA), b. Primary pathology of 
the articular cartilage, which subsequently can give rise to (mild) in-
flammatory changes in the synovial tissue. The prototype of this condi-
tion is osteoarthrosis, also called osteoarthritis (OA). So, in (chro-
nic) joint diseases we often find the combination of synovial tissue 
inflammation and cartilage pathology. Clinical symptoms and signs of 
this conditions include pain, stiffness, limited mobility and signs of 
inflammation. Therapy is directed at two goals: 1. suppression of in-
flammation, and 2. relief of pain and stiffness. 
As far as drug treatment is concerned the clinician has a vast arma-
mentarium of antirheumatic drugs (ARDs) to be used for these purposes. 
First, there is the group of nonsteroidal antiinflammatory drugs 
(NSAIDs). These drugs are used in both OA and RA. They suppress both 
pain and inflammation, act quickly but only for a short period of time, 
and generally do not alter the disease course in a positive way. In ad-
dition there are other drugs, mainly used in the treatment of RA, in-
cluding the so called slow acting drugs (antimalarial drugs, gold com-
pounds and D-penicillamine), cytotoxic drugs (azathioprine, methotre-
xate) and corticosteroids. Except for the corticosteroids, these drugs 
only become effective several months after institution of therapy and 
do not have a direct effect on pain and stiffness. Apart from their ef-
fect on the inflammatory process, ARDs are not believed to have any be-
neficial effect per se on pathological cartilage, except for some occa-
sional reports on salicylate (18, 25, 27). In contrast, experimental 
investigations (see below) and an occasional clinical study (71) sug-
gest that ARDs may be potentially detrimental to articular cartilage. 
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The present investigation was undertaken to study the, possibly nega-
tive, effects of NSAIDs on hyaline articular cartilage, using the mouse 
as the experimental animal. Before presenting the aim of this study, we 
should like to evaluate what is known at present on the iatrogenic ef-
fects of ARDs on cartilage proteoglycan metabolism, and, furthermore, 
on the test systems employed and their pitfalls. 
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1.2 IATROGENIC EFFECTS ON CARTILAGE PROTEOGLYCAN ÍCTABOLISM 
Experimental studies on noraal cartilage. In pathologic cartilage the 
metabolism of proteoglycans (PGs), besides water and collagen the major 
constituents of cartilage, is first affected, at least in the early 
phase of most joint disorders. Therefore, many drug studies on cartila-
ge cell (chondrocyte) function were and are directed on PG metabolism; 
little information is available on modulation of collagen metabolism by 
drugs (103). By far the greatest part of cartilage PGs consists of sul-
fated glycosaminoglycans (GAGs) of which the turnover can easily be 
measured with radiolabeled precursors. Frequently, radiosulfate incor-
poration is used as an indirect measure for PG formation or loss. 
As shown in Tables 1 and 2 variable effects have been reported for 
one particular drug and this holds for a large number of AROs of va-
Table 2. Effect of antirheumatic drugs on the basal rate of glycosami-
noglycan degradation by normal cartilage cells in vitro. 
Antirheumatic drug GAG degradation in vitro (Refs) 
Í - I 
Hydrocortisone 
Sodium salicylate 
Phenylbutazone 
Benoxaprofen 
Ibuprofen 
Fenoprofen 
Tiaprofenic acid 
Indomethacine 
Sulindac sulfide 
Piroxicam 
D-penicillamine 
Chloroquine 
Colchicine 
Arteparon 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
(20,113) 
(20,108,113) 
(20,113) 
(11) 
(74) 
(74) 
(72) 
(20) 
(74) 
(3Θ) 
(20) 
(113) 
(20) 
(1) 
I increase, f decrease, — n o change. 
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Table 1. in vitro and in vrvo effects of antirheumaric drugs on the basal rate of glycosami-
noglycan synthesis by normal cartilage cells. 
Antirheumatic drug 
GAG synthesis 
In vitro In vivo 
— 1 (Refs) 
SAIDS 
CortiEsone 
Hydrocortisone (Cortisol) 
Hydroc ortisone-acetate 
Prednisone 
Prednisolone 
Predmsolone-acetate 
Triamcinolone 
Dexamethasone 
(112,113) 
(21,51,64,82,112) 
(113) 
(54,113) 
(113) 
(θ?,85,113) 
(2) 
(10,37) 
(37) 
(54) 
(37) 
NSAIDS 
Salicylates· 
Acptylsalicylic acid (aspirin) 
Salicylic actd/salicylate 
Sa]irylamidc 
Methylsalicylat es 
Pyrazoles 
PIip ny 1 bu ta ζ one 
Oxyphenbuta/ono 
Phenylacetic acid derivative· 
Diclofenac 
Propionic acid derivativas: 
Benoxaprofen 
Ibuprofen 
Naproxen 
Flurbiprofen 
Fenoprofen 
Tlaprofenic acid 
Indomethacin 
Sulindac sjlfoxide 
Sulindac sulfide 
Tolnftin 
(21,112,111) 
(64,74,108,112,114) 
(112,113,114) 
(114) 
(113,114) 
(m) 
(22,37) 
(10,16,107) 
(34) 
(10,54) 
(10,37) 
(24) 
( U ) 
(64,74) 
(106) 
(64) 
(74) 
(72) 
(21,52,64 
(74,106) 
(70,74) 
(11) 
,74, ,115) 
• 
• 
• · 
• 
(16) 
(72) 
(24,111 
(16) 
Metenamc acid 
Flufpnamic acid 
(45) 
Piroxicam 
Isoxiram 
(38,70) 
Diftalone 
Paracetamol 
GOLD COMPOUNDS 
Gold sodium rhiosulphate 
Aurothioqlucose 
Auranofin 
Aurothiomalate 
ΑΝΤΙ MALARIALS 
Chloroquine 
Hydroxychloroquine 
Chloroquine diphosphate 
OTHERS 
Colchicine 
Calcitonin 
Arteparon 
(113) 
(115) 
(70,110) 
(70) 
(113) 
(113) 
(113) 
(113) 
(3) 
(63,101) 
(1,47,105) 
(115) 
(115) 
(10,115) 
(N)SAIDS = ( n o n ) s t e r o i d a l ant i - in f la i ranatory d r u g s , I i n c r e a s e ; Τ d e c r e a s e ; — no change. 
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rious groups and chemical classes (see the nonsteroidal antiinflammato-
ry drugs = NSAIDs). The drug effects summarized were examined on the 
GAG metabolism of normal cartilage and, in some cases of in vitro stu-
dies, also on isolated cartilage cells (chondrocytes) following either 
short-term in vivo or in vitro use. The variability is presumably a 
consequence of the use of different biochemical assays, the source of 
cartilage, or because of biological variability, existing in analogous 
specimens derived from different animal species (see below). Also very 
important, in this respect, is the concentration or dosis of drug used 
in the various studies. 
For example, it appears that in vitro very low concentrations of 
some drugs, corresponding roughly with their free (i.e. non-protein 
bound) therapeutic concentrations, stimulate basal GAG synthesis. No 
effect or even the reverse is seen if higher concentrations are used 
(hydrocortisone, dexamethasone, salicylic acid, indomethacin). Unfortu-
nately, only a few drugs are examined at these low concentrations, so 
at present it is not known if more ARDs exist with potentially stimula-
ting properties. In addition, there are also reports on drugs devoid of 
any suppressive effect, some of which even stimulate GAG synthesis. 
This holds for broad concentration ranges up to very high (nontherapeu-
tic) concentrations (diclofenac, benoxaprofen, tiaprofenic acid, sulin-
dac sulfide, piroxicam, aurothioglucose). These latter drugs would po-
tentially deserve first choice for therapeutic use if their in vivo ef-
fects, concerning cartilage, were identical with those in vitro. Howe-
ver, this choice strongly depends also on other (potential) harmful si-
de effects. Due to detrimental side effects, the promising drug benoxa-
profen was withdrawn from the market shortly after its introduction in 
1982. 
Data on in vivo drug effects on normal cartilage are more scanty and 
the results, as far as the data in Table 1 are concerned, do not always 
correspond with in vitro data. Like in vitro, also in vivo low doses of 
steroids tend to stimulate cartilage GAG synthesis (37), an effect not 
seen at higher doses (hydrocortisone-acetate and dexamethasone). 
It is striking that, as far as we know, no data exist on potential 
drug effects on in vivo basal cartilage GAG degradation, except those 
of de Vries et al (107). Only eight references were found on in vitro 
effects of drugs on degradation (Table 2). If both basal synthesis and 
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degradation are disturbed to the same extent by a drug, there would be 
no change in the integrity of cartilage, unless PG properties would be 
affected. Consequently, the data in Table 1, on their own, do not in-
form about any net effect on cartilage! 
It is of interest that no drug exerts an accelerating effect on the 
basal GAG degradation rate (Table 2). Some of these studies were per-
formed concomitantly with synthesis studies (Table 1) under almost 
identical conditions. These data are summarized in Table 3. Tentative 
conclusions can be made about a net effect of these drugs on basal car-
tilage PG content (increase/decrease). With the available in vitro data 
(Table 3), one would anticipate that tiaprofenic acid, piroxicam, so-
dium salicylate and perhaps fenoprofen are harmless to normal cartilage 
in vivo. However, sodium salicylate (107) was found to significantly 
suppress in vivo GAG synthesis in articular cartilage of healthy mice, 
without an effect on in vivo GAG degradation. Theoretically this would 
lead to PG depletion if healthy mice were treated chronically with this 
drug. Nevertheless, light microscopical observations revealed no chan-
ges in articular cartilage (stained for PG) after daily treatment for 
7.5 weeks (72, Chapter 6 and 8). In this particular case the results of 
Table 3. Net effect of antirheumatic drugs on the basal glycosaminogly-
can metabolism by normal cartilage cells in vitro. 
Antirheumatic 
drug 
GAG metabolism 
synthesis degradation 
Tentative 
conclusion: 
net effect 
PG-increase 
PG-increase 
PG-depletion 
No effect? 
No effect 
No effect 
PG-depletion 
No effect 
(Refe) 
(11) 
(74) 
(74) 
(74) 
(72) 
(38) 
(113) 
(72,108) 
Benoxaprofen 
Sulindac sulfide 
Ibuprofen 
Fenoprofen 
Tiaprofenic acid 
Piroxicam 
Chloroquine 
Sodium salicylate 
I increase, t decrease,—no change 
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short-term in vivo studies (inhibition of cartilage GAG synthesis) are 
not predictive for gross changes in cartilage after long-term drug 
treatment. Slight changes in proteoglycan quality cannot be excluded 
yet and are currently under investigation. No explanation for this dis-
crepancy is at hand, perhaps it has something to do with the reversibi-
lity of the described drug effects (72), another aspect often neglected 
in chondrocyte metabolic studies. Perhaps chondrocytes may also show 
adaptation upon long term drug treatment. 
Experimental studies on pathological cartilage. On the basis of the 
contradictory observations, no generalization can be made as to the 
potential role of ARDs in disturbing basal cartilage GAG metabolism. 
Furthermore, the experiments were performed on healthy cartilage, fre-
quently not of articular origin. The practice of medication with ARDs 
comprises human subjects with already more or less deteriorated articu-
lar cartilage. So it is more rational to investigate potential side ef-
fects of drugs under these conditions. Except for the group of Palmoski 
and Brandt (78) who observed an aggravated suppressive effect of sali-
cylate and indomethacin on the augmented PG synthesis of OA cartilage, 
no in vitro drug studies are done with (osteo)arhritic cartilage. In 
vivo some efforts have been made in experimental models of OA. However, 
in contrast to the findings in vitro, the altered in vivo PG synthesis 
in OA cartilage was not influenced by the administration of salicylate, 
Ibuprofen, sulindac sulfoxide, diclofenac or indomethacin (16,23,24). 
Apart from our study (Chapter 7) no reports exist about in vivo drug 
effects on the adversely affected PG metabolism in articular cartilage 
of animals with experimentally induced inflammatory arthritis. Long-
term drug studies with experimental animal models of OA and RA are of 
utmost relevance, since they resemble medical practice. Studies on this 
issue have been performed already for several years, however, again 
with conflicting results as far as the integrity of articular cartilage 
is concerned (Table 4). In experimental animal models of inflammatory 
arthritis, the attention, hitherto, was more directed to the antiin-
flammatory properties of ARDs than on potential chondrotropic proper-
ties. Except perhaps for glucocorticoids and immunosuppressives or dis-
ease modifiers like azathioprine and sulphasalazine, there are no clear 
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indications of any NSAID induced attennuation of cartilage erosions, 
caused by experimental joint inflammation (40-42). 
With all these data in mind we realize that it remains arduous to 
the physician to make conclusions about potential detrimental or bene­
ficial effects of particular ARDs towards human articular cartilage. 
These drug effects might be entirely determined by the kind of experi­
mental test system in use. The relevance and value of some test systems 
are doubtful but will not be evaluated apart; instead a general discus­
sion about this subject will follow. It will be confined particularly 
to the NSAIDs, drugs commonly used in antirheumatic therapy, and varia­
bles present in cartilage test-systems, both in vitro and in vivo, 
which might influence chondrocyte metabolic activity and perhaps drug 
susceptibility and which may lead to false conclusions. Owing to their 
potential predictive value and relative inexpensiveness, short-term 
studies are very important for the clinician as well as for the pharma­
ceutical industry, designing and developing new ARDs. Nevertheless, 
promising drugs should always be tested in vivo and preferably in ar­
thritis and arthrosis models. 
Table 4. Effect of long-term treatment (several weeks) with some NSAIDs 
on degenerative articular cartilage of experimental animal models. 
Antirheumatic Severity of cartilage erosion References 
drug 
increased unchanged reduced 
Salicylate 
Indomethacin 
Phenylbutazone 
Ibuprofen 
Piroxicam 
• ι 
• ι 
• I 
• i 
I · 
ι a 
ι · 
(11,19,25,2B,28a,96,116) 
(19,23,116) 
(19,116) 
(19,116) 
(19,61) 
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1.3 CARTILAGE TEST SYSTEMS: AN EVALUATION. 
1.3.1 CARTILAGE 
Cartilage is a tissue lacking most of the attributes of other body tis-
sues: it has no nerves, no blood vessels and no lymphatic system. It is 
a tissue whose properties are established not by the properties of its 
cells (chondrocytes), but by what the cells secrete: an elaborate net-
work of giant molecules the cells deposit around themselves to form an 
extracellular matrix. The matrix includes some of the largest proteins 
made by any cell in nature: proteoglycans. It also includes collagen 
and great volumes of water. These three major constituents determine 
the cartilage properties: tensile strength and resilience (17). 
Type and distribution of cartilage (5,17). There are three types of 
cartilage: fibrocartilage, elastic- and hyaline cartilage. The molecu-
lar structure of each type of cartilage governs its properties, needed 
for specialized functional requirements. They will briefly be discussed 
here with reference to Figure 1. 
Fibrocartilage (f) is found among others in the intervertebral disks 
and the interarticular disks of the knee joints (menisci). It also 
blends in with tendons and ligaments, particularly at their junction 
with bones. Compared to hyaline cartilage, it contains more collagen 
and less proteoglycans leading to higher tensile strength. 
Elastic cartilage (e) is found where more elasticity is required and 
predominates for example the cartilage of the auricle of the ear and 
the front of the rib cage; it contains a normal amount of collagenic 
fibers but has, in addition, elastic fibers. 
Hyaline cartilage (h) occurs in nearly all the fetal skeleton. La-
ter, in the growing body, the epiphyseal plates at the tips of bones 
are still composed of this type of cartilage. Throughout life, hyaline 
cartilage provides a covering for the ends of the bones that withstands 
compressive forces yet enables the bones to slip over each other 
smoothly. It is also found in the nose, larynx, trachea and bronchi. 
With the exception of the free surfaces of articular cartilage, hyaline 
cartilage is always invested by a perichondrium. 
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Figure 1. Some locations of three different types of 
cartilage in the humein skeleton, f = fibrocartilage; 
e = elastic cartilage; h = hyaline cartilage. 
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Cartilage source for drug studies. Several kinds of cartilage, often 
derived from different species, were used to study ARD effects on car­
tilage metabolism and properties (section 1.2). Regarding the age at 
which joint diseases occur, young and adult articular cartilage are 
most relevant for these studies. Experimental drug studies on fetal 
cartilage might serve to elucidate potential teratogenic effects, due 
to iatrogenic harm in pregnant rheumatoid patients (34,92). The compo­
sition and metabolism of articular cartilage will now be reviewed 
shortly. 
Articular cartilage proteoglycan. The major molecular components of 
articular cartilage - the molecules known to be responsible for the 
tensile strength and resilience of the tissue - are collagen and pro­
teoglycan. The collagen of articular cartilage differs from collagen of 
other interstitial connective tissues and is termed, type II. Because 
collagen metabolism is almost inert in normal adult cartilage, and con­
sidered not to be involved in early stages of joint disorders, this 
component will not be discussed here; see for review Lane and Weiss 
(56). 
Proteoglycan monomers (PCs) are constructed of a protein core to 
which large numbers of highly sulfated glycosaminoglycans (GAGs), term­
ed chondroitin sulfate (CS) and keratan sulfate (KS), are attached. 
These GAGs have variable chain lengths and, in addition with several 
types of short length oligosaccharides, are covalently bound to the 
protein core in a lateral way (Figure 2A). CS consists of repeating 
units of glucuronic acid and N-acetylgalactosamine. In the average 
chain of CS (MW 20,000) there are about 25-30 such disacchande units, 
and there is almost one sulfate group per disacchande. KS is more va­
riable than CS in both chain length (MW 5000-10,000) and in degree of 
sulfation. It does not contain uromc acid and is essentially build up 
of repeating disacchande units (about 13) of N-acetylglucosamine and 
galactose. The current model for cartilage PG has a central core pro­
tein to which about 100 CS and 50 KS chains are attached to yield an 
overall molecular weight of 1-4x106 daltons (Figure 2A). Bound to hya­
luronic acid (HA), another, non-sulfated GAG (MW 500,000), comprising 
1-5л of the cartilage content, very large aggregates are formed with 
21 
hyaluronote keratan 
binding sulphale-rKh 
region region 
chondroitin 
sulphate-rich 
region 
[link protein 
Figure 2A. Model of a proteoglycan monomer bound to hyaluronic acid. 
HA 
Figure 2B. Model of a proteogly-
can aggregate. PG = proteoglycan 
monomer; HA = hyaluronic acid. 
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molecular weights extending to 10 daltons (67). This interaction is 
stabilized by the additional, non-covalent, binding of link proteins to 
the PG and to HA (Figure 2B). 
PG-GAG synthesis: radioprecursor incorporation. The sulfated GAGs, CS 
and KS, are not formed if core protein synthesis is ceased. The core 
protein, shortly after its synthesis or during intracellular transport, 
serves as a primer on which GAG chain synthesis is initiated. An addi­
tional key step in the synthesis of PG-GAGs is the metabolic activation 
of inorganic sulfate prior to its incorporation into the growing carbo­
hydrate chain. Sulfate conjugation requires 3-posphoadenosine-5-phos-
phosulfate (PAPS) as an intermediate. The synthesis of PAPS proceeds 
via two steps: first, activation of sulfate to form adenosyl phospho-
sulfate (APS), catalyzed by ATP-sulfurylase, followed by phosphoryla­
tion to form PAPS, catalyzed by APS-kinase: 
1. 50ц + ATP — APS + PPi 
2. APS + ATP — • PAPS + ADP 
(ATP=adenosine triphosphate;AD=adenosine diphosphate;PPi=pyrophosphate) 
Recent studies with brachymorphic mice suggest that the availability of 
the sulfate donor PAPS may be the rate-limiting step in the sulfation 
process. Without disturbing GAG chain elongation, decreased sulfation 
can be achieved by a defect in ATP-sulfurylase or APS-kinase (100) as 
well as by a decreased supply or production of SOi, (69) or ATP (45, 
114); these latter events are induced by some antiinflammatory drugs 
(30,92,103,107, and Chapter 4). Since the sulfated GAGs are practically 
the only molecules in articular cartilage to which sulfate is attached 
(66) and sulfation proceeds concomitantly with GAG chain elongation, 
radiosulfate is an useful radioprecursor to study ultimate PG turnover 
in cartilage (see also Chapter 2). Of course, other radiolabeled pre-
• cursors can be used to study GAG chain metabolism (e.g. 3H-glucosamine, 
H-glucose, Η-acetate), as shown for CS and HA in Figure 3, but they 
are less specific for GAGs in that they also incorporate in other mole­
cules present in cartilage (e.g. glycoproteins). Moreover, in contrast 
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Plasma 
Membrane " • i S = = = i - Sulfate 
CHONDROCYTE 
Figure 3. Precursors to assess chondrocyte GAG metabolism. 
to SOi,, they have to proceed through a large intracellular hexosamine 
pool before they become incorporated into growing GAG chains, making 
their use for quantitative measurements less attractive (109). 
Pathological cartilage. In most joint disorders PG metabolism and 
properties are adversely affected whereas, at least in the early stages 
of the diseases, collagen remains relative intact. 
Osteoarthrosis or osteoarthritis (0A) is a disease of joints that 
leads to progressive deterioration of the articular cartilage. The fo-
cal nature of the characteristic 0A lesion and its localization in in-
dividual joints suggest that mechanical destruction of the articular 
cartilage is an essential pathological process in the development of 
0A, however systemic factors cannot be excluded (43). Several investi-
gators have detected a decrease in PG content and an increase in PG 
synthesis in 0A articular cartilage (58,90). The chondrocytes apparent-
ly attempt to replenish the PG depletion. Since the rate of degradation 
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of the PGs in OA cartilage exceeds their rate of synthesis, drugs which 
stimulate synthesis or retard degradation would perhaps be of benefit. 
Rheumatoid arthritis (RA), is a systemic disease with unknown etio-
logy. It is accompanied by severe destruction of articular cartilage. 
Studies made on carrageemn-, zymosan- or antigen-induced inflammatory 
arthritis in experimental animals (9,55,60), models exhibiting features 
of RA, demonstrated not only an accelerated breakdown of cartilage PGs 
but also a markedly reduced PG synthesis. These processes ultimately 
result in severe depletion of matrix PGs and might even lead to chon-
drocyte death (55). Probably, because suppressive factors remain pre-
sent in the joint fluid, chondrocytes are not able to restore the PG 
depleted matrix. 
Since the biochemical response of joint tissues is markedly diffe-
rent in RA and OA, drugs developed to treat the former are unlikely to 
be of benefit in the latter. 
1.3.2. EFFECTS OF DRUGS ON ARTICULAR CARTILAGE 
Drugs can exert their effects on cartilage in three ways (Figure 4): 
A. A direct effect by interfering with the chondrocyte metabolic machi-
nery i.e. disturbance of degradative and synthetic processes of pro-
teins, proteoglycans (PG) and glycosaminoglycans (GAG). Enzymes in-
volved in the degradative processes are probably present both within 
the chondrocyte and within the surrounding matrix and drug effects 
are expected at both sites. Direct drug effects can only be studied 
in vitro. In vivo, drugs may influence systemic factors, important 
for cartilage turnover (see below), making proper interpretation of 
mechanistic actions nearly impossible. 
B. An indirect effect by influencing (systemic) essential endogenous 
factors necessary for growth and development, or for maintaining op-
timal function of cartilage. For instance, supply of nutrients in 
its most broad sense (large molecules like proteins, carbohydrates, 
amino acids and small molecules like inorganic ions) and growth fac-
tors (vitamins, somatomedins) come into consideration. These studies 
can only be performed in vivo. 
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С. An indirect effect by affecting production, release or activity of 
inflammatory mediators which influence chondrocytes or merely attack 
the extracellular matrix. Inflammatory mediators influencing carti­
lage metabolism are, for instance, arachidonic acid metabolites 
(prostaglandins, leukotriens) cytokines (interleukins, tumor necro­
sis factor, catabolin), oxygen metabolites and proteolytic and sac-
charolytic enzymes. Drug studies on this subject can be done in vi­
tro (co-culture of cartilage with mediators, activated cells or in­
flamed tissue) as well as in vivo. In the latter case beneficial or 
deleterious effects of drugs cannot simply be ascribed to modulation 
of one mediator system. Of course in medical practice of patient 
treatment all 3 types of drug actions can play an important role. 
However, most experimental studies so far have mainly focused on ac­
tions A and С and surprisingly little attention has been payed to 
action B. Potential effects of drugs on nutrients and growth factors 
is a rather unexplored field in general and especially with respect 
to antiinflammatory drugs like the commonly used NSAIDs. 
Screening of the various drug effects on cartilage, as mentioned 
above can be undertaken in vitro as well as in vivo, and a combination 
is obviously most informative. Studies on synthesis and breakdown of 
cartilage constituents are mainly focused on proteoglycans rather than 
collagen. When drugs are screened in in vitro systems, usually short-
term experiments are performed and effects are quantitated using radio-
labels like S-sulfate or Η-glucosamine (see section 1.3.1 and Chap­
ter 2 ) . Such studies are aimed to unravel mechanistic actions of drugs. 
Long-term drug effects can be studied in vivo and radiolabel studies 
then have to be combined with histological and biochemical analysis 
(Chapter 3) of the overall composition and quality of the cartilage. 
In vitro screening 
Screening of direct drug effects on cartilage has been performed in a 
wide variety of culture systems and under variable conditions. Culture 
systems in use include: isolated chondrocytes (51,70,104) damaged car-
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tilage explants like disks and slices (11,52,64,112) and anatomically 
intact cartilage specimens like^ limb buds (17), femoral heads (106), 
whole metatarsal bones (77), whole femoral condyles (78) and whole pa-
tellae (108,109, Chapter 2). Proper evaluation of effects obtained is 
furthermore hampered by variables like age of the cartilage (112,113), 
anatomical location the specimen is taken from (11,77,113), and intrin-
sic species differences. For instance, salicylate mediated suppression 
of GAG synthesis appeared to be markedly higher in rat compared to mu-
rine patellar cartilage (own unpubl obs). Moreover, salicylate caused a 
clear suppressive effect in habitually unloaded cartilage, whereas it 
did not affect loaded cartilage (11 and Chapter 9). By far most studies 
are done with normal cartilage, some data were reported on cartilage 
from experimental osteoarthrosis (11), whereas until recently (Chapter 
7) no studies were done with arthritic cartilage. 
The magnitude of a chondrocyte response upon direct action of anti-
rheumatic drugs depends on the drug concentration ultimately reaching 
the cell as well as the chondrocyte susceptibility. Both variables are 
determined by environmental factors like extracellular matrix composi-
tion and culture conditions. Apart from already being affected in vivo 
by whatever cause (e.g. disease, trauma, degeneration, infection), car-
tilage, isolated from its natural environment, will ultimately possess 
chondrocytes with more or less deviations from their in vivo metabolic 
state due to: 
1. withdrawal from systemic or local factors influencing chondrocyte 
metabolism directly or indirectly (pressure and joint motion). 
2. disrupting or removing the cartilage matrix by making slices or iso-
lating chondrocytes respectively. 
3. keeping it alive in artificial culture conditions. 
Drug concentration. In vivo more than 80% of most drugs are bound to 
plasma proteins; unfortunately this circumstance is almost never met in 
in vitro culture systems. Nothing is known about potentially different 
effects of protein-bound drug over free drug. Anyway the amount of free 
drug concentration in the culture medium is determined by the amount of 
drug-binding substances, whatever they are. De Vries et al (108, Chap-
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ter 5) found a decrease in the degree of suppression of GAG synthesis 
in murine patellar cartilage if serum or albumin were put into the cul-
ture medium containing sodium salicylate, indicating that the free sa-
licylate concentration reaching the chondrocytes is decreased owing to 
protein binding. In this respect it is important to note that the sup-
pressive effect of therapeutic salicylate concentrations (10- - 2x10" 
M) was not obvious anymore in the presence of 25% serum, suggesting 
that salicylate will do no harm in vivo on healthy cartilage. Very low 
concentrations of salicylate and indomethacin are reported to even sti-
mulate chondrocyte GAG synthesis (21,108). These observations suggest 
that the two drugs in vivo will exert merely a slight stimulating ef-
fect instead of the opined suppressive influence on articular GAG syn-
thesis. Also the extracellular cartilage matrix on itself can influence 
the drug amount reaching the chondrocyte. Palmoski and Brandt (78) de-
monstrated that the uptake of salicylate and indomethacin was enhanced 
inside cartilage with decreased PG content. Consequently, isolated 
chondrocytes, devoid of any matrix, are exposed to much higher drug 
load than chondrocytes surrounded by a protective cartilage matrix. 
Chondrocyte susceptibility: influence of the culture medium. An impor-
tant factor in chondrocyte susceptibility is the composition of the 
culture medium. Besides the normal nutrients which can vary substan-
tially in between commercially available media, extra supplements like 
vitamins, growth factors, antibiotics, serun and synovial fluid may af-
fect chondrocyte function (Table 5). Moreover, additives like organic 
chemical solutes (e.g. ethanol, dmso, propylene glycol in which drugs 
sometimes are dissolved initially), supernatants from other cell, tis-
sue or organ cultures or products liberated by these cultures, when in-
troduced into the cartilage/chondrocyte culture system (co-culture), 
may lead to changes (reversible or irreversible) in chondrocyte metabo-
lism. Chondrocytes might ultimately even dedifferentiate to other cell 
phenotypes (e.g. fibroblasts) attended with altered properties (8). Al-
so factors like atmospheric composition (oxygen tension;15) mechanical 
and osmotic pressure schedules (44,52,93,97,104), temperature and incu-
bation time (113) can contribute to these changes. Sometimes a check on 
synthesis of collagen type II (a characteristic marker for hyalin arti-
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Table 5. Nutrients, factors and additives in culture medium, 
exerting a profound effect on chondrocyte GAG metabolism. 
Medium component References 
Serum + growth factors 
Conditioned mediun factor (CM) 
Oxygen tension 
Nutrients: 
Glucose 
D-glucosamine 
L-glutamine 
Serine 
Anorganic ions: 
НэО
4
- (=pH) 
Na+, K+, Mg 2 + 
Ca2+ 
Mn 2 + 
so; 
РОц 
Vitamins: 
A 
С 
E 
К 
Antibiotic: 
Actinomycin D 
Drug vehicles: 
Ethanol 
Propylene glycol 
Inflammatory mediators, like: 
Prostaglandins 
Catabolin/Interleukin I 
Tumor necrosis factor (TNF) 
Other lymphokines 
Proteases 
Hydrogen peroxide 
(3,80,83) 
(98) 
(15) 
(3,49,113,114) 
(50,106) 
(3,113) 
(3) 
(3,53,102) 
(3) 
(73) 
(65,94) 
(53,93,108) 
(53) 
(68,81) 
(53,83,95) 
(95) 
(54) 
(3) 
(21) 
(113) 
(52,59) 
(85) 
(88) 
(39) 
(7) 
(91) 
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cular cartilage chondrocytes) is used to "identify" the cell phenotype 
(8), but notwithstanding the production of the right cartilage matrix 
components, variable responses towards drugs might be expected depen­
ding on which of the above mentioned conditions is met. Remarkably lit­
tle investigations have been devoted to a possible relationship of 
chondrocyte metabolic condition and the magnitude of direct drug ef­
fects. Some data are available. For instance, we found substantial evi­
dence that there seems to exist a threshold sulfate concentration above 
which, the sulfate incorporation rate into chondrocytic GAGs is maximal 
(107,108, Chapter 4 and 5). Below this threshold, the suppressive ef­
fect of sodium salicylate on murine articular GAG synthesis signifi­
cantly increased as compared to the magnitude of suppression achieved 
at threshold sulfate concentrations. Ommission of sulfate from the me­
dium, often done to obtain high radiosulfate incorporation values upon 
labeling with carrier-free 50ц, even more enhanced the suppressive 
effect, mediated by salicylate (108). The sulfate threshold varies for 
cartilage expiants derived from different species and seems to corre­
spond with their physiological sulfate concentrations in the circula­
tion (69) i.e.: human, 0.3 mM (62,93), mice 1,0 mM (107), rat 0.8 mM 
(own obs), cow 1.2 mM (62). Аз far as we know our study is the only 
existing report, demonstrating a variation in chondrocyte susceptibili­
ty towards an antirheumatic drug, mediated by variation in the concen­
tration of only one nutrient in the culture medium. It would be of in­
terest to know if this phenomenon, described here for sulfate and the 
antirheumatic, salicylate, also exists for other nutrients and drugs. 
Another example of increased susceptibility is reported by Steinberg et 
al (99) who studied the effect of hydrocortisone on normal cartilage PG 
breakdown. They found that the greater the basal PG degradation rate, 
the more effectively it was inhibited by hydrocortisone, suggesting a 
higher susceptibility of the metabolically-changed chondrocytes to hy­
drocortisone. 
The action of antirheumatic drugs can be more complex but will also 
be more adequate by introducing in the culture medium (direct or via 
co-culture) substances with high potency in modulating chondrocyte me­
tabolic processes (e.g. hormones, cytokines, prostaglandins, vitamins; 
Table 5) or components possessing merely destructive properties, di-
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rected in first instance to the cartilage extracellular matrix (e.g. 
enzymes, reactive oxygen metabolites; Table 5). The affected chondro­
cytes can be rendered more susceptible towards drugs, but also the ac­
tion of these chondrocyte- and matrix affecting factors can be influ­
enced by antirheumatic drugs by inhibiting or just enhancing production 
or activity of these factors. An example, concerned with affected chon­
drocytes and higher susceptibility is found in the literature (51). Ar­
ticular chondrocytes, not sensitive to a relative low concentration of 
hydrocortisone (2.2 χ ΙΟ"6 M), obtained a reduced GAG synthetic activi­
ty after exposure to conditioned-synovium-medium. The decreased GAG 
synthesis in these affected chondrocytes was suppressed still more if 
θ 6 
hydrocortisone was present in concentrations of 2.2x10" -2.2.ХІ0" M. 
Chondrocyte susceptibility: influence of cartilage composition and 
chondrocyte function. It is not precisely known if and to what extent 
the composition and condition of the extracellular matrix, besides pro­
viding variable access of drugs to the chondrocytes, influences the me­
tabolic state of the chondrocytes and with it perhaps the degree of 
drug-susceptibility. In general a decrease in PG content will lead to 
an increased rate of PG synthesis (35). This situation was created in 
hyaluronidase treated canine cartilage slices (75); these slices demon­
strated higher vulnerability to the action of salicylate (suppression 
of GAG synthesis) than normal cartilage slices did. Of interest is 
that, whereas these latter cartilage slices were affected to some ex­
tent by a therapeutic salicylate concentration (10~ M), anatomically 
intact cartilage, from which the slices in question originated, did not 
respond to a similar salicylate exposure (11,78). Along this line an 
important observation was made with anatomically intact 0A cartilage 
and atrophic cartilage, isolated from experimental dogs with unilateral 
affected joints (78). Both cartilage specimens had matrixes depleted of 
PG to a comparable extent (Table 6), but GAG synthetic rate in 0A and 
atrophic cartilage was significantly increased and decreased, respec­
tively, as compared to control values (contralateral joint). Assuming 
an almost similar drug uptake by these cartilages, the only relevant 
aspect is a difference in chondrocyte metabolic state. Upon exposure of 
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Table 6. Effect of sodium salicylate (10" M) on articular cartilage in 
the presence of 10% serum.* 
100 
50 
65 
100 
100 
150 
50 
100 
100 
15 
40 
79 
(78) 
(78) 
(78) 
(75) 
Articular cartilage % PG % GAG synthesis Ref 
content control salicylate 
1. Anatomically intact, normal: 
2. Anatomically intact, 0A: 
3. Anatomically intact, atrophic: 
4. Slices of 1: 
5. Slices of 1, treated with 
hyaluronidase: 60 132 64 (75) 
•Taken from Palmoski and Brandt. 
these cartilages to therapeutic concentrations of salicylate (10~ M) 
or indomethacin (4 χ 10" M), GAG synthesis was suppressed profoundly 
in OA cartilage while only moderately in atrophic cartilage, indicating 
that 0A chondrocytes were more susceptible to these NSAIDs than "atro­
phic" chondrocytes. Recent data, however, suggest that this phenomenon 
is only apparent when the chondrocytes are embedded in their natural 
surrounding (affected) cartilage matrix, since differences in drug-sus­
ceptibility disappeared when isolated chondrocytes were examined (12). 
So it might be that the cartilage matrix, in whatever condition, is a 
potential factor in determining the susceptibility of chondrocytes to­
wards antirheumatics (Table 6). This knowledge is important for in vi­
tro studies and necessitates future research on this issue. 
The discussion above leaves us with a dilemma with respect to a pro­
per choice of a relevant in vitro system for drug screening. On the one 
hand it seems reasonable to perform short-term in vitro studies with 
anatomically intact cartilage. On the other hand long-term drug expo­
sure is more like the in vivo situation, but bears the substantial risk 
of culture induced changes of cartilage integrity and potential changes 
in chondrocyte susceptibility. 
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In vivo screening 
No doubt, in vivo drug studies are of utmost relevance to test an even-
tual harmful or beneficial effect on articular cartilage. In vitro 
methods can impossibly cover all in vivo facets influencing and regula-
ting chondrocyte metabolism, nor the pathophysiological processes pre-
sent in arthropathies. A number of comments made in the previous sec-
tion about chondrocyte susceptibility in vitro also apply to the in vi-
vo situation. Apart from direct effects on cartilage, drugs may exert 
indirect effects in vivo, by interfering with endogenous regulating 
factors and by suppressing the inflammatory process (see Figure 4). The 
further discussion will be mainly restricted to the last two items. 
Since experimental in vivo studies cannot be performed on healthy 
subjects or patients, at the least because of the lack of adequate con-
trols, experimental animals are needed. To avoid intenndividual dif-
ferences in outcomes, experiments are often performed with inbred 
strains. In this respect only small animals, like mice, rats, guinea 
pigs (and rabbits) are considered; sometimes dogs are used because 
their physiology is more comparable to humans. In addition, many expe-
rimental models exist of several kinds of arthropathies, resembling pa-
thological features found in rheumatoid patients. Frequently, these 
joint disorders can be induced in a reproducible way with predictive 
magnitudes of seventy and duration, allowing reliable drug studies in 
which articular cartilage is the main topic. The most convenient way to 
obtain information about in vivo drug effects on normal and pathologi-
cal cartilage is to work with experimental models with unilaterally in-
duced knee joint disorders, for example the antigen induced arthritis 
model (40,55) and the various experimental arthrosis models (19,23,61, 
77,96). The potential dual action of drugs in the antigen induced ar-
thritis model is depicted in Figure 5. As a consequence of joint in-
flammation, synthetic function of the chondrocyte is already suppressed 
(9) and relief of joint inflammation will indirectly have a beneficial 
effect on chondrocyte function. On the other hand, drugs may exert a 
direct harmful effect on the chondrocyte and this effect may potential-
ly be enhanced in already damaged cartilage (see in vitro screening 
section). The usefullness of a drug in the treatment of arthritis de-
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EFFECT OF ARDS ON ARTHRITIC CARTILAGE 
III 
INDIRECT 
III 
DIRECT 
ANTIGEN INDUCED ARTHRITIS 
99 m Tc-uptake -
arthritic knee 
normal knee 
5 30 day 
Severity of inflammation 
35 S-mcorporation • 
arthritic knee 
5 30 day 
Chondrocyte function 
Figure 5. The potential dual action of antirheumatic drugs. 
pends on its overall action, on both inflammation and cartilage. Upon 
drug treatment its effect can be screened by measuring the severity of 
the inflammation (99rlrlTc-uptake, 55) and the chondrocyte synthetic acti-
vity (radiolabel incorporation, section 1.3.1) either in vivo or ex vi-
vo. The latter method is less expensive in terms of radiolabel use, but 
may yield different results (see forecoming section about systemic drug 
effects and pitfalls). Upon long-term drug treatirent radiolabel studies 
have to be combined with biochemical analysis of the cartilage. When 
drug effects are not that impressive, electron microscopy has proven to 
be a valuable tool to detect alterations in chondrocyte function (4). 
Effect on endogenous regulating factors. Aside from effects on carti-
lage or the inflammatory process, drugs may directly influence the sup-
ply and turnover of endogenous factors like nutrients and hormones 
(Table 7A). Also along this line indirect effects have to be considered 
since inflammation may damage endogenous mediators (e.g. by oxygen ra-
dical attack) and antiinflammatory drugs may suppress this event. Our 
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Table 7A. Drug mediated disturbance in the supply or turnover of 
nutrients and hormones, affecting chondrocyte function in vivo. 
Drug Humoral factor References 
Glucocorticoids 
Sodiun salicylate* 
Salicylamide 
Paracetamol 
Calcitonin* 
Arteparon 
Vitamin A 
Tolbutamide 
Triiodothyronine 
Rape-seed oil* 
glucose, insulin, K + 
SO^ 
so; 
50ц 
S0¡;,P0Í,Ca2+ 
hydrocortisone 
so; 
so4 
so; 
so; 
(26,79) 
(92,107) 
(31) 
(69) 
(63,89) 
(13,32) 
(92) 
(92) 
(92) 
(92) 
*Sulfaturic effect. *Used as a drug vehicle. 
Table 7B. Some drugs, serving as substrate for sulfate conjugation. 
Drug References 
Salicylamide 
Flufenamic acid 
Paracetamol 
Phenylbutazone 
Oxyphenbutazone 
Prednisolone 
Cortisone 
Hydrocortisone 
Most corticosteroids 
Chloroquine diphosphate 
Hydroxychloroquine 
Most phenols 
Vitamin C, D 
(29,69) 
(10) 
(69) 
(10,29) 
(10) 
(29) 
(29) 
(10) 
(69) 
(10,29,30) 
(29) 
(69) 
(69) 
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interest wab especially drawn to effects of drugs on endogenous sulfate 
levels (Chapter 4 and 5). Chondrocyte synthesis of sulfated GAGs is 
highly dependent on the sulfate level (107) and our in vivo observa­
tions with salicylate point to interference at this level. Shortly af­
ter salicylate administration to mice a deep fall in endogenous sulfate 
was seen and this was probably responsible for the observed suppression 
of chondrocyte sulfated GAG synthesis (107,108). Some drugs may influ­
ence endogenous sulfate by a diuretic effect (Table 7A) or by serving 
as a substrate for sulfate conjugation (Table 7B). 
Famacokinetic of drugs. Drug concentration, exposure time, chondrocyte 
susceptibility and reversibility of drug effects all determine the mag­
nitude of a potential side effect of drugs on articular cartilage in 
vivo. The drug concentration reaching the chondrocyte is determined not 
only by the amount of drug binding substances in the circulation and 
composition of the cartilage matrix, but also by absorption and elimi­
nation kinetics. Consequently chondrocytes are exposed to a gradient of 
drug concentrations. Since some drugs may exert different effects at 
various concentrations this aspect must be born in mind with in vivo 
(radiolabel) studies. 
Pitfalls in experimental in vivo drug studies. Drug administration; To 
achieve the same therapeutic "window" of drug concentrations in plasma 
of man, corresponding with antiinflammatory properties, most animal 
species need different doses of a drug (mg/kg) compared to man, for 
their pharmacokinetics with respect to that drug differ (Table Θ). For 
instance, m mice 200 mg sodium salicylate per kg body weight was need­
ed to achieve temporary a plasma concentration of 1-2 χ 10" M salicy­
late (107), a therapeutic window for humans (57). In man this window is 
settled after intake of only 50 mg sodium salicylate/kg (31). This 
means that in mice some organs, dependent on the route of administra­
tion and the absorption- and elimination kinetics, are overloaded with 
this drug (e.g. stomach, liver, kidneys). Consequently, different from 
the human situation, a potential drug effect on articular cartilage in 
animals might be, more or less, attributable to indirect effects, 
exerted by the drug affected organs which, for example, disturb the 
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Table В. Doses of antirheumatic drugs in humans compared to those in 
mice.* 
man 
50 
6-9 
0.7-1.5 
0.4-1.4 
1.4 
0.1-0.6 
mouse 
200 
50-100 
1-9 
1-3 
15-50 
1-10 
mouse/man 
4 
8-11 
1.5-6 
2-2.5 
10-35 
10-17 
Antirheumatic drug Oral dose (mg/kg) 
Sodium salicylate 
Ibuprofen 
Flurbiprofen 
Indomethacin 
Phenylbutazone 
Prednisolone 
•Summarized from refs: 31,41,87,107,116. 
normal nutrient supply towards cartilage. 
Drug metabolites: Biotransformation of (pro)drugs (conjugation, hydro­
lysis) may be different in various species, and metabolites of drugs 
may be more or less potent than the original substance. 
Radiolabel studies: Optimally, one should like to be informed about the 
actual chondrocyte metabolic activity, at the moment of maximal drug 
effect. Short-term label studies (15 - 30 minutes) are most appropriate 
for this goal, but such experiments are very expensive and ungracious 
to the milieu (high amounts of radiolabel needed). Moreover, the time 
span of maximal effect after a single drug dose does not necessarily 
have to synchronize with that of maximal drug concentration. Usually, a 
2 - 24 h labeling period is chosen, starting at the same time or short­
ly after drug administration (10,16,107). When double-label studies are 
performed, e.g. to obtain information about effects on synthesis of GAG 
backbone ( C- or Η-glucosamine) and GAG sulfation ( S-sulfate), 
another problem is met. The incorporation kinetics of the two radiola-
bels are rather different, resulting in discrepancies in labeling in­
tensity of the two labels in just synthesized sulfated GAGs (50,109). 
This holds, of course, also for in vitro studies. 
Salicylate causes a drastic fall in endogenous sulfate shortly after 
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administration to mice and, dependent on the moment of S-sulfate 
injection, this may result in changes in the specific activity ( SO4/ 
50ц) in drug treated versus control animals. As a consequence S in­
corporation values must be corrected for these changes in specific ac­
tivity (36,107). It seems that numerous investigators (e.g. 16,85 and 
refs cited in 36) did not pay attention to this aspect in their in vivo 
S-sulfate studies. These problems, encountered with salicylate are of 
utmost relevance and should always be kept in mind when screening a new 
drug. 
Upon long-term drug treatment the proper choice of the time period 
to screen chondrocyte metabolic function is a matter of considerable 
debat. In our studies with mice (Chapter 8), the animals were treated 
with drugs one or two times a day (9 h a.m. and 6 h p.m.). At the end 
of a 4-8 weeks drug treatment one should like to be informed about the 
overall status of the chondrocyte and not about the effect related to 
the last drug dose. On the other hand, when the period between the last 
drug injection and administration of radiolabel is too long, relief of 
potential suppression may occur and the chondrocyte will try to restore 
the balance, resulting in an overshoot phenomenon. These latter issues 
are also involved in ex vivo studies, after drug treatment in vivo, 
(and might also occur in mere in vitro drug studies). 
Stress: Another practical problem encountered with (chronic) drug do­
sing to experimental animals is the potential stress caused by e.g. 
oral gavage. Recently, experiments were started to compare arthritis in 
"stressed" and resting animals but conclusive data are not yet avail­
able (Chapter 8). If stress leads to changes in steroid levels (6), the 
arthritis may already be suppressed to some extent thereby preventing 
potential beneficial effects of administered antiphlogistic drugs. 
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1.4 НОИ ТО PERFORM RELIABLE DRUG STUDIES 
Evaluation of the presented information leads to the conclusion that 
joint cartilage, and no other connective tissue, should be used to 
screen potential drug effects. Moreover it is necessary to examine also 
cartilage resembling arthrotic or arthritic cartilage, since during 
drug therapy we have to face pathological joint cartilage. Studies fo­
cused on chondrocyte metabolism should include anabolic as well as ca-
tabolic processes in addition to guality control of matrix consti­
tuents. 
Most reliable information ought to be revealed by in vivo studies, 
not the least because of drug-induced indirect effects on joint carti­
lage. Since one has the opportunity to make use of several relevant 
animal OA and RA models, antirheumatic drugs should be tested herein. 
Some investigators like Colombo et al (19), Maier and Wilhelmi (61), 
Hunneyball et al (40-42), and Palmoski and Brandt (77) already perform­
ed more or less long-term drug exposure studies in these kind of animal 
models. The advantage of short-term in vivo drug experiments is that 
they can give rapid information about drug modulation of cartilage PG 
metabolibm and properties. It should be a matter of future research to 
perfect these short-term studies, by preventing pitfalls like those 
mentioned above, to obtain an in vivo model with real predictive value 
concerning ultimate cartilage damage. Actually, results obtained with 
drugs in inbred strains should be reinvestigated in animals with more 
human-like physiology and (cartilage) properties (e.g. dogs), before 
any reliable conclusion can be made in respect to drug action towards 
human cartilage during medication. 
In vitro studies have the advantage of being relatively cheap, and 
may serve to elucidate a potential mechanism of drug action. With re­
gard to the many variables influencing chondrocyte metabolism (section 
1.3.2) and (perhaps) drug susceptibility, results should be interpreted 
with caution. Culture conditions resembling the physiological environ­
ment of joint cartilage of the animal strain in question are difficult 
to realize, but should be approached as much as possible. This holds 
also for co-cultures with other tissues. Culture medium with the same 
composition as the synovial fluid would already be a good alternative 
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for an in vivo condition. Furthermore, it is important to use drug con-
centrations in the range of therapeutic plasma values to avoid toxic 
effects. Chondrocytes should not be isolated because their "natural" 
drug susceptibility is probably changed compared to chondrocytes em-
bedded in the (pathological) cartilage matrix. This on its turn should 
preferably not be extra damaged by preparing slices or disks. Since the 
in vivo condition never can be met in vitro (e.g. absence of the right 
pressure rhythm, humoral regulating factors), articular chondrocytes 
might change their behaviour, and (perhaps) drug susceptibility, with 
increasing incubation time. Thus, short-term studies (hrs), immediately 
performed after isolation of fresh expiants of anatomically intact 
joint cartilage, are most informative. If under these conditions a real 
effect, harmless or harmful, of drug on animal cartilage is evident it 
should at least be reexamined, in vitro, on human (pathological) carti-
lage. 
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1.5 AIM OF THE PRESENT INVESTIGATION 
The main purpose of our study has been to elucidate the potential side 
effects of NSAIDs on articular cartilage. The first Chapters (2,3) deal 
with optimizing a screening system for effects of drugs on articular 
cartilage GAG metabolism. In Chapter 2 the suitability of various ra-
diolabels is shown for the measurement of GAG synthesis and its sulfa-
tion in murine patellar cartilage. In Chapter 3 a sensitive method is 
described to enable sulfate determinations in small serum and cartilage 
samples. 
Acetylsalicylic acid (aspirin) is in many contries the NSAID of 
choice in the management of rheumatoid arthritis. In these contries the 
use of newer NSAIDs is only justified if they are demonstrably more ef-
fective, less toxic or better tolerated than aspirin. This drug is con-
sidered as the prototype of NSAIDs and used in many experimental drug 
studies as a reference drug. Our studies of drug effects on cartilage 
were also started with salicylate, both in vivo (Chapter 4) and in vi-
tro (Chapter 5). A comparative study with tiaprofenic acid is described 
in Chapter 6. Since drugs are normally given to QA or RA patients who 
have already damaged cartilage, the following Chapter (7) was aimed to 
elucidate differences in drug-susceptibility of normal, artificially 
damaged, and arthritic cartilage. This was performed both in vitro and 
in vivo using short-term drug exposure. Finally, long-term drug effects 
were determined in an animal model of rheumatoid arthritis, namely an-
tigen-induced arthritis (Chapter 8). Since this study has not been com-
pleted yet, tentative results are only briefly discussed. 
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Summary. We investigated the usefulness of the whole 
mouse patella to quantitale the synthesis of the glycos­
aminoglycan (GAG) backbone and its sulfation by intact 
munne articular cartilage both in vitro and in vivo Using 
"S-sulfate 'H-glucosamine or 3H-acetate as precursors of 
GAG synthesis it was found that more than 90% of the 
incorporated radioactivity was confined to the patellar 
cartilage laver compared to the »hole patella Overnight 
papain digestion was enough to liberate more than 95% of 
the incorporated radiolabcls except for 3 Η-acetate for 
which 15-25% was not digestable Comparison of radio 
activity in the patella and that in quantitattvelv isolated 
GAGs revealed that for 3 S S sulfate incorporation studies 
the whole patella can be used as a reliable measure for 
sulfated GAG synthesis The situation was different for the 
GAG backbone precursors 'H-glucosamine and 3 H 
acetate more than 50% of the 3 H labels were incorporated 
into compounds other than GAGs or non covalently 
associated with matnx components Hence in studying 
GAG-backbone metabolism polysaccharides must be iso­
lated quantitatively from cartilage In vivo studies made it 
clear that both 3 ! S-sulfate and 3H-glucosamine are in 
corporated into patellar GAGs in amounts high enough to 
enable proper quantitation and that the route of adminis­
tration (intraperiloneally or intravenously) is of minor 
importance Due to its low specificilv for cartilage GAGs, 
3
 H-acetale is not suitable for such studies 
Key words Articular cartilage - Glycosaminoglvcans 
3 5
 b-sulfale 3 H-glucosamine - 3 H-acetate 
Introduction 
The metabolism of articular cartilage glycosamino 
glycans (GAGs) can be studied using various radiolabels 
3 5
 S-sulfate is the one most frequently used as precursor of 
GAGs 11-4] Strictly speaking this radiolabel only gives 
information about the sulfate metabolism of sulfated 
GAGs This seems of importance since it has previously 
been shown that the synthesis of the GAG polysaccharide 
chain and its sulfation are uncoupled phenomena [5] Un 
coupling can be demonstrated using low sulfate concentra­
tions [6 7] Recent observations from our laboratory 
suggest that the same phenomena may occur during drug 
treatment of mice Salicylate was shown to induce a 
signilicanl depletion of endogenous sulfate resulting in a 
low serum sulfale concentration and this was held respon 
siblc for the observed decrease in synthesis of sullated 
GAGs [8 9] 
Another important point which deserves attention is 
the intaclness of the articular cartilage matrix Many 
in vitro studies arc performed with cartilage slices ι e 
damaged cartilage to investigate the effects of inflamma-
tory mediators or drugs Upon cultivating these cartilages 
tend to loose proteoglycans (PGs) mainly at the sliced 
sides [10 11] Since it has been shown that drugs exert a 
greater effect on chondrocytes in a PG depleted matrix 
[12] it is necessary to investigate undamaged cartilage in 
these kinds of studies Reccnth an easy and fast cartilage 
assay was developed in our laboratory 113 15] using the 
patella of the mouse as a source of anatomically intact 
articular cartilage The usefulness of this assav has been 
demonstrated for 3 S S-sulfate and it has been used in 
several mediator studies [8 16 18] In the present in» 
vestigation we extend the suitability ol this assay by 
showing that both GAG backbone synthesis and Us sulfa 
Hon can reliably be quantitated in vitro as well as in vivo 
Materials and methods 
Animals Male 6-8 week old C57B110 mice in good health and 
ranging in weight from 20 25 g were used The animals were 
maintained on a commercial pellet diet lap walcr was provided 
ad libitum 
In \itro studies Mice were sacrificed using ether anesthesia fol 
lowed by cervical dislocation Whole palellac with a standard 
amount of surrounding ussue were dissecltd from the knee joints 
and assayed as described bv van den Berg ci al [13] In brief they 
were placed in RPMI culture medium (200 μΐ/palella) conlaming 
- in addition to the usual ingredients (How laboratories Irvine 
Scotland) - genlamvcin (SOng/ml) and L glutamine (2 mM) 
Hepes as well as bicarbonate (ratio 1 1) served as buffer in 
53 
maintaining tht pH л 7 4 After a preincubdtion penod of 2 h at 
Ή Τ under S'? C 0 2 atmosphere the patella sptumens were 
transferred to fresh medium with χν,ο ndioaciivc GAG precursors 
(each 20 uCi/ml) and intubation was continued for an additional 
2 h Double label expenments were carried out with \ d j ' s S 0 4 
(ICi/mmol) and D 6 ' H glucosamine hydrochloride (40Ci/ 
mmol) or the sodium salt of ï H acetate (300 mCi/mmol) (all 
purchased Irom Radiochemical Centre Amtrsham LK) 
Fffect4ofc\clohe\irn¡de salmlaie andox\gen meiaboUia Csclo 
hcximide and sodium salicvlaie known inhibitors ol protein and 
GAG s\nthesis respcciL\el\ [8 19] were used for in vitro studies 
These drugs were present during the whole incubation penod (i e 
2 h preincubation followed bv 2 h label incorporation) 
Oxygen derived melabohtes (superoxide anion and hydrogen 
peroxide) were generated b\ a xanlhine xanthine oxidase 
(XaXaOx) system and palella specimens were exposed to 
XaXaOx for 45 min as recently described [17] SubsequentU these 
patella specimens were washed and radiolabeled as described 
above 
In wvo studies Groups of mice were injected intravenously 
or intrapentoneallv with , SS and 3H labels simultancously 
Na i "S04 (50 m( i/mmol 2 nCi/g) and J H glucosamine 
(8μ(Γΐ/^) or 3 H accutc (8 μ Ο ^ ) 3 Η specific activity as staled 
above Radioactivity was liken up in 0 15 M NaC 1 and ad 
ministered at ΙΟμΙ/g bodv weight to the animals At various time 
intervals аПег injection of radiolabel mice were sacrificed and 
whole patellae with surroundinc tissue were removed and ana 
lyzed Blood samples (ΙΟμΙ) obtained from the tail vein were 
taken at difierent times after radiolabel adminisiration and Ivscd 
in 0 5 mJ of water 
Autoradiography Radiolabeled patella specimens fixed in 109c 
formalin and decalcified in 51 formic acid were embedded in 
paraffin Seven μπι sections were prepared and mounted on 
gelatin coated slides These were dipped in K5 emulsion (Ilford 
Basildon hsscx LK) and exposed for 3 weeks Slides were 
developed and stained with hematoxylin and eosin (Hb) 
Isolation of whole patellae In vitro or in vivo radiolabeled patella 
specimens were washed in 0 15 M NaCI (twice 10 min) lixed for 
I h in 10% formalin ( p H 7 0> supplemented with 0 2% cetyl 
pvridimum chloride and decalcified overnight in fixative sa 
turated with Na 2 EDTA Some patella specimens then were 
treated with acetone (or 1 h in order to remove fattv substances 
Finally all tissues were transferred to formalin again In everv 
step 3 ml liquid was used per patella This procedure removed all 
unbound radiolabel and in addition enabled the whole anatomi 
callv intact patella to be punched out easily from the surrounding 
tissue Both the punched out patellae and the (issues left behind 
were anaKzed for radioaclivitv content (sec below) 
Ічоіапоп of patellar cartilage To remove the cartilage layer quan 
titativelv from the underlying bone patella specimens were fixed 
in ethanol (96^) instead of formalin for at least 1 hour followed 
bv decalcification in 5У formic icid overnight ITIL patellae were 
punched out from the adherent tissue and placed under a stereo 
microscope Using twee/ers the whole cartilage layer could be 
stripped off quantitatively from the subchondral bone as was 
confirmed by histology 
Isolation of ghcosaminoglycans Λ papain mixture (pH 6 0) a 
modification ofthat described by Adams and Muir [20] consisting 
of 1 mg/ml papain (Merck Darmstadt FRG) 0 2 M NaCI 0 1 M 
Na acetate 10 mM L cvsleine hydrochloride 50 mM Na 2 LDTA 
and 50 μg GAG carrier/ml (chondroitin 6 sulfate chondroitin 4 
sulfate h\aluronic acid™3 3 1) was used to digest formalin 
fixed whole patellae (200 μΐ/patella) at 60 o C overnight Ln 
digested patellar remnants were spun down To Ι50μ1 superna 
tant of papain digest was added 150 μ! 0 2% cetvlpyndinium 
chloride (CPC) After 2 h at 37 0 C the precipitate (CPC GAG 
complexes) was ccntnluged at 10 000 g for 30 mm at room 
temperature The supernatant was discarded and the pellet was 
treated once with 300 μΐ 0 05% CPC to remove small amounts of 
adherent radioactivity 
Measurement of radioaamn Whole patellae extra patellar 
tissues cartilage layers as well as CPC GAG complexes were 
solubilized overnight in 500 μΐ Solulyte (J Γ Baker Chemicals 
Deventer The Nelherl inds) at 60 0 C and subsequcntlv taken up 
in 10ml Lipofiuor scintillation fluid (J Τ Baker Chemicals) The 
water Ivsed radioactive blood samples were mixed with 10 ml 
Aqualuma plus (I umac/3M Schaesberg fhe Netherlands) 
Tritium and 3 S S radioactivity were counted in a liquid 
scintillation spectrometer (Philips PW 4700) ί1 Η window 
0 4 8ke\ " S window 15 160 keV) The channel overlap from 
the " S to the 3 H channel was about \5% and reversed it was 
about 1% Appropriate corrections were made for these overlaps 
Fhere was no need for quench correction since tissues and С PC 
GAG complexes had the same quenching as measured by auto 
matic external standardization Blood samples on the other hand 
had a constant shift owing to quenching as compared with the 
other samples Radioactive contents were expressed as counts per 
minute (cpm) 
Results 
Measurement of GAG wnthesiì m patellar cartilage Whole 
patel lae with su r round ing tissue were incuba ted with 3 5 S 
sulfate Ή g lucosamine a n d J H acelate as precursors of 
G A G s The incorpora t ion pa t te rns in the var ious struc 
turcs of the patella spec imen were d e t e r m i n e d with a u t o 
rad iography C o m p a r e d with the non labeled patella in 
Fig 1 clear black granules a b o v e the pate l lar cart i lage 
were seen with all three radiolabcls (Figs 2 4) Hardly 
any radioactivity was found in the under ly ing b o n e a n d 
b o n e m a r r o w cells N o t e the absence of epiphysea l car 
lilage in the patella R a d i o l a b e l was also found in t h e 
pate l lar plate a n d at the insert ion sites of l i g a m e n t o u s 
structures a t tached to the patel lar b o n e Significant 
a m o u n t s of 3 H g lucosamine a n d 3 H acetate were also 
found in the s u r r o u n d i n g connect ive tissue a n d t h e lat ter 
in part icular in fat tissue Quant i ta t ive d a t a on the part i 
Поп of the various labels over the patella a n d the sur 
r o u n d i n g tissue a re shown in Table 1 
In a d d i t i o n we separated the carti lage laver from the 
under ly ing b o n e of the patella F o r all three radiolabcls 
m o r e than 90% of the r a d i o a t t m l y i o u n d in the whole 
patella a p p e a r e d to b e confined to this cart i lage layer 
(Table 1) This indicates that the radioactive c o n t e n t of the 
patella can be used as a rel iable m e a s u r e for the a m o u n t 
of radioactivity in the carti lage at least for the labels in 
quest ion 
To d e t e r m i n e t h e a m o u n t of radiolabel incorpora ted 
into G A G s isolated pate l lae were first digested with 
p a p a i n followed by precipi tat ion of the rad io labe l with 
c e t y l p y n d m i u m chlor ide ( C P C ) Overnight p a p a i n diges 
tion a p p e a r e d to be sufficient to release m o r e than 9 5 ^ of 
3 S S a n d 3 H glucosamine b u t 15-25% ' H acetate r e m a i n e d 
associated with undigested pate l lar r e m n a n t s Near lv all 
the incorpora ted 3 5 S-sulfate (94%) could be precipi ta ted 
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Fig. 1. Section of a mouse patella surrounded by connective tissue. Notice 
the absence of epiphyseal cartilage X 40. Ill staining с = cartilage. 
b = bone. bm=: bone marrow. p p = patellar plate. 1 = ligament. f= lat tissue 
m ^muscle 
Fig. 2A. B. Autoradiograph of a section ot a patella .specimen labeled with 
35S-sulfate in vitro Hh staining Abbreviations as in Fig. I 
A Cartilage and the patellar plate (cartilaginous, extra-patellar tissue) con­
tain incorporated radioactivity h a r d l y any incorporation is detectable in 
other tissue structures x4(). 
В Detail ol "S-labeled patella. X400 Notice the heavily labeled chondro­
cytes in the cartilage and the absence oí label in subchondral bone (s) and 
bone marrow 
••ν 
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Table 1. Incorporation of radiolabel in patella specimens 
Radiola be! Patella 
(cpm) 
Tissue 
(cpm) 
Patella/tissue Cartilage/patella' (%) 
"S-sulfale 
^-glucnsamine 
ïH-acetate 
1 659 ±274' 
906 ± 92 
I618±205 
2 252± 552 
6 875+ 1818 
60 151 ±19 109 
42 
12 
3 
99 
92 
1
 Patella specimens, from a separate experiment, were fixed in ethanol and dcuikified in 5% formic acid Cartilage 
was removed completely from the subchondral bone and radio-content was compared with that of similarly 
treated, whole patellae 
h
 Values represent the mean ± SD for six mice 
ьь 
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Fig. ЗА, Β. Autoradiograph of a section of a patella specimen labeled with 3H-glucosamine in vitro HE staining Abbreviations as in 
Fig I A Label is almost exclusively present ш cartilage, X40 В Detail of JH-glucosamme-labeled patella. X400 Besides labeling in the 
chondrocytes some radioactivity is incorporated in bone marrow cells 
Fig. 4A, B. Autoradiograph of a section of a patella specimen labeled with 'H-acetate in vitro HE staining Abbreviations as in Fig I 
A A substantial amount is incorporated ш the chondrocytes, but label is also found in fat tissue attached to the ligament and in the 
synovial lining (arrow). X40 В Detail of a îH-acetate labeled patella, x400 The cartilage chondrocytes are clearly labeled and almost 
no radioactivity is present m the subchondral bone (s) and bone marrow 
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Table 2. incorporation of radiolabel ш whole patellae and isolated patellar GAGs Effeu ofcydo-
heximide* 
Radiolabel 
"S-sulfate 
IH-glucosamme 
JH-acetate 
'H-acetate 
(degreased) 
Cycloheximide 
(0 1 mM) 
+ 
+ 
+ 
+ 
Patella 
(cpm) 
15951344 
101+ 9 (6"f)b 
9531198 
4 7 2 1 89(50¥) 
i 7531344 
1 5651391 (84ct) 
1 3051324 
9071118(74? ) 
GAGs 
(cpm) 
1 5041286 
9 1 1 11 ( 6 Ï ) 
4571 61 
5 1 1 10(11?) 
З О Н 53 
2 2 1 9 {Ti) 
3231 75 
2 4 1 5 0%) 
GAGs/palella 
( ? ) 
94 
48 
17 
25 
Data represent the mean 1 SD t)f patellae obtained from five mice 
Percentage of cpm incorporated in cvclohcximidc-treated patellae compared with controls 
with CPC. whereas for 'H-glucosamine and 'H-acetate the 
precipitable radioactivity appeared to be much lower 
(Table 2). 
Since autoradiography revealed that large amounts of 
'H-acetate were incorporated in fat tissue (fig 5) and the 
cartilage matrix and chondrocytes also contain fatty sub­
stances. we performed an additional experiment using 
acetone pretreatment Double-labeling with "S-sulfate 
demonstrated that this procedure had no effect on the 
digestion efTiciency and precipitation of GAGs. De-
greasmg wdh acetone had only a small effect on the 
amount of'H-acelate retained in whole patellae (Table 2): 
the amount of precipitable label (GAGs) remained un­
changed 
Table 2 further shows the effect of cycloheximide on 
label incorporation. Initiation of proteoglycan-GAG syn­
thesis has been described as protein-core dependent [21] 
and almost complete inhibition by cycloheximide 
(0.1 mM) was found for the CPC-precipitable material, in 
contrast to minor effects on the bulk of 'H-label incor­
porated in the patellar cartilage In addition. CPC preci­
pitations were performed under various ionic strengths 
Compared to the amount of radioactivity precipitated at 
0 15 M NaCl. the standard salt concentration used 
throughout this study, about 95% of JH-labeled material 
was still precipitable between 0.2 M and 0.8 M NaCl. Sig­
nificantly less precipitation (less than 50%) of both 3 H-
and "S-labeled material occurred at 0.95 M NaCl. This 
pattern of ionic strength dependence indicates that "S-sul­
fate and the majority of the 'H-label arc incorporated in 
sulfated GAGs and that, probably because of a low 
metabolic turnover rate, hyaluronic acid does not play an 
important role in these label studies 
Effect of oxygen metabolites and salicylate. Patellae were 
exposed to a xanthine-xanthine oxidase (XaXaOx) system 
or sodium salicylate followed by incubation with " S -
sulfate and ^-glucosamine (double-label) The incorpora­
tion of'H-glucosamine into the whole patella or isolated 
GAGs was inhibited to the same extent by XaXaOx treat-
f 'Vf 
Ί 'i 
• ''Wt'' ' 
Jm*. • . I e f 
Fig. 5. Autoradiograph of a section of extra-patellar fat tissue 
labeled with 3H-acctate. X250 Fat tissue (0 attached to the hga-
mentum patellae (1) contains 3H-aclivity. whereas label is almost 
absent ш the ligament 
ment (Ы% and 59% respectively: Table 3) indicating that 
oxygen metabolites impaired the overall synthetic activity 
of the patellar chondrocytes. Salicylate, however, appeared 
to selectively suppress the chondrocyte GAG synthesis. 
The incorporation of !H-glucosamine in the whole patella 
was hardly affected, in contrast to the clear inhibition 
found with isolated GAGs (Table 3). No differences were 
observed between the decreased amounts of " S incor­
porated in the whole patella or isolated GAGs 
Glycosaminoglycan synthesis in vivo. To investigate the use­
fulness of the three radtolabels for in vivo incorporation 
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Table 3 Effects üfüxvgen mLlaholites and salicylate on the шюгриглюп rale оГ г idiülabd in »hole 
patellae and in isohtcd OAOs' 
Radiolabel Analv/ed Control 
(cpm) 
XaXaOx* 
|cpm) 
SodSal 
(cpm) 
"S sulfate 
Ή glucosamine 
Paiellae 
OAOs 
Paiellae 
GAOs 
I S29Ï234 
Ι 435-Μ18 
102S+180 
467 ± 88 
785 ±198 (5 If)" 
696 ±216 (491) 
6 3 3 ± l 3 l ( 6 2 r f ) 
276 ± 66(591) 
1
 Values represent the mean ± SD of patellae obtained from six mice 
* \aXaOx = xanthine xanihine oxidase oxvgcn metabolites generating svsicm 
SodSal = sodium salicvlatc See Materials and methods for details 
'' Percentage of control 
534+102(35'?) 
551+126(381) 
840+114(821) 
274+ 58(591) 
Table 4 Incorporated radiolabcl 2 h after intravenous ad 
mimstralion ol "S sullalc Ml glucosamine ind'HaccLatt' 
Radiolabcl Dose Palella GAGs OAOs/ 
(цС i/g) (cpm) (cpm) patella 
(1) 
"S sullale 
3H glucosamine 
Ή acetate 
388±31 369±57 95 
1233 ±82 321164 26 
267 + 59 33± 9 12 
С pm values represent the mean ' SD for five mice 
studies mice were injected with high doses of the various 
labels either intrapcntoncalK (ι ρ ) or intravenouslv (iv ) 
Table 4 shows the incorporation values in patellae at 2 h 
after ι ν administration 
Both " S sulfate and Ή glucosamine seem suitable for 
studvmg sulfated GAG and GAG backbone synthesis The 
absolute amount of 3 H acetate recovered in isolated patel­
lar GAGs is however loo low The ratio between the 
incorporated amount ol Ή label in the isolated GAGs 
and in the whole palella as observed in vitro (Table 2) 
was reduced in vivo (Table 4) The incorporation kinetics 
ol I 5 S sulfate and 'H-glucosammc are shown ш big 6 for 
ι ρ administration of the labels Maximal incorporation 
was airead) achieved at 2 h for 'H glucosamine whereas 
for 5!S-sulfate a significant increase was still observable 
beiween 2 and 4 h The blood kinetics are shown in Fig 7 
The " S blood values steadily decreased after 15 30 mm 
while the 3 H values clearlv increased after 30 mm These 
phenomena were seen both after ι ρ (Fig 7 A) and iv 
(Fig 7B) administration Although small dilTcrences exist 
in the blood kinetics of the labels after ι ρ or ι ν 
administration m particular in the first 15 min no large 
differences were found in the amounts of radiolabcl in­
corporated in patellar GAGs 
Discussion 
Cartilage GAGs except hvaluronic acid are the polv 
saccharide chains of proieoglvcans immense molecules 
which together with collagen and water constitute the 
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Fig 6 Sulfur 35 saliate and 3H glucosamine contents of whole 
patellae and of isolated patellar OAGs at differenl points of lime 
after intraperitoneal administration ol 2 цС ι "S sulfate and 8 цСі 
Ml glucosamine per gram bodv weight Dala represent the mean 
+ SD from groups of five mice · = Inlium content in whole pa 
tcllae =1H contení in GAGs isolated from contralateral pa 
lellae A =35S content in whole patellae * = "S content in GAGs 
isolated from contralateral patellae 
cartilage ground substance GAGs are also present though 
lo a lesser extent in bone and bone marrow structures 
also present in the patella The average metabolic turnover 
in these structures is however much lower compared to 
cartilage as the results of this study clearlv show that after 
exposure of patellae to "S-sulfale Ή glucosamine or 
'H acelate these radiolabels almost exclusively incor 
porate into the articular cartilage lavcr of (he patella 
(Figs 2-4 Table 2) 
Isolation of GAGs by means of CPC precipitation of 
papain digested cartilage is a well known standard 
method [22] The almost complete recovery of " S label in 
CPC-precipitates derived from papain digests of " S 
labeled patellae indicates lhat patellar GAGs can be 
isolated quantitatively in this way 
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Flg. 7 А, В. Sulfur-35-sulfale and 'H-glucosamine contents in 10 μ| hlood samples obtained at various limes afler administration οΓ2μΓι 
"S-sulfale and 8 μΟ 'H-glucosamine per gram body weigh! Data represent the mean ± SD of blood samples obtained from five mice 
A Blood kinetics after intraperitoneal injection В After intravenous injection 
Degreasing cartilage prior to protease digestion is 
thought to be belter for GAG release from matrix proteo­
glycans 123] Except that the wash out of'H-acctale from 
the patella specimens was much faster with acetone as 
degreasing agent than with aqueous solutions we found 
no ditTerence in the ultimate 'H-GAG yield Neither the 
wash out of 'H-glucosamine or "S-sulfate nor the yield of 
GAGs marked with these radiolabels. was affected by 
acetone treatment 
We have no information about the overall GAG com­
position in murine patellar cartilage According to the 
definitions of Scott [22] about effects of ionic strengths. 
nearly all the radiolabel in CPC-complexes of GAGs 
isolated from the patella represented sulfated glycos-
ammoglycans. whereas the contribution of 'H-labeled 
hyaluronic acid (HA) was less than 5% If cycloheximide is 
added to the patella culture system the incorporated radio­
activity in CPC-complexes is much decreased (above 90%) 
This indicates that GAGs were precipitated since synthesis 
of GAGs, except HA, was shown to be protein synthesis-
dependent [21, 24] Moreover, because the turnover rate of 
HA is not influenced by cycloheximide [25] its formation 
can be neglected as judged by the low 'H-mcorporation 
in the presence of this drug Above all, these observations 
demonstrate that simple dilTusion of label becoming 
attached to precipilable GAGs can be ruled out 
Sulfur 35-sulfale appeared to be highly specific for 
sulfated GAGs. since other cartilage constituents - not 
precipilable with CPC after papain digestion - were not 
significanti) labeled with "S-sulfale. as can be concluded 
from the data in Table 2 In contrast, JH-glucosamine a 
precursor for glucosamine as well as galactosamine con­
taining GAGs [26, 27], and 'H-acelate are less specific in 
that they also incorporate in biomolecules other than articu­
lar GAGs (ι e CPC-precipilable material) or are bound 
non-en¿ymatically lo matrix components Less than 50^ 
of the radiocontent of the whole, punched-oul palella was 
associated with GAGs (Table 2) The lower specificity for 
GAGs is also illustrated by the relatively high uptake of 
the latter two radiolabels in non-cartilaginous extra-patel-
lar tissue (Table 1 and bigs 3, 4) Since glucosamine is 
known to be a characteristic constituent of glycoproteins 
[28] and acetate is the starting material for the synthesis of 
many biomolecules the above observations are not un-
expected 
Presumably a substantial fraction of the amount of 
3H-glucosamine and 'H-acetale present in the cartilage of 
a radiolabeled patella, is incorporated in (he large UDP-
N-atelylhexosamme pool of the chondrocyles. a pool wiih 
a slow turnover rate through which the radiotracers have 
to pass before they can enter the GAG backbone chain 
[29] Apart from the incorporation of the Ή labels in non-
GAG compounds, the presence of such a pool, which is 
probably difficult to wash out [6] also stresses the need for 
papain digestion followed by GAG precipitation On the 
other hand, "S-sulfatc is very rapidly conjugated to the 
GAGs of proteoglycans via the intracellular 3'-phos-
phoadenosine-5'-phosphosulfate (PAPS) pool, which has a 
high turnover rate and, moreover, was found to be present 
in very small amounts [29] From this point of view there 
is no need lo isolale sulfated GAGs Almost all the " S 
label in cartilage is theoretically expected to be incorpo­
rated into GAGs. as in fact is found with our patella assay 
These considerations further demonstrate that if radio-
labeling is performed with a double label ( " S and ^H) it 
is important to make allowance for the differences in 
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incorporation kinetics when studving proteoglycan mctab 
olism As outlined 3,S-sulfatc is incorporated almost 
immediatek in sulfated GAGs whereas ^i-glucosaminc 
incorporation proceeds with a time lag [29 30] Therefore 
uncertainly exists whether incorporation of 3 H and " S 
takes place in the same GAG molecules and moreover 
information is lacking about the specific activities o f ' H 
GAGs [26] Ibis knowledge would be of value in studies of 
undersulfation ol GAGs (see below) 
Fxamming the inhibitorv effects of SodSal on in vitro 
GAG synthesis revealed that " S incorporation in isolated 
GAGs as well as in the whole patella obviously is more 
suppressed than the incorporation ofMI-glucosamine into 
patellar GAGs (Table3) This phenomenon has been 
observed by us in previous studies [31] and is also reported 
to occur in other connective tissues [32 33] We feel that 
detailed analyses of the GAGs in question should be 
performed before conclusions can be drawn about under­
sulfation It is furthermore shown bv our experiments that 
short-term exposure to oxygen metabolites impairs the 
overall patellar chondrocyte synthetic activity to a sig­
nificant degree Not only is GAG synthesis aflected but 
also the svnlhesis of UDP-N-acetvlhexosammes seemed 
impaired since 3 H glucosamine uptake in the whole 
patella was equallv suppressed as the 3 H incorporation 
into isolated GAGs ( lable 3) 
In vivo G\G synthesis was investigated by measuring 
the amount of incorporated radiolabel injected ι ν or ι ρ 
Comparing the data in Table 4 with those of Fig 6 
demonstrates that the amount of incorporated radio-
activitv in patellae is hardly influenced bv the route of 
label administration Trmated-acetate appeared to be un­
suitable for in vivo studies since onlv a very small fraction 
(33 cpm) of the high dose given (8 μ Γ ^ ) was incorporated 
ш patellar GAGs We do not know whether this low 
uptake is due to a relalively low specific activity of J H 
acetate ultimately reaching the articular chondrocytes 
Maximum labeling was already found 30 mm after i y 
injection (data nol shown) 
The kinetics of incorporation of ι ρ administrated " S 
sulfate and 'H-glucosamine in whole patellae and m 
quantitatively isolated patellar GAGs were examined over 
a period of 4 h Ader 2 h maximum incorporation of ^H-
glucosamine into patellar GAGs was achieved whereas 
3sS-sulfate incorporation still continued to increase As 
shown in vitro, "S-sulfale incorporation in the whole 
patella behaves in a similar way to the incorporation in 
patellar GAGs indicating that on both occasions J ! S is 
associated with the same molecular entities Of note the 
ratio of Ή labeled GAGs over 'H-labeled patellae 
appeared to decrease with time We have no explanation 
for this phenomenon The Ή blood content increased 
during the exposure lime of mice to this label ad 
ministrated i p or ι ν (Fig 7 A B) Since maximum in­
corporation of ι ρ ^-glucosamine was found at 2 h the 
high amounts of Ή label found in the blood between 2 
and 4 h cannot represent 'H-glucosamine These observa­
tions are consistent with the findings of Shetlar et al [34] 
who studied the fate of ι ρ administered " С glucosamine 
in the rat Maximum "C-contenl in the serum appeared 
3 h after injection and represented 24? of the total 
injected dose However already within 2 h as little as 1% 
of the original injected dose represented still free 1 4 C -
glucosamme The increasing "C-conlent was attributable 
to labeled serum glycoproteins produced by the liver 
Apparently a similar situation exists in the mouse As 
determined in recent studies [8] 3 ! S sulfate in serum 
represented more than 95% inorganic sulfate over the 
whole period studied 
Finally we also did some preliminary experiments 
with 3H-glucose another cheap and frequently used GAG-
precursor which not only incorporates into hexosamines 
but also into the uronic acid moieties of GAGs In vitro 
incorporation characteristics much resembled those of 3 H-
acetale (data not shown) Since the incorporation kinetics 
of glucose into GAGs is still more complicated as is 
reported for glucosamine [26] we did not make further use 
of this label 
In summary 35S-sulfate is a good precursor for quanti­
tative studies on the sulfation of sulfated GAGs Isolation of 
"S-GAGs is not necessary since the radiosullate content 
of the anatomically intact patella appeared to be ex 
clusively associated with sulfated GAGs in the cartilage 
On the other hand 3 H glucosamine proved to be a suitable 
label lor GAG backbone metabolism both in vitro and 
in vivo Unfortunately this precursor is not specilically in­
corporated into GAGs and hence quantitative isolation of 
GAGs is required Because there is no epiphyseal cartilage 
present in the patella this assav is particularly convenient 
for metabolic studies on articular and moreover anatomi­
cally intact cartilage There is no need to quantitale the 
content of cartilage constituents or determine tissue 
weights as routinely done in most assays Whether or not 
GAGs are isolated results can simply be expressed as 
radioactivity content per whole patella 
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DETERMINATION OF SMALL QUANTITIES OF SULFATE (0-12 tmol) IN SERUM, 
URINE AND CARTILAGE OF THE MOUSE 
ABSTRACT 
Using disposable 96 well-microplates instead oF individual cuvettes the 
colorimetrie benzidine method oF Dodgson and Spencer (1953) For the 
measurement of inorganic sulfate, could be scaled down about 100 times. 
Ten μΐ samples of serum and urine, derived from mice, could be analysed 
in a simple, rapid and reliable way without the need to sacrifice the 
animals. Without prior isolation of sulFated glycosaminoglycans, ester 
sulfate in mouse patellar cartilage was liberated quantitatively as 
inorganic sul Fate upon acid hydrolysis in 3 M HCl For 16 h at 80 0 C . To 
this end the articular cartilage layer of the patella had to be sepa­
rated in toto from the underlying bone. Subsequent hydrolysis in poly­
propylene tubes gave accurate results. In contrast hydrolysis in boro-
silicate glass vials turned out to be useless, since nanomoles sul Fate 
added could not be recovered adequately. The thin patellar cartilage 
layer obtained from male mice, 10 weeks of age, contains about 5 nmol 
sulfate, an amount easily measured with the developed microplate benzi­
dine method. 
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INTRODUCTION 
Certain drugs are known to have an effect on the sulfate contents of 
mouse serum, urine and cartilage. Recently we obtained evidence that 
sodium salicylate, administered to mice, decreased inorganic serum sul­
fate levels to such an extent that the concurrently observed inhibition 
of sulfated glycosaminoglycan synthesis in patellar cartilage could be 
related to this(1). In this particular study a turbidimetric method was 
used (2) for the determination of inorganic sulfate in serum and 
urine. Although sulfate measurements were satisfactory, mice had to be 
killed in order to obtain enough serum (150-500 μΐ) for analysis. To be 
able to study serun sulfate kinetics and ester sulfate contents in car­
tilage of animals as small as mice, there was a need for a quick and 
easy sulfate assay with a low detection limit. We did not succeed to 
scale down the turbidimetric method, originally described by Berglund 
and Sorbo (3) and thereafter modified by others (2,4). A number of 
other, highly sensitive methods are reported (detection limits<20 nmol 
ЗОц), based on different techniques (5-13). However, none of them ap­
peared useful to us since they either are too laborious, gave no repro­
ducible results or make use of expensive analytical instruments not 
present at our laboratory. We herein describe the application of a 
scaled down version of the spectrophotometric benzidine method as re­
ported by Dodgson and Spencer (14). Using disposable ELISA microplates 
instead of cuvettes large numbers of samples containing small amounts 
of sulfate can readily be measured. Special attention is paid to the 
acid hydrolysis of cartilage, necessary to measure the ester sulfate 
content. The modified assay appeared simple, rapid, reliable and prac­
tical for our research purposes, (e.g. only 10 μΐ serum is needed for 
sulfate analysis). 
MATERIALS AM) »CTHODS 
Samples. Serum and urine were obtained from C57B110 male mice, about 10 
weeks of age. Prior to analysis urine was always diluted 50 times with 
deionized and distilled water. Articular cartilage was obtained from 
mouse patellae. To be able to remove the cartilage layer quantitatively 
from the underlying bone, ethanol {96%) fixed (> 1 hr) patellae, with 
still adjacent surrounding tissue, were decalcified in 55ó formic acid 
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overnight. After punching the whole patellae out of the adherent tis­
sue, the wet, intact cartilage layer could be stripped of from the sub­
chondral bone using a stereomicroscope and forceps (see Figure 5 and 
6). 
Sulfate deteraination method. All solutions were handled and made in 
plastic (usually polypropylene or polystyrene), disposable labware; de-
lonized and distilled water was used throughout the analytical proce­
dure. Procedure: 10 or 15 μΐ aliquots of serum or diluted urine are 
placed m Eppendorf microtubes (0.5 ml) with or without 5 μΐ deionized 
water respectively, and 60 μΐ 6.25 % trichloroacetic acid (TCA; Merck, 
Darmstadt, FRG), a protein precipitating agent not affecting inorganic 
sulfate (15), is added (final concentration 5 % ) . The tube contents are 
centnfugated for 15 minutes at 10,000 χ g. Supernatants are subse­
quently analysed. Fifty μΐ aliquots of standard solutions (0-0.24 mM 
N3250^ in 5 % TCA), supernatants or 5 Ж TCA solutions of dried carti­
lage hydrolysates (see below) are placed in Eppendorf microtubes (1.5 
ml). Hundred and twenty-five μΐ of benzidine reagent (0.5 % benzidine 
in 96 % ethanol; Sigma, St Louis, USA) is added and the mixture is al­
lowed to stand 1 hour at -20 0 C followed by centnfugation at 4 0C for 
30 minutes at 10,000 χ g. The supernatant is carefully decanted and 
discarded; 450 μΐ aceton-ethanol (1:1) is added followed by recentrifu-
gation. After again careful décantation (draining by inverting tubes) 
mouths of the mirotubes are wiped with tissue paper to remove last tra-
ces of aceton-ethanol (all free benzidine must be removed1). The preci-
pitate (benzidine-sulfate) is dissolved in 75 μΐ 1 M HCl and allowed to 
stand 30 minutes at room temperature. Benzidine is diazotized by the 
addition of 75 μΐ 0.033 M NaN02. After 5 minutes, 125 μΐ thymol reagent 
(0.5 % thymol in 2 M NaOH; Merck, Darmstadt, FRG) is added and a red 
coloured product, stable for at least 4 hour, will appear. Extinction 
of 100 μΐ volumes is read at 492 nm in polystyrene ELISA microtiter 
plates, consisting of 96 U-shaped wells (Greiner, Nürtingen, FRG), with 
a Titertek Multiscan Spectrophotometer (Flow laboratories, Irvine, 
Scotland). Sulfate concentrations are calculated from a standard curve. 
Hydrolysis of cartilage. Patellar cartilage layers were hydrolysed m 3 
M HCl (100 μΐ/cartilage layer) in closed polypropylene microtubes (1.5 
ml) for 4-72 hour at 80 0 C . Hydrolysates were dried under vacuun and 
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taken up in 60 μΐ 5 % TCA. Fifty μΐ aliquots were analysed for sulfate 
content as described above. 
Recovery experiments. Serum and urine, were depleted from 50ц and sub­
sequently reconstituted with МвгЗОі, to test recovery. Upon exact deter­
mination of the inorganic sulfate concentration in pools of serin and 
diluted urine, with an established turbidimetric method (2), stoichio­
metric amounts of ВаСІ2 were added. ВаЗОц precipitate was allowed to 
form at 4 0C overnight and subsequently removed by centri fugation at 
10,000 χ g for 30 minutes at 4 0 C . With this procedure the sulfate con­
centration decreased to below 0.1 mM, but was still detectable with our 
modified benzidine method indicating that no free Ba++ was present. 
Preceeding to the sulfate recovery experiments known amounts of N8250^ 
were added to the BaClj-treated fluids; in the case of cartilage, 
МагЗОц was added to 3 M HCl prior to hydrolysis. For S recovery stu­
dies, patellae were labeled in vitro with SO^ conform a described me­
thod (16). 
Gag depleted cartilage. To obtain cartilage with decreased GAG contents 
some patellae, still embedded in surrounding tissue, were treated with 
trypsin (1 mg/ml RPMI 1640 medium) for two hours, or patellae were de­
rived from zymosan induced arthritic mice (17). GAG contents were esti­
mated with a dimethylmethylene blue dye-binding assay as described by 
Farndale et al. (1θ). 
Statistical analysis. Correlation curves were fit by the least-squares 
method, and, where appropriate, mean data were compared by a two-tailed 
Student's t-test. 
RESULTS 
Analysis of standard sulfate solutions. Since there always was some 
difference (<5й) in optical density between the individual (empty) 
wells of a microplate, the absorbance of the red coloured thymol conju­
gate was taken as the mean of readings in two wells. The whole micro-
plate (96 wells with 100 μΐ each) could be measured within one minute 
by a multiscan spectrophotometer. A typical standard curve for diffe­
rent amounts of inorganic sulfate, as measured with the scaled down 
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standard curve 
y: 0.185* 5.78χ 
г: 0-997 
0.05 0.10 0.15 0.20 
mM SO¡ (¡η 50 μΙ TCA) 
Figure 1. Relationship between the absorbance (492 nm) of the thymol-
conjugate product, measured in indidual wells of a 96-well microplate, 
and the sulfate concentration in 50 μΐ samples containing 5% TCA. Line 
of best fit is shown, calculated from 10 sulfate determinations. Cor­
relation is significant. Each value represents the mean ± SD of three 
measurements. 
69 
benzidine method in microplates, is shown in Figure 1. Lineair correla­
tion of concentration (0-0.24 mM) and absorbance (492 nm) was obtained 
with standard samples of 50 μΐ in which TCA was present in a final con­
centration of 5 S (w/v); the absolute amount of measured sulfate ranged 
from 0-12 nmol. Since, as a contaminant, a small amount of sulfate is 
present in the TCA, we currently use, the regression line in Figure 1 
does not pass through the origin. Measurement of sulfate in distilled 
water containing various amounts of Ма250ц by the benzidine method cor­
related well with the results found by the established turbidimetric 
assay, in which B a + + ions are used as sulfate precipitating agents (Fi­
gure 2 ) . About 3S of the original sample volume (500 μ ΐ ) , needed for 
the turbidimetric method (2), suffices the benzidine method. The first 
method could not be scaled-down by using microplates, since the turbi­
dity could not be measured adequately in the micro wells. 
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Figure 2. Correlation between results of sulfate determinations in 6 
water samples by the microplate benzidine method and the established 
turbidimetric method. The regression line depicted is not significantly 
different from the line of identity. 
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Recovery of added sulfate from serun and urine. Preceeding to analysis 
of endogenous sulfate in normal serum and urine we investigated the re­
covery of added sulfate to test the reliability of the benzidine method 
for such body fluid samples. To this end mouse serum and urine were 
treated with ВаСІ2 to remove specifically inorganic sulfate (see the 
Materials 4 Methods section). In this way, except for sulfate, the com­
position of these biological fluids remains almost unaffected. Since it 
was already known that mouse serum and urine contained approximately 1 
mM and 50 mM SQi, respectively, serun and urine samples (the latter al­
ways diluted 50 times) were reconstituted with МагЗОц to obtain sulfate 
concentrations in the range of 0 - 1.2 mM. As can be seen in Figure 3 
for serum as well as in Figure 4 for diluted urine, recovery of added 
inorganic sulfate from 10 μΐ samples was complete. These results indi­
cate that constituents, normally present in serum and urine, do not 
disturb the measurement of sulfate by our benzidine method. To illu­
strate applications of this analytical method, small amounts (10 μΐ) of 
serim and diluted urine, obtained from mice, were analysed for inorga­
nic sulfate content (Table 1). Also the effects of sodium salicylate 
and paracetamol on the serin sulfate concentration in mice were tested. 
In addition, serum and saliva, obtained from healthy humans, and serum 
and synovial fluid from rheumatoid arthritis patients were analyzed 
(Table 1). The measured sulfate concentration in normal mouse (1.04 mM) 
and human serum (0.33 mM) are identical with formerly reported values. 
Saliva, apparently, has the same sulfate concentration as is found in 
serum. In rheumatoid arthritis patients the serun and synovial fluid 
sulfate concentrations were essentially identical and did not differ 
from serun values obtained from healthy subjects. The antirheumatic 
drugs these patients took, at different times before sample collection, 
apparently had no effect on the sulfate level. Sodiun salicylate as 
well as paracetamol significantly decreased the sulfate concentration 
in mice, a phenomenon also described by others using different sulfate 
detection methods. The very high sulfate concentration in urine was al­
ready corroborated by analysis with the turbidimetnc method we former­
ly used. 
Ester sulfate content in patellar cartilage. The relative huge amount 
of sulfate in cartilage tissue is covalently bound as ester sulfate to 
glycosammoglycans and to a negligible extent to other matrix molecu-
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,—RECOVERY OF SULFATE FROM SERUM—, 
0 5 
Added sullate (mM) 
10 
Figure 3. Recovery of inorganic sulfate added to sulfate depleted mouse 
serum. The regression line, calculated from 10 sulfate determinations, 
has a slope not significantly different from unity. 
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Figure 4, Recovery of 50ц added to sulfate depleted and diluted (50 ti­
mes) mouse urine. The regression line, calculated from 10 sulfate de­
terminations, has a slope not significantly different from unity. 
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Table 1. Inorganic sulfate in serum, synovial fluid, saliva and urine^. 
Species 
Mice 
Humans 
Healthy*: 
RA^: 
Sample 
Serum 
Serum 
Serum 
Urine 
Serum 
Saliva 
Serum 
Synovial fluid 
Treatment 
_ 
sodium salicylate 
paracetamol 
-
-
-
antirheumatics 
mM SO,, (mean+SD) 
1.04 ± 0.05 
0.62 ± О.О Г* 
0.65 ± 0.1Ϊ* 
44.1 ± 6.0 
0.33 ± 0.05 
0.31 ± 0.10 
0.303 ± 0.030 
0.295 + 0.008 
(n) 0 
(6) 
(6) 
(6) 
(6) 
(20) 
(20) 
(5) 
(5) 
§ Sulfate assay applied on 10 μΐ samples; prior to analysis urine was 
diluted 50 times with deionized and distilled water. 
0
 η = number of samples obtained from η mice or humans. 
# Samples were taken 4 hours after oral administration of 200 mg of 
each drug per kg body weight. p<0.001 as compared to serum values of 
untreated mice. 
* Samples obtained from human volunteers, 20-35 years of age and of 
either sex. Saliva was collected 15 minutes after subjects had tho­
roughly rinsed their mouths with tap water. 
Δ Samples obtained from 5 patients suffering from definite rheumatoid 
arthritis (RA), 42-61 years of age and of either sex. These patients 
were regularly taking a number of concurrent medications, but none of 
these were drugs known to be disturbing sulfate levels. 
les. Mostly acid hydrolysis is performed upon which the liberated inor­
ganic sulfate can be guantitated. We applied this procedure to articu­
lar cartilage and bone derived from the mouse patella. Ethanol as fixa­
tive and 5S formic acid as décalcifier enabled excellent separation of 
first the whole patella from the natural surrounding tissue (Figure 5) 
and second the guantitative separation of the cartilage layer from the 
underlying bone (Figure 6). Acid hydrolysis of these patella specimens, 
performed in disposable borosilicate glass vials (2 ml) with teflon-
lined (srew-) caps, gave some problems. Vials purchased from several 
suppliers (e.g. Wheaton, Chrompack, Pierce) leaked variable amounts of 
absorbing material (2-5 nmol sulfate eguivalents) whereas those from 
another supplier (ATS) just diminished the amount of (added) inorganic 
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Figure 5. Safranin 0 staining of a section of a mouse patella embedded 
in natural surrounding tissue. Only the cartilage layer, covering the 
patellar articular side, with some processes penetrating the underlying 
subchondral bone (arrows) is stained, indicating that no other cartila­
ginous tissue is present in the patella. Original magnification 40 x. с 
= cartilage; b = bone; bm = bone marrow; pp = patellar plate (cartila­
ginous, extra-patellar tissue). 
Figure 6. Safranin 0 staining of a section of a quantitatively removed 
cartilage layer from a mouse patella (see Figure 5), embedded in liver 
tissue (L). For male mice, 10 weeks of age, the estimated, average car­
tilage thickness is 0.1 mm and its (wet) weight about 80 μg; inorganic 
sulfate release, after acid hydrolysis, is circa 5 nmol (Table 4). Ori-
ginial magnification 100 x. 
sulfate (nmol range) as ultimately measured by 492 nm scanning of mi-
croplates (Table 2). These phenomena were seen with acids (3 M HCl and 
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Table 2. Recovery of inorganic sulfate added to 3 M HCl after standing 
overnight at 110 0 C in borosilicate glass vials from several suppliers. 
Sample 
(100 μΐ) 
3 M HCl 
Distilled, 
Added SO4 
(nmol) 
0 
2 
4 
6 
deiomzed wati 
Wheaton 
2.7 ± 3.9 
nd 
7.5 ± 3.5 
9.θ ± 3.0 
вг nd 
Fc lund SOi, -eguivalents 
Chrompack 
4.5 ± 1.9 
7.θ ± 1.2 
9.5 ± 2.5 
11.1 ± 1.8 
2.1 ± 0.9 
(nmol)* 
ATS 
0 
nd 
1.3 ± 0.6 
4.1 ± 1.6 
nd 
Results represent the mean ± SD of six to ten sulfate analysis; nd 
not determined. 
5л ТСА) as well as with water and both at elevated (110 0C) and mode­
rate temperatures (about 60 0 C ) . Conseguently, after hydrolysis (>60o 
C) in borosilicate glass vials, measurement of small quantities of es­
ter sulfate such as present in the cartilage of one mouse patella («5 
nmol; see below) cannot be performed adequately. Polypropylene Eppen-
dorf microtubes (1.5 ml) can be heated overnight at 80 0 C without sig­
nificant evaporation of 3 M HCl. We tried to use these tubes for acid 
hydrolysis experiments. Recovery of added sulfate was complete and suf­
ficiently accurate (coefficient of variance <152S) from 3 M HCl with and 
without patellar cartilage layers (Figure 7). 
Examination of the time of hydrolysis needed to liberate maximal a-
mounts of inorganic sulfate revealed that 16 hours seems enough for the 
cartilage layer and patellar bone (Table 3). Since the sulfate content 
in bone accounted for about 20% of that of the whole patella, cartilage 
should be separated from bone prior to analysis. 
To be sure that the whole content of glycosammoglycan (GAG) sulfate 
in the patellar cartilage could actually be liberated as inorganic sul­
fate by acid hydrolysis, additional experiments were performed. Normal 
and GAG-depleted patellae were analysed for GAG contents, estimated as 
described (18) and expressed in chondroitin 4-sulfate units, and ester-
sulfate contents, measured with our version of the benzidine method. 
Trypsin treatment resulted in a similar loss (41 %) of both sulfate and 
GAGs (Table 4). Also patellae derived from mice with 3 day-lasting zy-
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r-HYDROLYSIS: RECOVERY OF ADDED SULFATE 
Added sulfate (nmol) 
Figure 7. Recovery of S0 4 added to 100 μΐ 3 M HCL with or without a pa­
tellar cartilage layer. Inorganic sulfate analysis was performed, after 
24 h at 0оС in closed polypropylene microtubes, on evaporated hydroly-
sates. Regression lines, calculated from the mean results of 6 sulfate 
determinations are shown. Correlation is significant. Data represent 
the mean ± SD of 5 to 6 samples. Coefficient of variance (SD/mean) was 
always below 15л. 
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Table 3. Inorganic sulfate liberated from patellar bone and car­
tilage after various hydrolysis times in 3 M HCl at 80 0 C * . 
Hydrolysis time nmol 50ц liberated^ 
(hours) 
cartilage bone 
U 3.22 ± 0.77* 0.59 ± 0.30 
16 4.B0 + 0.79 0.94 ± 0.48 
24 4.49 ± 0.86 0.98 + 0.68 
72 4.66 ± 0.47 1.04 ± 0.51 
* Hydrolysis performed in polypropylene Eppendorf tubes. 
» Results are expressed as the mean ± SD of patella specimens 
obtained from 5 mice. 
* p<0.02 as compared to the amounts of liberated sulfate from 
cartilage at later time. 
Table 4. Sulfate and GAG contents in cartilage derived from normal, 
trypsin treated and arthritic patellae. 
Patella samples^ Contents per cartilage layer* (SO^/GAG)0 
nmol SO,, (%) μq GAG {%) 
Normal patellae 4.58 ± 0.60 (100%) 2.26 ± 0.34 (1008) (19.5) 
Arthritic patellae 3.77 ± 0.52 (82»)·* 1.70 ± 0.18 (758)" (21.0) 
Trypsin treated 2.71 + 0.15 (595;)" 1.34 ± 0.34 (59Х)* (19.4) 
patellae 
Δ See materials and methods section. 
* Results are expressed as the mean ± SD of cartilages obtained from 7 
mice. 
0
 Percentual ratio calculated on weight basis. 
* Values are significantly lower than normal values (p<0.02). 
mosan induced arthritis, demonstrated equal declines in contents of or­
ganic sulfate and cartilage GAGs (20-25 %). These observations indicate 
that sulfate is firmly associated with the quantitatively removed GAGs. 
Since the S04/GAG ratios seem not affected (Table 4), the GAG sulfation 
degree in cartilage is probably not significantly changed by trypsin 
treatment or by inflammation. Finally, experiments done with SO^-la-
beled patella revealed that the S content in cartilage layers, known 
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to be fully associated with GAGs, did not significantly differ from the 
amount of S found in benzidine- 50ц precipitates, obtained from a-
cid hydrolysed cartilages (24 h schedule). Thus there is substantial 
evidence that virtually all ester sulfate can be released as inorganic 
sulfate upon acid hydrolysis. 
DISCUSSION 
Application of microplates instead of cuvettes enables, besides rapid 
screening, absorbance measurements of small volumes. 100 μΐ/well is ge­
nerally sufficient to read the absorbance in a 96-well microplate. With 
respect to the original benzidine method (14) much smaller sample volu­
mes (10 μΐ versus 1 ml) can be analysed for inorganic sulfate. Although 
the sensitivity is not improved (the optical system of a ELISA plate 
reader is of inferior quality compared to most spectrophotometers), the 
detection limit is scaled down about 100 times. Nowedays many laborato­
ries possess these ELISA plate multiscans and are familiar with them. 
So, our version of the benzidine method can easily be introduced in 
contrast to other existing, very sensitive sulfate assays for which in­
struments are needed which are often not present or are too expensive 
to purchase (6,7,9,12). 
In our hands the microplate benzidine method is satisfactory. Re­
sults correlate well with the established turbidimetric method (2). The 
sulfate contents can reliably be measured in 10 μΐ serum, 10 μΐ diluted 
urine and in cartilage obtained from one mouse knee cap. Sulfate levels 
found in mouse and human serum, are in agreement with data reported in 
several recent publications (9,12,15,19,20). Since only as little as 10 
μΐ mouse serum is needed for analysis, serun sulfate levels in indivi­
dual mice can be followed in time; blood sampling at the sacrifice of 
mice, as was formerly done, is not necessary anymore. Influences of 
factors like drugs, diet, stress (1,2,21,22) on serum sulfate kinetics 
can now be studied in individual small experimental animals in a rela­
tively easy and rapid manner. As an example sodium salicylate and para­
cetamol, analgesics commonly used by many people, were demonstrated to 
decrease serum sulfate in mice. In addition, with our microassay, spe­
cific activities of serum S-sulfate can be followed, important for in 
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vivo S-sulfate incorporation studies (1). The higher concentration of 
inorganic sulfate found in mouse urine as compared to that of serum (a-
bout 30-50 times) was also observed by others in humans (4,13) and rats 
(23). Of course, due to these high urine sulfate levels other establis-
hed macro methods are suitable as well to guantitate urine sulfate in 
small experimental animals. 
Sulfate analysis in human saliva revealed no significant difference 
in sulfate concentration in comparison with human serum. However, re-
cent studies on saliva sulfate analysis (24) gave another picture; the 
sulfate levels (0.07 mM) were much lower than in matched serun samples 
(0.3 mM). Sample collection and preparation of saliva prior to sulfate 
analysis (by controlled-flow anion chromatography) differed from our 
method and, perhaps, could explain this discrepancy. Irrespective of 
medication, serin and synovial fluid of 5 rheumatoid arthritis patients 
had similar sulfate concentrations, not different from normal serum va-
lues. 
Reproducable determination of ester sulfate in the range of 0-12 
nmol turned out to be impossible when acid hydrolysis is performed in 
disposable borosilicate glass vials (2 ml). Heating with acid or even 
with ordinairy water caused release of benzidine precipitating material 
out of vials purchased from several suppliers, whereas in vials obtain-
ed from another supplier sulfate was just absorbing away1 These gains 
or losses in sulfate equivalents were quite variable (2-5 nmol), obser-
ved either at 110 0C or 60 0C and even persisted after extensive treat-
ment with chromosulfunc acid followed by exhaustive rinsing with dis-
tilled, deiomzed water. Suchlike problems were also reported by other 
investigators developing sulfate assays (25,26). 
Fortunately, no such complications were encountered with disposable 
polypropylene Eppendorf tubes (1.5 ml), provided that they were heated 
not higher than 100 0 C . No "sulfate" leakage or absorbance was observ-
ed, and recovery of added sulfate was complete (Figure 7). Sixteen 
hours hydrolysis in 3 M HCl at 80 0C appeared to be sufficient to libe-
rate a maximal amount of inorganic sulfate. Here, also, added sulfate 
was completely recovered (Figure 7) indicating that this procedure is a 
reliable one. 
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Since a considerable amount of 50ц was detected in hydrolysed patel­
lar bone (up to 20% of the cartilage layer) this part of the patella 
has to be removed in order to quantitate the cartilage sulfate content. 
Routinely, chondrocyte metabolic activity is quantitated by radiolabel 
incorporation using the whole, undamaged patella as a source of anato­
mically intact cartilage. To this end the patella is removed from the 
natural surrounding tissue, after formalin fixation and EDTA decalcifi­
cation (16). However, such a procedure seems not suitable for inorganic 
sulfate determination, since quantitative removal of the cartilage lay­
er is hardly possible from formalin fixed patellae. Ethanol (96%) fixa­
tion followed by decalcification in formic acid (5%) enabled easy and 
quantitative separation of the cartilage layer from subchondral bone. 
In this respect it is worthwhile to mention that one should anyway be 
careful with formalin and EDTA when using the benzidine method, because 
these agents precipitate benzidine (data not shown). 
Ester sulfate determination in cartilage without first isolating 
proteoglycans or glycosaminoglycans (GAGs) is an unusual procedure. Ne­
vertheless, direct acid hydrolysis of these tiny patellar cartilage 
specimens (estimated dry weight about 20 μς) turned out to be less cum­
bersome, and sufficient to liberate all sulfate as, in fact, is indica­
te 2 5 
ted by the S recovery experiments. Since S was shown to be fully 
associated with sulfated GAGs (1), all ester sulfates are transformed 
to inorganic sulfate. Evidence for this latter statement is also obtai­
ned by the observation that cartilage, derived from trypsin- or arthri­
tic patellae, demonstrates similar decreases in both sulfate content 
and GAG content, indicating that measured sulfate originated from GAGs. 
Since the sulfate content is expressed as an amount (nmol) per whole 
patella (-cartilage) no information is obtained about the GAG sulfation 
degree. For this to be achieved hexuronate and/or hexosamine contents 
have to be determined in microgram amounts of purified cartilage GAGs, 
isolated from mouse patellae. This matter is currently under investiga­
tion. 
In general, the benzidine method appears to find little present day 
use. No doubt its known carcinogenicity (27) has contributed to this. 
However, an analogue of benzidine, ft-amino-A'-chlorodiphenyl (CAD), is 
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a highly sensitive and selective precipitant for sulfate (6,2B) and is 
reported to be non-carcinogenic (13,29). This compound merits more at­
tention, especially because (СА0)2-50ц is less soluble in water then 
benzidine-SOi, (28), twice as much CAD is precipitated per sulfate mole­
cule as compared to benzidine, and reported molar extinction coeffici­
ents of coloured conjugates of diazotized benzidine and CAD (at 510 nm 
and 480 nm respectively) are in the same order of magnitude (5,30). 
From this it is clear that for sulfate determination, benzidine should 
be replaced by CAD. Unfortunately, as far as we know, CAD is not com­
mercially available at present. 
The herein described benzidine method can still be improved and made 
more easy to perform. Absorbance was measured at 492 nm, since we had 
an equipment with filters of fixed wavelength, but maximal sensitivity 
ought to be acchieved at 510 nm (5). To remove all free benzidine after 
sulfate precipitation, the precipitate is washed once and the tube 
mouths are wiped with tissue paper. This treatment is a serious draw­
back in the analytical procedure, since it demands some manipulative 
skill. Alternatively an extra wash procedure can be introduced with the 
risk of loosing some precipitate as well. For this purpose a mixture of 
ethanol-ethyl ether (1:2) is recommended above the ethanol-aceton (1:1) 
we used (31). Finally, it seems worthwhile to investigate whether the 
whole assay (precipitation, washing, conjugation, absorbance reading) 
can be performed in one or two microplates instead of using individual 
microtubes. 
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SALICYLATE-INDUCED DEPLETION OF 
ENDOGENOUS INORGANIC SULFATE 
Potential Role in the Suppression of Sulfated Glycosaminoglycan Synthesis 
in Murine Articular Cartilage 
BbRNARD J DC VRIhS. WIM В VAN DÌ Ν BKRG, and LEVINUS В A VAN DE PUTÌ L· 
Sodium salicylate has been shown to suppress 
glycosaminoglycan (GAG) synthesis by articular hyaline 
cartilage in vitro. We investigated the in vivo effect of 
sodium salicylate on murine patellar cartilage, using 
incorporation of intraperiloneally administered "S-sul-
fate as a measure of sulfated GAG synthesis. Our results 
indicated that a single dose of sodium salicylate (200 mg/ 
kg) inhibited in vivo sulfated GAG synthesis by 56%, 
compared with controls, and had no effect on sulfated 
GAG breakdown. A striking finding was that sodium 
sulfate treatment reduced the serum concentration of 
inorganic sulfate from 1.1 mV/ to approximately 0.Э 
HLW, and that this serum reduction was associated with 
a twofold increase in urinary excretion of sulfate. Using 
anatomically intact patellar cartilage, in vitro studies 
clearly showed that, in concentrations reached in vivo 
(2:1 mM), salicylate suppressed murine chondrocyte 
GAG synthesis. However, in the presence of serum, the 
effects of 1 mM salicylate were abolished. We also found 
that sulfated GAG synthesis was clearly inhibited at low 
concentrations of sulfate (<0.5 mM). Our data indicate 
that sodium salicylate can suppress articular chondro­
cyte sulfated GAG synthesis in vivo, and that this effect 
may particularly be due to a drug-induced reduction of 
endogenous sulfate. 
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Several nonsteroidal antiinflammatory drugs 
(NSAIDs) commonly used in the trealmcnt of arthritis 
have been shown to provoke suppression of glycosam­
inoglycan (GAG) synthesis in organ cultures ol normal 
articular tartildgc (1-3) Studies have clearly shown 
that salicylate administration suppresses in vitro GAG 
synthesis in normal human articular cartilage and that 
degenerated cartilage is aflcclcd even more by this 
drug (4,5) In experiments on canine osleoarthnlic 
cartilage (6). an almost complete suppression was 
observed at salicylate concentrations of 10 λΜ (14 
mgÇf), a level which is readily achieved in human 
serum 
Because patients with rheumatic diseases often 
receive long-term treatment with NSAIDs, it is rele-
vant to know whether the suppressive effect of these 
drugs, as observed in vitro, also occurs in vivo A 
deleterious effect of salicylates on articular cartilage 
after long-term treatment has been shown m studies of 
animals (7,8) However, the chondrocyte synthetic 
function of saltcylate-trcatcd animals has only been 
tested ex vivo (7,9). and a direct action of salicylates 
on in vivo articular GAG synthesis has not been 
established 
Originally the present study was aimed at 
investigations of the short-term cffeU of sodium sa-
licylate on in vivo sulfated GAG synthesis m normal 
aiticular cartilage A preliminary experiment showed 
that sodium salicylate indeed inhibited "S-sulfate 
incorporation in articular cartilage, but the most strik-
ing observation was a decrease in the serum content of 
J,S-sulfate, which paralleled a decrease in the en-
dogenous scrum sulfate level ( 10) With these observa-
tions and those of others (II), who found that the 
lowering of environmental inorganic sulfate per sc may 
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influence sulfated GAG synthesis by articular chon­
drocytes, wc focused our study on salicylate-mduced 
depletion of endogenous sulfate and its potential efleel 
on in vivo sulfated GAG synthesis These studies were 
earned out on analomiLally intact murine patellar 
cartilage (12) 
MATERIALS AND METHODS 
Animals We used 7-9 week old male С ^7HI mice 
weighing 20-2^ gm purchasLd from the Radiobiological 
Instilule Rijswijk The Netherlands The mice were housed 
in plastic cages containing wood shd\ mgs fed a commercial 
pellet diet and given water ad libitum Mice were in good 
health showed no signs of infection and had normal weight 
gain 
In W*o studies Weight matched mice were injected 
intraperitoneal!) with SO—400 mg of sodium salic> late/kg (10 
μ\ gm) I іПееп minutes after the first injection a group ot 
sodium sahcylale-trealtd mice and a gioup of saline treated 
controls received inlrapenloneal injections of 2 μ Ο of 
Na-."SOj/gm (up to 100 mCi mmole Radiochemical Cenlre 
Amersham Tngland) 
Blood and urine samples were taken at various 
intervals after radiosulfatc administration and the " S con 
tent and the concentrations of inorganic sulfate and sal icy 
late were measured Blood samples were obtained from the 
tail or by eye extraction at the lime of killing Lnnc samples 
were obtained b> squeezing the urinary bladder between 
finger and thumb 
Four hours after " S sulfate administration mice 
were killed and whole patellae were dissected from the knee 
joints in order to measure the amount of'"'S sullale incorpoi-
ated in ihc patellar cartilage (see below) 
Io study ihe effect of sodium salicylate on in vivo 
degradation oft»AGs patellae were prelabeled by intraperi­
toneal injection of radiosulfate (2 juCi of Na "SO* gm) 48 
hours prior to sodium salicylate or saline treatment Patellae 
were isolated at the start of the sodium salicylate or saline 
treatment and 24 hours later Patellar content of l sS was 
determined as described below 
Measurement of radioactivity in blood and urine. 
Blood and urine samples ( 10 μΙ) were assayed lor radioactive 
content using 10 ml ol Aqualuma plus (Lumac IM Schaes 
berg Τ he Netherlands) m a liquid scintillation spectrometer 
Hlood samples were lyscd in 0 5 ml ol water before addition 
of the scintillation fluid 
Measurement of sulfated GAG synthesis As a mea 
sure of in vivo chondiocytc synthetic function the amount 
of " S sulfate incorporated m the cartilage of isolated patel­
lae was determined according to the method of vanden Berg 
el al (12 Π) Briefly patellae with surrounding tissue were 
dissected from ihe knee joint washed with saline fixed for I 
hour in 4C¿ phosphate buflcred formalin (pH 7 0) and 
decalcified overnight in fixative saturated with Na^-hDl A 
Unbound " S was removed by thorough washing The 
whole anatomically intact patellae were easily punched out 
from the surrounding tissue after decalcification Patellae 
were solubili7cd in Solulytc (J 1 Baker Chemicals Deven-
ter I he Netherlands) and the incorporated "S was counted 
(using Lipofluor scintillation fluid J Τ Baker Chemicals) in 
л liquid scintillation counter 
I о verify that the l sS content of a whole patella may 
be used as a measure of sulfated GAGs in patellar cartilage 
we isolated '"SO^GAGs according to the method of Adams 
and Muir (14) Washed celylpyndmium chlonde-GAG com­
plexes precipitated from papain digests of whole patellae 
were solubihzed in η propanol and the "SOj GAG content 
was counted m a liquid scintillation counter as above More 
than 90(/с of the " S content of whole patellae was recovered 
in GAGs isolated from them 
Analvtie methods Serum salicylate concentrations 
were determined by a colorimetrie method described by 
Grciling and Schuier (IS) Salicylate standards were estab 
hshed using normal mouse serum obtained from age 
matched mice By using microplates (instead of cuvettes) 
and a Tilertek Muluscan (Flow Laboratories Irvine Scot­
land) to read the absorbancc 20 μΙ of scrum was sufficient 
for a duplicate determination (reproducible within a range of 
±109ί) 
Inorganic sulfate was measured by a turbidimetnc 
method that has been described and modified by Knigsheld 
et al (16 17) Io MM) μΙ of (diluted) serum or urine containing 
0 1-1 * m\f inorganic sulfate 2 ml of trichloroacetic acid 
solution {^r/f weight volume) was added and ihc mixture 
was allowed lo sland at room lemperalurc for 10 minutes 
After centnfugation I ml of clear supernatant was added to 
2^0μΙ of BaCl· reagent (20 gm of ВаСЬ2НЮ and 100 gm of 
dextran in I liter of distilled water) m a disposable semi 
microcmette and after 3^ minutes Ihc absorbancc (at 460 
nm) was read against a sample background (I ml of superna 
tant and 24) μΐ ol reagent containing 100 gm ol dextran liier 
of distilled water) 
To determine the percentage of the inorganic form 
("SOj ) of " S in ihc serum samples from radiosulfatc-
trealed mice were analyzed as follows After determination 
of (he scrum sulfate concentration by (he lurbidimctnc 
method the contents ol the cuvettes were centnfuged and 
the pellet (inorganic sulfate traction m the form of precipita 
ble Ba'SOj) and the supernatant were counted In normal 
mice 979í of "S was m the inorganic toim ( " S d ) in 
sodium sahcylatc-lreated mice it was slightly less but was 
always ^Wí ol the total serum ,SS coment In both the 
treated and the unireaied mice the "S content in blood 
paralleled that in the derived serum Thus blood samples 
could be used as equivalents of serum samples in measure 
ments of inorganic radiosulfate content 
In \itro studies Normal male C^IBL mice were 
killed by cervical dislocation and patella specimens were 
caretully removed from the knee loints The patellae were 
incubated as described (12) using RPM1 culture medium 
(200 μΙ patella) containing gentamycm СЧ) μg''ml) L gluta 
mine (2 mW) and Na-'SOj (0 4 mW) Sodium salicylate was 
added in concentrations ranging from I χ 10 ftV/ io s к 
10 V/ medium without sodium sahcvlate served as the 
control 
After 2 hours at Î7ÛC under a Sc4 CÖ> atmosphere 
the patellae were transferred to fresh medium containing 
sodium salicylate in the original concentrations The sulfate 
concentration was increased to 0 S-0 6mV/by addition of 10 
μ Ο of Na-^SOj ml and incubation was continued for an 
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addilioiMl 2 hours Patellae were then processed lor " S 
countine as described above 
I o investigate the eftects οΓ low sulfate coneenlra 
tion on chondroi.>te GAG svnthesis a sulfate depleted 
medium was use^l Patellae with surroundinp tissue were 
incubated in basal minimal Eagle's t H M l I diploid medium 
(How Laboratories) with added geniamycin (^) д р т і ) in 
which the amount of inorganic sullate was adiusted with 
Na^SOj to give the desired concentration (0 1-1 ^ т М ) ЛГіег 
I hour ol preincubation the patella specimens were trans 
ferred to Na."S() 4 containing B M E diploid medium ( 10 μί ι 
ml) with SOi concentrations the same .is those used 
during preincubation and inciibiil ion was continued (or an 
additional 2 hours 
I he amount of incorporated sulfate (in mmoles) was 
calculated from Ihe "S-sulfate contení (in dismiegralions per 
minute) of the patellar cartilage and Ihe speuhc activity ol 
" S C ^ " " in the incubation medium (dpm'mmole) 
Statistical analysis Statistical significance was calcu 
lated using Suident s / test and anahsis ol variance 
RESULTS 
Effect of sodium salicylate on in vivo rate of " S -
sulfale incorporat ion in patel lar cart i lage. Th i r t y m in -
utes after a single in t raper i toneal in ject ion o f 200 m p o f 
sodium sa l icy la lc 'kg peak sen im u j n t c n t i a t i o n ot 
sal icylate (2 8 χ 10 'Λ/ 18 mgU) was reached ( I igurc 
I) A t 4 hours p o s l m j c c t t o n . the c o n c e n t r a t i o n was st i l l 
> I 0 'V/ (14 m g 9 f ) . this is a c o n c e n t r a t i o n w h i c h may 
inhibit in v i t r o G A G synthesis (see b e l o w ) M i c e that 
were treated w i t h th is 200 m g ' k g dose received an 
intraper i toneal i n j e c t i o n o l N a ^ S O j IS minutes later 
and palellac w e i e isolated 4 h o u r s thereafter 
T h e a m o u n t o f " S - s u l l a t e i n c o r p o i a t e d in Ihe 
patellae ot s o d i u m s a l i c y l a l e - l r c a t c d mice was re 
Table 1 Measuremenl of m v ivo mcorporal ton ot ^ S mío p. iKl lai 
cartilage and bloml coment ol " S after sodium salicylate or s il ine 
(controls) t reatment* 
-Salicylate conccnlralion in se rum-
05 1 2 Э » 
hours after ι ρ injection or SodSal 
l igure I Serum concentrat ions o f salicylate at various intervals o f 
time after intraperitoneal (ι ρ > admimstra l ion o f 200 mg o f sodium 
sahcvlafc (SodSal) kg b a c h dol represents the mean · S D lor 6 
mice Salicvlaie conccntra l ions above the shaded irea demoivslr i le 
a suppressive etleet on m v i t ro art icular glveosammoglyean svnthe 
sis (sec fable 1) 
Conimi 
Sodium 
sdln.\Ute 
Wlwle 
patellae 
(cpm) 
190 ± 28 
107 ΐ 2 9 ( 4 0 ' 
" S eonlem 
Isolated 
GAOs 
(cpm) 
17S · 10 
[02 ί 19 (SKI 
Blood 
(cpm χ 10' 
HI ЦІІ 
6 6 - 0 8 
2 0 ± 0 1 (411* 
- Values represent the mean SD loi 6 mice (/-«/s - glveosamin 
oglveans Numbers m parentheses ale '< inhibi t ion compared u i l h 
controls Sec Materials and Methods lor details 
' Sigmfieamly d i l lercnl f rom conlro ls /' - 0 001 bv Sludenl s 
unpaired 2 tailed ( test 
d u c e d t o 56 - l7'/r (mean ± SD) (Ρ < 0 001). 
c o m p a r e d w i t h saline t reated c o n t r o l s (Table 1) S imi­
lar i n h i b i t i o n values were obta ined when isolated 
G A G s were c o u n t e d instead ol w h o l e patel lae, indicat­
ing that the dcc icased " S - s u l t a t c i n c o r p o r a t i o n rate 
signif ies л suppressed sul fated G A G synthesis 
T o examine the effect o l sodium sal icylate on in 
v i v o d e g i a d a t i o n o f G A G s patellae were p ie labcled 
by i n t i a p e r i t o n e a l i n j e c t i o n o f radiosult. i te 48 hours 
before s o d i u m sal icylate or saline (realment The <SS 
content in p ie labeled patel lae of c o n t r o l mice was 
signif icantly dcc icased 24 hours a l ter saline t tealment 
(Table 2), i n d i c a t i n g that a mcasutable " S O 4 G A G 
degradat ion had o c c u n e d S o d i u m sal icylate t real-
ment seemed to have no effect on this m v i v o b icak 
d o w n A st i rp i is ing o b s e r v a t i o n in the mice given ' S-
sul late short ly attet s o d i u m sal icylate admirus l rat ion 
was the low content o f '"'S in then b l o o d al the t ime ol 
k i l l i n g ( Fable 1) this c o u l d also be the icason for the 
decreased rate ot ^ S - s u l f a t e incoi p o r a t i o n in patcl la i 
ca i t i lagc 
Effect of sodium salicylate on the " S content i n 
b l o o d . T h e b l o o d content ot , S S was already sigmh 
40 
30 
20 
10 
Table 2 In v ivo e/Teet o f sodium 
content o l prelabcled palellac* 
Group 
1 
•> 
3 
Trealment 
Saline 
Sodium sahevlale 
salicylate 
l i m e 
(bonis) 
0 
24 
24 
tre i l inent on the ' 'S 
^ S eonlent 
cpm ρ iteli 1 <rr 1 
184 11 (НЮ) 
128 * I t CO) 
111 i 27(711 
• Values represent ihe пи.an - SI) fin 6 m i n . Р<іиІІ.іе W C I L isoUned 
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2 3 
hours after ι ρ inject on of S 0 4 
Figure 2 bffect of äüdium ^alitylati. (SodSah on the blood content 
of "S Fifteen minutes after mlraperitonLal (ι ρ I administration of 
either "ΌΟ mg of sodium salicylate kg or saline mice received 
intraperitoneal Na "Μ)« bach dot represents the mean •* SU for t» 
mice 
canlly decreased m the early phase after sodium 
salicylate treatment (200 mg/kg) and this difference 
between the sodium sahcylate-treated group and the 
control group gradually increased thereafter (Hgure 
2) This phenomenon was accompanied by an in­
creased urinary excretion of , SS which reached 2009f 
of control values at approximately 4^ minutes Two 
hours after sodium salicylate administration urinary 
"S excretion was almost the same as that in the 
control group and at 22 hours " S content ultimately 
declined to 50% of control values 
Effect of sodium salicylate on the endogenous 
Inorganic sulfate concentration In serum As was found 
for "S sodium salicylate administration (200 mg/kg) 
caused a marked decrease in the endogenous sulfate 
concentration in serum This lasted for at least 3 
hours The concentration of inorganic sulfate de­
creased from the physiologic serum level of 1 1 mM lo 
approximately 0 3 mM (Figure 3) The decrease in 
serum concentration was accompanied by increased 
urinary excretion of inorganic sulfate within 2 hours 
after drug treatment 
The decline in serum concentration of SO«"" 
(in mM) coincided with the decrease m scrum content 
of "S (in counts per minute) Consequently the 
specific activity of circulating "S-sulfate is virtually 
the same m sodium salicylatc-lreated and control mice 
(Figure 4) This indicates that the decreased "S-
sulfate incorporation found in the patellar cartilage 
(Table I) in fact represents a suppressed rale of 
incorporation of inorganic sulfate 
Table 3 shows the dose dependency of the 
sodium saltcylate-tnduced decrease in inorganic se-
mM 
t p -
i o -
α β 
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0 4-
02-
morgan с sulfate concentrat ion m serum 
il τ 
I 
к 
л 
NaCI I 
, 
\ 
S o d S a l ^ i ^ _ _ ^ Г ^ _ ^ _ - -
1 2 3 4 
hours alter ρ injection of SodSa or NaCI 
Flgun 3 Effect ol intraperitoneal (ι ρ ) sodium salicylate (Sodbal) 
(200 mg/kg) administration on ihe concentration of inorganic serum 
sulfdle Control mice received saline Fach dot represenls ihe me in 
± SD for S mice 
rum sulfate levels We found that a 50-mg/kg dose 
induced a significant effect on serum content of sul 
fate 
In vitro effects of sodium salicylate and Ion 
sulfate concentration on the rate of sulfate incorporation 
in patellar cartilage With the data obtained thus far it 
was still unclear whether sodium salicylate itself 
caused decreased sulfate incorporation by acting di 
rectly on the chondrocyte or whether the sulfate drop 
(caused by sodium salicylate) was responsible for this 
phenomenon To investigate these aspects separately 
we conducted in vitro experiments 
The direct effect of sodium salicylate was stud 
led by incubating whole patellae for 3 hours in sodium 
SPECIFIC ACTIVITY Of 3 5 S 0 4 IN StRUM -
1 2 3 
hours after ι« injection of N a ? 5 ^ 
Figure 4 The specific activity of inorganic radiosulfale in the 
serum of mice treated inlrapcntoneally (ι ρ ) with sodium salicylate 
(SodSal) and with saline Values ire derived from the data shown in 
Figures 2 and 3 
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Table 3. Serum sahcyLuc and sulfate concentrations 2 hours after 
intraperitoneal treatment uiih sodium sahevlale* 
SO« mcorpofatran versus SO4 concentratnn-
Dose 
(mgkgl 
Serum salicylate 
ImMI 
Serum sulfate 
ImVil 
0 
50 
100 
400 
0 
0 s ± 0 : 
1 1 * 0 1 
31 ± 0 4 
1 01 * oos 
0 79 * 0 14 
0 "¡8 · 0 11 
0 47 * 0 08 
* Values represent the mean ± SD for 1 mice There was a 
significant sodium sallc>lale-mediated decrease in serum stillate 
concentration. Ρ ' 0 OS by one-way analysis of \ariance 
salicylatc-containmg medium, the last hour in the 
presence of radiosulfate. As measured by S incor­
poration. sodium salicylate exerted a dosc-depcndcnt 
suppression on the incorporation of sulfate into sulfat­
ed GAGsof patellar cartilage dable 4) However, the 
suppressive effect of 10 'W sodium salicylate was 
completely abolished when the culture medium was 
supplemented with ^l^/t normal mouse scrum 
The effect of a icduced sulfate concentration on 
patellar chondrocyte metabolism was examined by 
incubating whole patellae in medium with vanous 
concentrations of sulfate (0 0-1 2 mW) At serum 
concentrations of sulfate varying about the range of 
the normal endogenous level ( I 0 mM). the rate of 
sulfate incorporation was hardly adecled. However. 
sulfate incorporation in patellar cartilage was found to 
be decreased at sulfate concentrations below 0 5 m.Vi 
(Figure 5), such concentrations are readily achieved 
after in vivo sodium salicylate treatment. 
DISCUSSION 
Our data indicate that treatment of mice with 
salicylate caused a clear reduction of in vivo sulfate 
incorporation in articular cartilage and a marked fall in 
the endogenous serum sulfate level In addition to a 
direct action of salicylate on the chondrocyte, the 
drug-induced decrease in sulfate availability may be a 
Table 4. In vitro effect of sodium salicylate on *\S incorporation in 
anatomically intact patellar cartilage* 
Sodium salicylate concenlralion 
(moles/liter) 
Incorporated " b 
( 4 of control) 
S X 10 ' 
1 x 10 ' 
I x 10 ' 
I x 10 * 
S4 i. II 
81 * 11 
110 ± Π 
109 -L 19 
<() 001 
«101 
\S 
NS 
* Values represent the mean ± SI) for 5 nuce Patellae were 
incubated for 1 hours, for the last hour in the presence of radiosul­
fate Control patellae were cultured in the absence of salicylate 
+ Versus controls Calculated using Student s unpaired 2-tailcd 
Mes! NS - not signihcant 
SO4 concentration (mM/l) 
Figure 5. Sulfate incorporation into sulfated gkeosammogkeans 
by normal murine patellar cartilage cultured m the presence ol 
various concentiations of sulfate Results are expressed .is mmoles 
of sulfate incorporated into the cartilage ol I patella m 2 hours b.ich 
dot represents the mean * SD lor 5 mice 
potential mechanism for the reduced sulfate incor­
poration, since under low sulfate concentrations in 
vitro, sulfated GAG synthesis was shown to be highly-
suppressed 
Aflci a single intraperitoneal dose of sodium 
salicylate, 200 mg'kg. a scrum salicylate concentration 
between 15-40 mg% (1-1 mM) was reached in these 
mice, and this treatment was found to induce a signifi­
cant reduction in the " S incorporation in the articular 
cartilage in vivo. Similar results (with salicylate and 
other drugs) have been reported for a number of 
tissues (18-21), and these data have been interpreted 
as demonstrating a drug-induced inhibition of sulfate 
incorporation and therefore a reduced sulfated GAG 
synthesis. However, our analysis of serum sulfate 
levels after salicylate treatment showed a rapid fall in 
the endogenous sulfate level, hence, changes may 
occur in the specific activity of the "S-sulfate in the 
drug-treated mice, and these changes are dependent 
on the timing of the radiolabel administration There­
fore, exact knowledge of the specific activity is an 
absolute prerequisite for translating "S incorporation 
values into chondrocyte sulfated GAG synthesis 
The best way to examine drug-induced changes 
in sulfate levels is to examine blood samples, although 
Herbal (21) described an elegant double isotope meth­
od of determining endogenous sulfate levels from I 
droplet of urine. Analysis of 24-hour urine samples, the 
method used by Boslrom et al (22) to measure a drug's 
effect on the endogenous sulfate concenlralion. seems 
unsuitable since temporary increases and decreases in 
urinary sulfate excretion after drug treatment, as ob­
served in our experiment, escape notice in such an 
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overall measurement In the experimental method we 
used, the specific activity of "S-sulfale remained at 
the same level in sahcylate-treated and control mice. 
therefore, the decieascd ''S content of the patellar 
cartilage could be interpreted as a decrease in the 
amount of newly formed sulfated GAGs 1 his must be 
due to inhibited synthesis, since salicylate was shown 
to have no eflfccl on the in vivo degradation of prc-
labeled GAGs from the patellar cartilage (Table 2) 
Studies were performed with only ,sS-sulfatc as 
a radiolabcl. this gave information about the sulfation 
of GAGs and not about the synthesis of the carbon 
chain of GAGs Although "S-sultatc incorporation is 
commonly used as a measure of GAG synthesis, some 
care must be taken in drawing general conclusions. 
especially since sulfation and GAG backbone synthe­
sis can occur uncoupled. 
A distinct decline in the endogenous sulfate 
level was observed after a 5()-mg'kg dose ol sodium 
salicylate It seems unlikely that drug sultalion is 
responsible for (his decrease in scrum sulfate since 
neither salicylic acid nor its sodium salt or acetyl 
derivative is a substrate for sulfation (15,23.24). Fur­
thermore, chemically sullaled salicylic acid is com­
pletely hydrolyzed in an aqueous environment (15) 
The most reliable explanation is a salicylate induced 
diuresis occurring by direct action on the kidneys, 
since levels of inorganic sulfate excreted in the uimc 
were increased twofold shortly after drug treatment. 
There arc at least 2 potential mechanisms for 
the salicylate-medialcd suppression of in vivo sulfate 
incorporation into the articular cartilage hirst, salicy­
late could exert a direct effect on in vivo chondrocyte 
GAG synthesis, as it docs in vitro Second, the de­
creased endogenous sulfate level could be the caus­
ative factor. 
Palmoski and Brandt (25) showed that salicylate 
concentrations in excess of 10 \V/ caused a clear 
inhibition of chondrocyte GAG synthesis in canine 
cartilage in vitro, measured cither by "S-sulfatc or Ή-
glucosamine incorporation It is believed that salicy­
late provokes suppression of GAG synthesis by de­
creasing the availability of glucuronic acid, one of the 
major components of GAGs. This is caused either by 
the inhibition of the activity of undine diphosphate 
(UDP)-glucose dehydrogenase, which catalyzes the 
conversion of UDP-glucosc to UDP-glucuromc acid 
(25,26). or by conjugation of glucuronic acid to salicy­
late itself (19). Oui in vitro studies made it clear that 
salicylate may also exert an inhibition of chondrocyte 
GAG synthesis in intact murine articular cartilage 
However, in the presence of 25c/c mouse scrum, the 
inhibitory effect of 10"'A/ salicylate was abolished. 
and this casts some doubt on the relevance of this 
mechanism in vivo This may be due to protein binding 
of salicylate, resulting in a decreased concentration of 
free salicylate 
Regarding the second mechanism, lowered sul­
fate availability as a factor causing inhibition of sulfat­
ed GAG synthesis in vivo, we have obtained sugges­
tive in vitro evidence Maximal sulfate incorporation 
was seen at approximately I m.Vi sulfate (the physio­
logic sulfate level in the serum of C57BL mice) (27), 
and a distinct decrease in sulfate incorporation was 
demonstrated at sulfate concentrations below 0 5 m,V/ 
(Figure 5), which are readily achieved in vivo after 
salicylate treatment (Figure 3) The dependence of 
sulfate incorporation on the sulfate concentration has 
been described by Maroudas and Evans (11) m their 
studies of human articular cartilage They concluded 
that inorganic sullalc must be one of the rate-limiting 
substrates in the sy nthesis of sulfated GAGs Maximal 
sulfate incorporation was found at approximately 0.4 
mM sulfate, the concentration that is physiologic for 
humans (2S), and a clear decrease was found at 
concentiations below 0 2 mM. 
The observation of a plateau level of sulfate 
incorporation occurring wnh sulfate concentrations 
varying widely aboul the physiologic range in each of 
the 2 species may indicate the existence of an impor­
tant homcostatic mechanism. Thus, the clearly ob­
served fluctuations in endogenous sulfate levels corre­
sponding with circadian rhythm (28) have no 
implications for cartilage metabolism. 
Besides penetration of various solutes, the re­
silient and load-bearing properties of articular cartilage 
are closely dependent on the concentration of nega­
tively charged ionic gioups Of these, only sulfate 
groups (-OSOi ) are icsponsible for a stable interac­
tion of proteoglycans with collagen, the 2 major matrix 
components of cartilage (29) Hence, drug-produced 
inhibition of chondrocyte sulfated GAG synthesis may-
cause a loss of cartilage integrity Wilhelmi's finding 
that acetylsalicylic acid, admimsteied once daily for 5 
months in oral doses of M) mg'kg and 150 mg/kg, 
piomoled the development of spontaneous osteoar­
thritis in C57B1. mice (ti) is relevant in this respect 
Further evidence for in vivo drug-induced carti­
lage damage emerged from studies by Palmoski and 
Brandt (7). who found that experimental canine osteo­
arthritis was aggravated in animals that received daily 
doses of aspirin for 9 weeks Interestingly, this dose 
regimen had no apparent effect on the cartilage of the 
contralateral normal joint, indicating that arthritic car-
90 
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lildge may be more vulnerable to sahcylate-induted 
damage 
Finally since the kinetics of pharmacologic 
response to salicylates are likelv to be different be­
tween animal spocics as well as between animals and 
humans, one should be cautious in interpreting these 
data for diseases in humans 
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CHAPTER 5 
THE EFFECT OF SALICYLATE ON ANATOMICALLY INTACT ARTICULAR CARTILAGE IS 
INFLUENCED BY SULFATE AND SERUM IN THE CULTURE MEDIUM 
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de Putte 
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The Effect of Salicylate on Anatomically 
Intact Articular Cartilage is Influenced by 
Sulfate and Serum in the Culture Medium 
BERNARD J de VRIES, WIM В van den BERG, ELLY VITTERS, and LEVINUS В A van de PUTTE 
Absiracl The established, suppressive effect of salicylate on sulfated glycosaminoglycan (sGAG) 
synthesis by normal articular cartilage was rein\estigated using anatomically intact articular 
cartilage of the whole mouse patella. Employing the physiological murine sulfate concentra­
tion (1.0 mM) sodium salicylate (1-5 χ ΙΟ-1 M) caused a dose dependent inhibition of , 5 S-
sGAG synthesis (10-35%). At a lower sulfate concentration (0.4 mM) this inhibition was in­
creased (15-45%) and the suppression was even more pronounced in sulfate deprived medi­
um. This observation stresses the need of using physiological sulfate concentrations in cartilage 
culture studies. In the presence of 100% serum the therapeutic drug concentration (1-2 χ 10"J 
M) had no longer any suppressive effect, cither at 1.0 mM or at any lower sulfate concentra­
tion. Our data suggest that salicylate has no direct effect on sGAG metabolism in normal artic­
ular cartilage m vivo and that adverse effects may be due to the observed salicylate induced 
lowering of the endogenous sulfate level. (J Rheumatol 1986, 13:686-693) 
Key indexing Terms 
ARTICULAR CARTILAGE SULFATE CONCENTRATION 
SODIUM SALICYLATE GLYCOSAMINOGLYCAN SYNTHESIS 
SERUM 
Salicylates and several other nonsteroidal antiinflammatory 
drugs (NSAID) have been shown to inhibit glycosaminogly­
can (GAG) synthesis by articular cartilage in virro' ' The 
initial studies were mainly performed with cartilage slices 
which contained damaged artificial surfaces In a recent paper 
it has been suggested that the proteoglycan content of the 
cartilage matrix may be an important determinant of the sus­
ceptibility of articular cartilage to drugs" It was found that 
the chondrocyte GAG synthesis was more suppressed when 
the proteoglycan content of normal cartilage had been 
reduced by hyaluronidase digestion before incubation with 
the drug The higher vulnerability to salicylate observed in 
osteoarthntic (OA) cartilage' as well as in articular cartilage 
from unloaded regions4 may also be related to the decreased 
proteoglycan content of these tissues 
Since it has been noted that significant proteoglycan loss 
may occur upon culture of cartilage slices close to the new­
ly cut surfaces", drug studies should preferably be per­
formed with intact cartilage, exposing only the articular 
surface to the culture medium In our study we examined 
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in detail the in vitro effect of salicylate on chondrocyte GAG 
synthesis by anatomically intact patellar cartilage of the 
mouse To resemble the ш vivo condition, special attention 
was given to the influence of serum in the incubation medi­
um Since we have recently shown that the suppressive ef­
fect of sodium salicylate, as observed in vivo, is probably 
not due to a direct effect of the drug on chondrocyte synthe­
sis, but to a salicylate induced sulfate diuresis, which resulted 
in a reduced availability of endogenous, inorganic sulfate', 
we further examined the influence of variations in the inor­
ganic sulfate concentration. 
MATERIALS AND METHODS 
Animals Male CS7B1 mice 6-10 weeks of age and weighing 20-27 g were 
used They were malched for weight (mean ± 1 0 g) and age (mean ± 
0 5 week) before the start of each experiment 
Cartilage culture Patellar cartilage was used as a source of articular car 
tilage GAG metabolism was studied by described methods9 10 In brief, 
mice were sacrificed by cervical dislocation and both intact patellae with 
surrounding tissue still attached were dissected carefully For each test freshly 
isolated patella specimens from groups of 5 to 6 mice were incubated in 
medium consisting of RPMI (200 μΐ/patella), L gluiatmne (2 mM) gen-
tamycm (50 ¿ig'ml) and 0 4 mM SOI (all from Row Laboratories, Irvine, 
Scotland) In the presence of various concentrations of sodium salicylate 
(SodSal) all incubations were performed at 370C under a 5% COj at 
mosphere for short term periods, most of them lasting no longer than 4 
h hor the final 2 h whole patellae were radiolabeled with D - [ 6 - 3 H ] 
glucosamine HCl (20 /iCi'nil) or 15S-sulfate (Radiochemical Centre, 
Amersham, England) to assess GAG synthesis Both tamer and earner-
free 35S sulfate were used (10-40 /iCi'ml), the former raised the sulfate 
concentraion in the RPMI medium from 0 4 mM to 0 5-0 7 mM So 4 
GAG breakdown was studied by pulsing patellae with 3 iS sulfate for 2 h 
before exposure to salicylate The amount of radiotracer incorporated with-
95 
in this penod was, accepted as 100% 3 5S GAG breakdown rate was exa 
mined over the next 6 h culture with and without SodSal 
Determination of radiolabeled GAG iSS sulfate and H^ glucosamine in 
corporation into the patellar cartilage GAG were determined ш a manner 
previously described8 ч and briefly outlined here Radiolabeled patellae 
with surrounding tissue were fixed in 4% phosphate buffered formaldehyde 
(pH 7 0) and decalcified overnight in Na2fcDTA saturated fixative Nonm 
corporated free label was removed by thorough washing Due to decal 
cification the whole anatomically intact patellae could easily be isolated 
from their surrounding (issue J i S /Ή GAG were extracted from patellae 
Ъ\ means of papain digestion (200 /iL· patella) followed by cetylpyndinium 
chloride precipitaiion as described" Carrier GAG (SO pg/l00 μΐ) con 
sisting of chondroitin sulfate 4 and 6 and hyaluronic acid (3 3 1) were 
present in the papain digestion medium to obtain adequate precipitation of 
the radiolabeled GAG After solubilization in Solulyte (J Τ Baker Cherm 
cals Deventer NL) the 3 5S and 3H contents in patellar GAG were count 
ed by means of the scintillation fluid Lipofluor (J Τ Baker as above) in 
a liquid scintillation counter (3H window 0 4-8 keV 3SS window 15-160 
keV) The results were expressed as countb/mm (CPM) Also the 3SS and 
3H contents in whole patellae were determined by direct solubilization in 
Solulyte instead of firs) isolating GAG 
Sulfiae depletion of serum Normal mouse serum obtained from mice 8 weeks 
of age was depleted from SO 4 with BaCl, BaS04 precipitate was removed 
by centnfugation at 10 000 RPM for 30 min Care was taken not to use 
an excess of Ba + + over SO4 to avoid undesirable side effects of Ba + * 
This condition was always met by exact determination of the sulfate con 
cent rat ion and then adding Ba * + to serum SOT in the ratio 1 1 The sul 
fate concentration was decreased from about 1 0 mM to below 0 1 mM 
bul was still detectable with our sulfate assay (see below) indicating that 
no free Ba+* was present 
Ex VÌVO study Groups of mice were injected intrapentoneally with 200 mg 
SodSal/10 ml water/kg or 10 ml physiological saline/kg (controls) After 
blood sampling via heart puncture mice were sacrificed at different times 
!4 1 2 3 24 h) Immediately after dissecting patella specimens radiolabel 
ing was performed in "S sulfate containing RPMI medium for one h Patel 
lar 15S content was assessed as described above 
Analytical methods Inorganic sulfate was determined by a modification of 
the benzidine method described by Spencer et aln Serum salicylate was 
assayed by a modification of the method used by Greilmg and Schuier13 
Statistical analysts Differences between means were considered statisti 
cally significant when ρ < 0 05 according to Student s t test for unpaired 
data 
RESULTS 
Effect of SodSal on patellar GAG synthesis Whole patellae 
with intact articular cartilage were cultured in RPMI medi­
um in the presence of vanous SodSal concentrations Chon­
drocyte GAG synthesis was assessed with 3sS-sulfate and 
Ή glucosamine incorporation To verify the necessity of 
isolating GAG for quantitating newly formed GAG, the J5S 
and Ή content of whole patellae as well as of isolated patel 
lar GAG were determined As depicted in Table 1, the 35S 
content of whole patellae and of GAG quantitatively isolat­
ed from them are almost the same, as are the inhibition values 
provoked by SodSal The amount of 'H-glucosamine incor­
porated m whole patellae is, however, much higher com­
pared with isolated GAG, indicating that >H glucosamine is 
also incorporated into non-GAG compounds This makes 
clear that for radioglucosamme, GAG isolation is an abso­
lute prerequisite Both Ή and "S incorporation into GAG 
are depressed by salicylate, indicating inhibition of the whole 
GAG backbone and not merely sulfation 
In further experiments only ,SS sulfate incorporation was 
used because of the ease of assessing sulfated GAG (sGAG) 
synthesis simply counting the amount of S5S incorporated 
in the whole patella Using radiosulfate we noticed that chon­
drocyte sGAG synthesis was only moderately inhibited by 
therapeutic concentrations of salicylate (Ι-ΣχΙΟ^Μ) It is 
of interest that low SodSal concentrations tend to stimulate 
sGAG synthesis (Tabic 1) Although the effect seldom 
reaches statistical significance, this phenomenon has repeat 
edly been observed 
Table 2 shows the effect of SodSal on the normal release 
of "S GAG from prelabeled patellae After an incubation 
period of 6 h in drug free medium, the 35S content was sig­
nificantly decreased (p<0 02), indicating that a measura­
ble release of "S-GAG took place Even at high 
concentrations of SodSal no adverse effect was demonstrat-
Table 1 Effects of SodSal on the incorporation rate of JSS-sulfate and 3H glucosamine in whole patellae and isolated 
glycosammoglycans * 
SodSal 
(Mol/I) 
Control 
1 χ КГ 2 
5 χ 10 J 
2 X 10-J 
1 x 10 ' 
1 X io-" 
1 x 10 ' 
Whole Patellae 
415 ±60(100) 
I7g ± 30 (43) 
210 ± 59 (65) 
340 ± 38 (82) 
374 ± 64 (90) 
461 ±69(111) 
457 ± 91 (110) 
3 ! S Cor 
CPM ± SD (5 
Ρ' 
< 0 001 
< 0 01 
< 0 04 
NS 
NS 
NS 
Hem' 
ó of control) 
Isolated GAG 
396 ± 67 (100) 
162 ± 19 (41) 
249 ± 32 (63) 
-
-
-
-
Ρ 
< 0 001 
<0001 
-
-
-
-
Whole Patellae 
1735 ± 275 (100) 
1492 ± 134 (86) 
1579 ± 208 (91) 
-
-
-
-
CPM ± 
Ρ 
NS 
NS 
-
-
>H Content» 
SD (% of control) 
Isolated GAG 
ИЗО ± 103(100) 
746 ± 82 (66) 
802 ± 136 (71) 
-
-
-
-
Ρ 
< 0 00I 
< 0 001 
-
-
-
-
* 4 h s incubation final 2 h with both radiotracers 
' Values are mean ± SD of patellae from groups of 6 mice 
* Statistical significance of difference from control (unpaired 2 tailed) NS=not significant 
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Table 2 Effect of SodSal on the nonna! release ofS-GAG 
from prelabeled patellae 
Group 
1 
2 
3 
4 
5 
SodSal 
(Mol/I) 
-
2 X10 э 
5 x I O " 1 
1 χ IO" 2 
Time 
(h) 
0 
6 
6 
6 
6 
" S Contení' 
(CPM/Patella) 
712 ± 63 
583 ± 9 0 
586 ± 83 
527 ± 34 
574 ± 87 
(%) 
100 
82' 
82 
74 
80 
' Patellar 3'S tontenls represent mean ± SD of patellae from groups 
of 6 nuce 
^ Group 2 versus group 1 p<0 02, unpaired 2 tailed Student s 
t test No significant diffcience between Group 2 and SodSal 
treated groups3 3 
ed on this caiabolic process Thus the drug mediated 
decreased "S content in patellar cartilage, as listed in Ta-
ble 1, is solely due to a salicylate provoked suppression of 
sGAG synthesis and not to accelerated release of preformed 
3JS-GAG 
SodSal effect time dependence To examine the time depen-
dence of the suppressive effect of salicylate on GAG syn-
thesis, patellae were preincubated with 2 x l 0 - ' M SodSal 
for vanous periods, ranging from 0 to S h Subsequently, 
radtosulfate labeling was performed in drug containing medi-
um for one h Twenty percent inhibition of "S incorpora-
tion was already found without preincubation and this effect 
was not aggravated by prolongation of the drug exposure 
tune 
SodSal effect reversibility The ability of patellar chondro-
cytes to recover from the suppressive effect of salicylate 
was studied by preincubating patellae for 3 h in a rather high 
concentration of SodSal (10 :M), followed by a variable 
chase penod in excess medium (1 2 ml/patella) without drug 
"S labeling was performed for only 30 mm immediately af-
ter chase incubation Figure I shows a gradual recovery of 
the suppressed "S incorporation rate with increasing chase 
time, after 2 h control values were already reached 
SodSal effect age dependence Young and aged articular car-
tilage, assumed to be different in chondrocyte function as 
well as in matrix composition, were assessed for the sup-
pressive action of salicylate Whole patellae of mice 
(8,15,27-weeks-of-age) were cultured during 4 h in the 
presence of 5 χ 10 3M SodSal, the final 2 h with 3SS-sulfate 
Although the control " S incorporation rate in whole patel­
lae clearly diminished with increasing age, the SodSal medi­
ated suppression remained identical (Table 3) 
SodSal effect influence of sulfate concentration In previ­
ous studies it has been shown that sodium salicylate, ad­
ministered in vivo, provoked a drastic decrease of the 
endogenous inorganic sulfate level8 To investigate possible 
interference of environmental sulfate with the suppressive 
action of salicylate, patellae were incubated with SodSal at 
2 different sulfate concentrations The normal serum level 
m C57B1 mice (1 0 mM SO;) and the level reached after 
in vivo SodSal (200 mg/kg) treatment (0 4 mM SOj) were 
applied " S labeling was done with earner free "S-sulfate 
5 
I I 
20 40 60 80 « 0 120 
incubation time (hr) CHASE 
min. incorporation (%) 
ι—ι 
h 
3 5 
S 
H 
i-i 
ι—I 
control 
ι—ι 
S3CHASE SODSAL 
Fig I Reversibility of the SodSal (10~3 M) mediated inhibition of 3 5S incorporation in whole patellae 3 3S labeling was performed for 30 nun im 
mediately after chase incubation Incorporation values (% of control) represent mean ± SD of patellae from groups of 6 mice After a 2 h chase 
penod the difference from control is no longer statistically significant (unpaired and one tailed Student s t test) 
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Table 3 Fffeci of SodSal (5 χ IO 'M) on ¡he "S incorpora 
non rale in nhole patellae age dependence 
Age 
Control 
CPM patella' 
SodSal : of С ontrol* 
8 weeks 
15 weeks 
27 weeks 
1069 t 207 
678 ± 77 
574 ± 92 
578 ~ 49' 
132 ± 41 
294 ± 55' 
•И 
49 
SI 
' Data represent mean + SD of patellae from groups of 6 mite 
Signifitantlv different from controls p<0 001 (unpaired 2 tailed) 
* No signifiLant difference in the SodSal mediated suppression 
between the sanous age groups 
which had a negligible contribution to the sulfate concentra­
tion in the culture medium A tendency of a more pronounced 
inhibition of " S incorporation at the lower sulfate concen 
(ration was often found (Table 4) The therapeutic SodSal 
concentration of the ICMM affected chondrocyte sGAG 
synthesis only at a low inorganic sulfate level Many " S 
labeling studies arc performed m medium without sulfate to 
obtain a high "S incorporation rate Under such conditions 
drug effects may be artifactually overestimated (Table 5) 
SodSal effect influente of serum To examine phvsiological 
concentrations of free salicylate in the presence of protein 
bound salicylate, incubation experiments were performed in 
Table 4 SodSal effect on "S incorporation in vahóle patel-
lae at 2 sulfate < oneeniranons 
SodSal 
(Mol I) 
"S content ( Я 1 
l O m M S O j 0 4 m W S O ; 
1 χ 10 
2 χ 10-
5 x 10 
92 · 7 (n-9) 
84 ± 7 (n=10) 
64 ± 8 (n-5) 
84 ± 6 (n=6) 
74 ± 6 (n = S) 
S6 ± 8 (n = 5) 
<0 0S 
< 0 02 
NS 
' Values are expressed as the mean ± SD of the average 
pericntages"S incorporated in drug treated versus control patellae 
in separate experiments (n) Each experiment consisted of patellae 
obtained from groups of S to 6 mice 
1
 Significance of difference between the values obtained at 2 sulfate 
concentrations (unpaired 2 tailed lest) NS-not significant 
100% serum which shares many properties with synovial 
fluid (SF) In the therapeutic range (1-2 x 10 3M) either 
mouse or human semiti totally abolished the suppressive ef­
fect of SodSal (Table 6) Similar protecting effects were 
achieved by addition of serum albumin (of mouse and hu­
man ongin) to RPMI at a final concentration of 2-4% Higher 
SodSal concentrations still showed significant inhibition of 
" S incorporation under full serum conditions although to 
a lesser extent than without scrum (Table 1 vs Table 6) Since 
human serum has a relatively low sulfate concentration (0 3 
mM) compared to mouse serum (I 0 mM), the ISS incor­
poration values are higher in human serum owing to a higher 
specific activity ( " S ' [ S O Ï ] (Table 6) 
To study the influence of senni sulfate in detail, the ef-
fect of 2 x 1 0 'M SodSal on patellar chondrocyte sGAG 
synthesis was tested at various sulfate concentrations in 100% 
mouse serum To this end mouse serum was depleted of sul-
fate with BaCI, and made up to the appropriate sulfate con-
centrations by addition of Νϊ,βΟ, As shown m Table 7, 
the therapeutic concentration of salicylate docs not cause sup­
pression of "S incorporation under serum conditions, either 
at a normal (1 0 mM) or at a severely depleted sulfate con­
tent (0 05 mM) On the other hand, the amount of sulfate 
incorporation was highly dependent on the sulfate concen­
tration (Fable 7, 2nd column) At 0 4 mM SOï, the sul-
fate incorporation was already reduced to 60% of the value 
obtained at 1 0 mM SO, 
Ex Mvo studies Groups of 5 mice received a single in-
traperitoneal injection of SodSal (200 mg/kg) or saline ( con-
trols) In drug treated mice the serum salicylate concentration 
was 2 5 x 10 'M at 30 mm and slowly declined to 1 2 X 
10 3M at 3 h, after 24 h no salicylate was detectable En-
dogenous inorganic sulfate in serum was reduced from 1 1 
mM to 0 4 mM at 2 h and remained low at 3 h, at 24 h a 
normal (control) level (1 0 mM) was measured At various 
times (%, 1, 2, 3, 24 h) patellae were isolated and exposed 
immediately to "S-sulfate for 1 h Using such an ex vivo 
protocol, "S-sulfate incorporation values in patellae from 
SodSal treated mice were not found to be reduced compared 
to saline treated control mice at whatever time studied 
Table 5 SodSal (5x10 'M) effect on "S incorporation at high and low sulfate concen 
tration afier preincubation in high sulfate medium 
Drug 
С ontrol 
SodSal 
Control 
SodSal 
Premedium· 
[SO", 1 
1 OmM 
1 0 mM 
1 0 mM 
1 0 mM 
" S O , medium 
[SO,] 
1 0 mM 
1 0 mM 
0 00003 mM 
0 00003 mM 
" S incorp 
(CPM'Patclla) 
599 ± 126 
424
 ± 70 
10394 ± 1629 
4548 ± 691 
oration' 
)f Control), 
70 
44' 
Patellae were prcmcubatcd for 2 h in premedium (I 0 mM SO 4 before 1SS labeling wab itarud (for 
another 2 h) in 35SO 4 medium with either 1 0 mM S 0 4 or 0 00001 mM SO 4 During this whole mcu 
bation period (4 h) SodSal was present or not (control) 
Values represent mean ± SD of patellae from groups of 6 mice 
Significantly different from value obtained at high sulfate p<0 01 (unpaired 2 tailed) 
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Table 6 Influence of full serum on the SodSal mediated inhibition of "5 mi orporation 
in Hhole patellae 
SodSal 
(Mol/I) 
Control 
Ι χ I O " 1 
2 χ 10 ' 
5 x 10 ' 
Ι χ I O " ' 
100 % Моиы. Strum 
1066 ΐ 97 (100) 
1094 ± 171 (103) 
1055 ι 210 (99) 
856 ± 122 (SO) 
Ы 0 t 26 (60) 
CPV Patella ( 5 of Control)· 
P* 
NS 
NS 
< 0 0 l 
< 0 001 
lOOS Human Serum 
1580 i 588 (100) 
3658 ± 741 (102) 
3477 ± 521 (97) 
1086 ± 495 (86) 
2159 ± 280 (66) 
Ρ 
NS 
NS 
NS 
< 0 001 
DdU represenc mean ± SD of patellae from groups of 6 mice 
Statistical significance ol difference from control (unpaired 2 laikdi \S—not bigmficdnt 
Table 7 SodSal (2 x ÌO'^M) effect on ifS тсогрогапоп at 
хагшЫе sulfate с one entranons in lOOfc normal mouse serum 
SO 4 cone 
m M 
0 05 
0 2 
0 4 
1 0 
SO
 4 intorp 
(control) 
mmol χ I0 H 
0 15 (105!) 
0 5 (11%) 
0 9 (60%) 
1 5 (ІООЯ) 
Control 
1161 ± 241 
891 ± 196 
814 ± 64 
546 ± 44 
CPM Palella' 
SodSal 
1305 ± 2 8 7 ( 1 1 2 % ) ' 
993 ± 79 (111%)' 
746 ± 90 (92 %)» 
544 ι 110 (99 % ) ' 
' Valuer гергеьеш mean ± SD of patellae from groups of 5 mice 
t
 % of mmol sulfate incorporated at SO j = I 0 mM 
' % of control not blgnifìcamly different from control (unpaired 2 
tailed) 
DISCUSSION 
In our patella assay, salicylate suppresses articular cartilage 
GAG synthesis, as measured by 35S-sulfate and 'H-
glucosamine incorporation, in a dose dependent fashion 
However, therapeutic concentrations (1-2 χ IQ-'M) appear 
to have no significant effect if the assay is performed in the 
presence of 100% serum In a recent study we demonstrat­
ed that in vivo salicylate causes not only suppressed sGAG 
synthesis, but also a striking fall in the endogenous sulfate 
level* Although, the suppressive action of therapeutic 
salicylate concentrations tends to be stronger with decreas­
ing sulfate levels in the incubation medium, sulfate deprived 
serum still fully protects cartilage against antimetabolic drug 
effects Consequently, if synovial fluid in vivo has the same 
protective effect as serum in vitro, the salicylate induced sup­
pression of sGAG synthesis observed m vivo1 is not due to 
a direct effect on the chondrocyte 
Salicylate acts very fast Without serum, suppression of 
patellar sGAG synthesis was already demonstrated after one 
h's exposure to the drag (2 X 10 'M) Whitehouse1·1 
showed in a study employing cartilage slices, that only 20 
mm were needed to establish this effect We found no ag­
gravation of suppression when the exposure time was ex­
tended to 6 h Moreover, even at the high salicylate 
concentration of 10 :M, the inhibition appeared complete­
ly reversible, since the sGAG synthetic rate returned to nor­
mal values within 2 h after removal of the drug 
In view of the observations of Palmoski and Brandr1, pro­
teoglycan decreased cartilage slices may be more suscepti­
ble to the action of salicylate However, no evidence has been 
obtained that patellar cartilage with a decreased proteogly­
can content is more vulnerable to salicylate Trypsin treated 
patellae or even patellae obtained from arthritic mice'l0 do 
not show a higher inhibition upon exposure to salicylate com­
pared with normal patella specimens (data not shown) We 
also investigated patellae from mice of different age (8, IS, 
27 weeks) Although H is not known whether the patellar 
proteoglycan content is decreased with age as was found for 
human articular cartilage15, drug mediated suppression of 
sGAG synthesis remained the same in every age group 
studied (Table 3) The observed decrease in J5S incorpora­
tion with age is in agreement with previous studies* 
An interesting finding was the repeatedly observed, albeit 
statistically insignificant, stimulation of sGAG synthesis at 
low salicylate concentrations (Ю- 1 and 10-aM) There aie 
2 publications on cartilage studies in which the same 
phenomenon is reported2 " Assuming that only free salicy­
late affects articular cartilage, it is interesting that at ther­
apeutic levels (1-2 χ lO^M) the free, not protein-bound, 
salicylate concentration in biological fluids of patients is in 
this low range1' 
At a high salicylat» concentration of 10 2M, which 
causes severe suppression of "S-sulfate incorporation, no 
adverse effect was observed on the normal "S-GAG release 
in prelabeled patellar cartilage Studies of others, done on 
cartilage slices, revealed that salicylate either inhibited GAG 
breakdown (rabbit cartilage") or even accelerated it (canine 
cartilage2) to varying degrees, depending on drug concen­
tration In trying to explain these discrepancies there are 
several points to consider Comparing the above assay 
methods, differences exist in duration ^ of tissue culture, 
prelabehng schedule, animal species, medium composition 
and cartilage integrity (anatomically intact versus damaged 
cartilage) Our study reports only on short term (hours) 
salicylate effects Recent data on this subject suggest that the 
outcome may be dependent on the culture conditions We 
have indications that just by prolonging the 3<S prelabehng 
period from 2 to 17 h, salicylate (10 2M) causes some in-
99 
hibition of the subsequent "S GAG release compared to 
control values from patellae undergoing the same incuba 
lion schedule without drug 
We recently reported that SodSal, administered to mice 
in a dose of 200 mg/kg not only suppressed patellar sGAG 
synthesis in wvo but also induced a striking fall in serum 
sulfate from the normal level of 1 0 mM to less than 0 4 mM 
within 4 h" In subsequent in vitro expenments, we demon 
strated that lowering of sulfate per se already provoked a 
decreased sGAG synthesis8 To establish which mechanism 
underlies the observed in vivo suppression of sGAG synthe 
sis (direct salicylate action, deprived sulfate availability or 
both) the influence of sulfate and serum on the salicylate 
mediated suppression was examined in vitro In the RPMI 
culture medium used in our studies, the sulfate concentra­
tion was 0 4 mM and this is rather low compared with the 
physiological serum sulfate level of 1 0 mM m C57B1 mice 
Employing these 2 sulfate concentrations, we observed that 
salicylate provoked a higher degree of suppression at low 
sulfate (Table 4) An important message from this observa 
tion is that one should make allowance for artificial drug ef­
fects in performing cartilage assays at too low sulfate levels 
A'ong this line it is common practice to assess sGAG syn­
thesis by incorporation of J ,S sulfate in a sulfate poor cul­
ture medium in order to reach high incorporation 
values19 -" In assaying salicylate, this schedule leads to an 
even higher suppression, which is actually an overestimat­
ed effect (Table 5) 
Our findings indicate that at least in cartilage culture 
studies, one should preferably use sulfate concentrations also 
present in body fluids of species from which the cartilage 
tissues are derived The \ anous commercial culture media 
as well as sera from several species differ markedly in sul 
fate levels21 The lowest sulfate concentration is found in 
human serum (0 3 mM'2) and the highest concentrations are 
found (among others) in sera of cows (1 8 mM31), rabbits 
(2 0 mM11), fetal calves (0 9 mM22), dogs (1 2-1 8 
mM21,'^) and mice of the C57B1 strain used in our study 
( 1 0 mM) Presumably most cartilage studies to date were 
performed at nonoptimum sulfate concentrations At this 
point it is important to mention the many studies done by 
Palmoski and Brandt Starting about 7 years ago, they ex­
tensively investigated drug effects, particularly of salicylate, 
on canine articular cartilage As stated in one of their 
publications" the sulfate concentration in the culture medi­
um (Ham's F12) was 5 x 1 0 'M Despite the presence of 
10% fetal calf serum (FCS) in the medium, the sulfate con­
centration is far too low compared to the level found in dogs 
(1 2-1 8 mM) Moreover, they incubated cartilage slices for 
more than 24 h, probably in this sulfate deprived medium" 
A possible overestimation of drug effects therefore cannot 
be ruled out 
In the initial studies done to develop our patella assay', 
it was noticed that addition of 20% mouse serum to the cul­
ture medium did not stimulate or inhibit "S-sulfate incor 
poration, at least in short term incubations However, in 
studying NSAID in the therapeutic concentration range, it 
is very important to realize that in vivo most of the drugs 
are for more than 95% bound to plasma proteins (chiefly 
albumin) For salicylate the degree of binding (99-75%) ap­
peared to be inversely proportional to the concentration 
( 0 5 2 5 x 1 0 'M) m human plasma" If the amount of free 
drug determines its activity to articular cartilage, then the 
effectiveness of salicylate is reduced by the extent of pro­
tein binding Since the free salicylate concentration in SF 
is virtually identical to that in plasma26 it is plausible that 
equal concentrations of free drug will be obtained in vitro 
using 100% mouse serum as incubation medium for our 
patella assay Employing scrum, the antimetabohc action of 
salicylate appeared to be remarkably reduced Therapeutic 
concentrations of salicylate, present in mouse serum as well 
as in human serum, seem not to inhibit the chondrocyte 
sGAG synthesis anymore (Table 6) 
Many investigators working with cartilage cultures apply 
no more than 10 to 20% serum in the culture medium In 
performing drug studies these serum levels may be too low, 
since a higher fraction of the drug may remain in the free 
form compared to in vivo conditions, and consequently is 
expected to be more potent in its chondrocyte directed ac­
tion Nevertheless studies done by us with mouse serum9 
and by others with P C S ' " demonstrated that 10-25% se­
rum is apparently enough to completely abolish the suppres­
sive effect of a low but therapeutic salicylate concentration 
(10 'M) In one study this protective effect of serum (10% 
FCS) was observed only when anatomically intact клее car­
tilage from loaded portions of the joint was used5 28, with 
intact cartilage from unloaded sites or with slices of normal 
or OA cartilage, lO-'M salicylate continued to exert a 
moderate to marked suppressive effect on sGAG 
synthesis2' At all events, our studies with albumin of hu­
man and mouse serum suggest that, perhaps among other 
unknown factors, the protective influence of serum may be 
attributable to protein binding of salicylate 
As discussed before, it is evident that the suppressive ef­
fect of salicylate (1-2x10 'M) on patellar chondrocyte 
sGAG synthesis is more pronounced at relatively low sul­
fate concentrations, but also that this suppression is abolished 
by 100% serum In this respect it is important to note that 
chondrocyte sGAG synthesis is suppressed already by a 
decreased availability of environmental sulfate in mouse se­
rum, which phenomenon was also demonstrated in our previ­
ous studies using sulfate deprived culture medium without 
serum
8
 Reduction of sulfate incorporation in patellar car­
tilage is already manifest at 0 4 mM SO; (40% reduction) 
and markedly high at 0 05 mM SO; (90% reduction) In­
terestingly, despite this disturbed sulfate metabolism, salicy­
late (2x 10 3M) appeared to have no additive suppressive 
effect (Table 7) Thus, even at low sulfate concentrations, 
100 
the protective property of serum is completely preserved 
It is reasonable to assume that this protection is also true for 
SF which is in drug equilibrium with the blood circulation 
Consequently, the recently observed in vivo suppression of 
patellar sGAG synthesis by syslemically administered 
salicylate" cannot be due to a direct drug effect on Chondro 
cytes, but might be at least to some extent, attributable to 
a (salicylate induced) decrease in sulfate availability ( < 0 4 
mM SOi) 
The suppressed sGAG synthesis experienced by patellar 
cartilage in vivo upon exposure to low sulfate, is obviously 
a rapid and reversible phenomenon, since subsequent in ufro 
35S sulfate incorporation in patellae from salicylate treated 
mice was not decreased in comparison with patellae from 
saline treated mice The same kftid of ex vivo studies were 
performed by Palmoski and Brandt" on articular cartilage 
of dogs treated for 9 weeks with therapeutic doses of aspi 
rin They observed no adverse effect on sGAG synthesis by 
normal cartilage, which is consistent with results from our 
short term ex vivo studies However, OA cartilage showed 
severe suppression of sGAG synthesis in \itro upon this 
chronic in vivo drug treatment It is tempting to speculate 
that this inhibition of chondrocyte function is due to a salicy 
late induced chronically decreased sulfate availability, caus-
ing irreversible effects on OA cartilage 
All our experiments were performed with normal ana 
tomicdlly intact, articular cartilage of the mouse patella and 
sodium salicylate as representative of the many NSAID avail-
able It would be of interest to assess whether the concen 
(ration of sulfate and the presence of scrum also modulate 
effects of other drugs, and how this may be further influenced 
in diseased cartilage 
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Summary 
A number of non-steroidal anti-inflammatory drugs have been shown to sup-
press chondrocyte glycosaminoglycan synthesis. In this study, the effects of tia-
profenic acid and sodium salicylate on 15S04 incorporation into intact patellar 
cartilage of C57 Bl mice, in vitro and in vivo, were investigated. The water-
soluble trometamol salt of tiaprofenic acid was used for both incubation and 
intraperitoneal injection. After incubation with the equivalent of 5 or 20 mg/1 
of tiaprofenic acid, "S incorporation into patellar cartilage was slightly but not 
significantly increased. Trometamol alone had no effect. Sodium salicylate de-
creased incorporation of 3SS at a concentration of 1 mM (to 80% of control 
value) and to a greater extent at 5 mM (to 54% of control value). In the in 
vivo studies, single doses of 4, 8, 16 and 32 mg/kg of tiaprofenic acid were used. 
Trometamol on its own was tested at a dose of 15 mg/kg. Sodium salicylate 
was given at a dose of 200 mg/kg. Blood and patellar samples were taken two 
hours later and assayed for 35S. Tiaprofenic acid given orally or i.p. had no 
effect on blood 35S content but caused a slight reduction in 35S incorporation. 
Sodium salicylate caused a marked decline in blood 35S content, and this was 
probably responsible for the reduction in 35S incorporation observed. Sur-
prisingly, oral administration of the doses of tiaprofenic acid and sodium sali-
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cylate mentioned above for seven and a half weeks had no deleterious effect 
on the knee-joint cartilage as was shown by histological examination. 
Introduction 
Several non-steroidal anti-inflammatory drugs (NSAIDs) commonly used in 
the treatment of rheumatic diseases provoke suppression of glycosaminoglycan 
(GAG) synthesis when slices of articular cartilage are cultured in the presence 
of these drugs [1-3]. 
We recently reported that salicylate, the most common NSAID, reduced 
GAG synthesis in normal articular cartilage of the mouse patella in vitro as 
well as in vivo. It is of interest in the latter case that a salicylatc-induced deple-
tion of endogenous sulphate was probably responsible for the observed sup-
pression of sulphated GAG synthesis [4,5]. 
We describe here our findings from preliminary experiments on the in vitro 
and in vivo effects on normal articular cartilage of tiaprofenic acid (TA), a new 
NSAID. These studies were done using anatomically intact murine patellar 
cartilage [6]. 
Materials and methods 
Animais 
Normal male C57 Bl mice, 6 to 9 weeks of age and weighing 20 to 25 g, were 
used. They were matched for weight and age before the start of each experi-
ment. 
In vitro studies 
Mice were sacrificed by cervical dislocation, and patella specimens were care-
fully removed from the knee-joints. The patellae were incubated as described 
[6] using RPMI culture medium containing the water-soluble trometamol salt 
of tiaprofenic acid (TroTA), trometamol (Tro) alone, sodium salicylate (Sod-
Sal) or no drug (control). After 30 min the patellae were transferred to fresh 
medium of the original composition plus Na235S04 (10 /iCi/ml). The incubation 
was continued for an additional '2 h. Thereafter, patellae were analysed for 
newly-formed cartilage GAGs. This was done by counting the amount of in-
corporated 15S-sulphate [6], since it was shown that the 15S content of whole 
patellae is a reliable measure for newly-formed sulphated GAGs in the patellar 
cartilage [7]. 
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In vivo .studies 
Groups of mice were injected intraperiloneally (i.p.) with TroTa, Tro and Sod-
Sal (10 /d/g). Fifteen minutes later drug-treated mice and saline-treated con­
trols received an i.p. injection of 2 /iCi Na^^SOVg. At various time intervals 
blood samples (10 μΐ) were taken from the tail and assayed for radioactive con­
tent. Two hours after ,5S-sulfate administration mice were sacrificed and whole 
patellae isolated and processed for "S counting (see above). 
Results and discussion 
In vitro effect of tiaprofenic acid and sodium salicylate on ^S-sulphate incorpora­
tion in patellar cartilage 
The effect of TA was studied using the water-soluble TroTA in therapeutic 
concentrations. Whole patellae were incubated in drug-containing medium for 
2.5 h, the final 2 hours in the presence of radio-labelled sulphate. Control patel­
lae were cultured in the absence of drug. 
As measured by "S incorporation, TroTA and Tro alone seemed to have no 
effect on the sulphated GAG synthesis in patellar cartilage (Table I). On the 
Table I: In vitro effect oj TA and SodSal on "S incorporation in patellar carti­
lage. 
Group 
Control 
TroTA 
TroTA 
TroTA 
Tro 
SodSal 
SodSal 
SodSal 
Concentration 
-
30 mg/1 
7.5 mg/1 
0.15 mg/1 
9.5 mg/1 
5 m M 
2 m M 
I m M 
epm/patella* 
596+130 
680 + 75 
670+163 
541+88 
617+142 
322 + 68 
465 + 88 
507+127 
Percentage of 
control 
100 
114 
112 
91 
104 
54 
78 
85 
TA = tiaprofenic acid 
Tro = trometamol 
TroTA = trometamol salt of tiaprofenic acid 
SodSal = sodium salicylate 
*Values represent mean + SD of patellae from groups of at least 5 mice. 
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Table Π: In vivo 35S incorporation in patellar cartilage after TA and SodSal 
treatment. 
Group Concentration (mg/kg) 
Control 
Tro 
TroTA 
TroTA 
TroTA 
TroTA 
15 
48 
24 
12 
6 
cpm/patella* 
327 + 38 
334 + 95 
244 + 62 
250 + 55 
230 + 46 
239 + 30 
Percentage of 
control 
100 
102 
75 
76 
70 
73 
SodSal 200 197 ±28 60 
See Table I for abbreviations. 
•Values represent mean + SD of groups of 5 mice. 
other hand, SodSal clearly exerted a dose-dependent suppression of "S-sul-
phate incorporation. 
To examine the effect on the natural sulphated GAG breakdown in patellar 
cartilage, 35S pre-labelled patellae were incubated with the highest concentra­
tions of TA and SodSal (as given in Table I). No effect on the rate of GAG 
degradation in the cartilage was observed. 
It should be emphasized that in these experiments no serum or proteins were 
added to the incubation medium, so the drugs were in the free form. Binding 
to serum proteins would reduce the concentration of unbound drugs. We found 
that 25% or more normal mouse serum in the culture medium offered complete 
protection for the suppressive action of 1 and 2 mM SodSal, concentrations 
which are achieved in the serum of patients [7]. 
With the results of these in vitro experiments it would be anticipated that 
these drugs would have no effects on GAG metabolism in normal articular car­
tilage in vivo at least when applied in a short-term schedule. 
Effect of tiaprofenic acid and sodium salicylate on in vivo }5S-sulphate incorpora­
tion in patellar cartilage 
Groups of mice were treated with a single dose of Tro, TroTa or SodSal, and 
control groups received saline. Fifteen minutes after administration of the drug 
(or saline) mice were injected with radio-sulphate. Two hours later mice were 
sacrificed and patellae isolated. 
TroTa or Tro alone had a negligible effect on the " S content of the blood 
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compared with control values. In contrast SodSal caused a clear decline in the 
blood 15S content (up to 40% of control values). The amount of 35S-sulphate 
incorporated in the patellae of drug-treated mice was in all cases reduced as 
compared with saline- or Tro-treated controls (Table II). About the same re­
sults were obtained after application of TA in pure form per os. 
The effects were not irreversible. The suppressed uptake of 35S-sulphate seen 
immediately after TroTa or SodSal administration had already returned to 
normal 5 hours after drug application. 
As found in earlier studies [4,5], the decrease in 35S content in the blood 
caused by a SodSal-induced sulphate diuresis appeared to be responsible for 
the reduced incorporation of 35S in the patellar cartilage GAGs. It is difficult 
to interpret the data obtained for TA. There is no dose-response effect observ­
able with TA; all doses seem to suppress the 35S-incorporation in patellar carti­
lage to the same extent. Moreover, since TA appeared not to influence the 35S 
handling in the mouse, a decreased sulphate availability cannot be the reason 
for the reduced 35S uptake in cartilage. A direct effect of TA on the patellar 
chondrocyte seems unlikely since short-term in vitro studies showed no effect 
on sulphated GAG metabolism (Table I). At the moment, there is no reason­
able explanation for this in vivo observation, and it is currently under investi­
gation. 
Above all, it is very important to realize that in vivo drug effects can be total­
ly different from those found in vitro. 
Effect of chronic oral administration of tiaprofenic acid and sodium salicylate on 
mouse knee-joint cartilage 
Groups of mice received once-daily oral doses for 1\ weeks of TA (32, 16, 8 
and 4 mg/kg), SodSal (200 mg/kg) or water (controls). Twenty-four hours after 
the last drug application, mice were injected with radio-sulphate. Three hours 
later the mice were sacrificed and the knee joints removed in toto for histologi­
cal and autoradiographic studies. 
Sections of whole knee joints, from TA- as well as from SodSal-treated mice, 
showed no chondrocyte death or depletion of cartilage proteoglycans as mea­
sured with Safranin О staining. As indicated by the labelling intensity due to 
incorporated 35S (autoradiographs), the vitality of the articular chondrocytes 
was not affected, as compared with chondrocytes in control sections. 
Conclusions 
In view of the data obtained in short-term in vivo experiments (Table II), it 
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is surprising that on gross observation the mouse knee-joint cartilage seems 
normal in every aspect The effects of chronically administered drugs on 
articular cartilage will now be studied in more detail 
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ABSTRACT 
A number of nonsteroidal antiinflammatory drugs (NSAIDs) were studied 
for their effects on normal and damaged murine articular cartilage, 
both in vitro and in vivo. In vitro, in the absence of serum, sodium 
salicylate (SodSal) caused significant suppression of S-glycosamino-
glycan (GAG) synthesis, whereas tiaprofenic acid (TA), Piroxicam (PX), 
prednisolone sodiun phosphate (Pred) and several other NSAIDs were 
without effect. Trypsin-mediated proteoglycan depletion did not change 
the susceptibility of the articular chondrocyte to these drugs. When 
arthritic cartilage was taken from an acutely inflamed joint also no 
aggravation of drug effect was seen and Pred even seemed to diminish 
inflammation mediated suppression of S-GAG synthesis. 
Short-term in vivo effects of some drugs were tested in mice with 
unilateral zymosan induced arthritis. At day 1 after arthritis induc-
tion, in vivo S-GAG synthesis by the cartilage of the arthritic joint 
was decreased to 63SS. Only SodSal suppressed in vivo S-GAG synthesis 
in the healthy and arthritic joint, both to the same extent. At day 28, 
GAG synthesis in the postarthritic joint was enhanced to 160%. This 
type of cartilage appeared to be more susceptible to drug effects, sin-
ce all drugs tested showed clear suppression of the augmented GAG pro-
duction in vivo. Finally, in vivo drug effects were tested on normal 
and enhanced S-GAG degradation, the latter in the zymosan induced ar-
thritic joint. Both TA and Pred appeared to suppress degradation in 
healthy and, to some extent, in arthritic cartilage. In conclusion, of 
the drugs tested only salicylate seems potentially harmful towards ar-
ticular cartilage, Piroxicam showed no adverse effect and tiaprofenic 
acid and prednisolone even exerted some beneficial effects. 
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INTRODUCTION 
A serious drawback of the u&e of NSAIDs in the treatment of arthritis 
or arthrosis (osteoarthritis) may be their potential side effect on ar­
ticular cartilage. Using in vitro culture systems with slices of normal 
articular cartilage, suppression of GAG synthesis was demonstrated 
first for salicylate (1) and subsequently for a number of other NSAIDs 
(2). Later on, it was shown that the suppressive effect of salicylate 
was aggravated when arthrotic cartilage was used compared to normal 
cartilage (3). In addition, long-term in vivo treatment with salicylate 
enhanced the extent of cartilage damage m experimental arthrosis mo­
dels (4,5) and also the occurrence of spontaneous arthrosis in a sus­
ceptible mouse strain (5,6). 
Using anatomically intact murine articular cartilage we found no 
harmful effect of salicylate on basal GAG metabolism under nearly phy­
siological in vitro conditions (7). Furthermore, we provided evidence 
that in vivo suppressive effects, provoked by salicylate administration 
to healthy mice, could be related to a disturbance in the endogenous 
sulfate pool rather than to a direct influence on articular chondro­
cytes (8). In the present study we compared a nunber of NSAIDs for 
their effects on normal and damaged cartilage both in vitro and in vi­
vo. 
MATERIALS AM) METHODS 
Animals. Male C57B110 mice, aged 9-12 weeks at the start of each drug 
experiment were used. They were fed a standard, pellet diet and tap 
water ad libitum. They were in good health or suffered from monoarthr­
itis, which was induced by intra-articular injection of 180 μg zymosan 
in the ngh knee joint. Prior to the start of each experiment, mice 
(22-27 gram) were weight-matched (± 2 g) and age-matched (± 0.5 week). 
Antirheuaatic drugs. Tiaprofenic acid (TA) was obtained from Roussel 
Uclaf, Piroxicam (PX) from Pfizer, Indomethacin and Sulindac sulfoxide 
from Merck, Sharp and Dohme, Naproxen-sodium salt from Sarva-Syntex, 
Ibuprofen from the Boots Company, Pirprofen, Tnbenoside and CG 5391B 
(an experimental drug) from Ciba Geigy. Sodium salicylate (SodSal), 
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Acetyl salicylic acid, Paracetamol and Prednisolone sodium phosphate 
(Pred) were delivered by our in-house pharmacy. 
In vitro studies. Patellar cartilage was used as a source of anatomi­
cally intact articular cartilage and sulfated GAG metabolism was stu­
died by described methods (7,10,11). In the presence of drug in the 
culture medium (RPMI), most incubations were performed in a time-span 
of 4 hours of which the last 2 hours with 35S-sulfate (20 цСі/тІ). The 
amount of radiosulfate was expressed in radioactivity units. Incorpora­
tion values were adjusted to the mean control value (incubation without 
drug), which was accepted аз 100 units. The drugs were directly dis­
solved in RPMI culture medium, or first in 0.15 N NaOH (ТА, PX) or 
ethanol (Ibuprofen). During incubation the pH was 7.4 and ethanol, if 
present, below 0.1S. 
In some experiments normal patellae were first subjected to trypsin 
(1 mg/ml RPMI) treatment for one hour (37 0 C ) , in order to deplete the 
cartilage matrix of proteoglycans. After thorough washing with RPMI 
they were used for the described drug incubation experiments. 
In vivo studies. Groups of mice with 1 day-lasting monoarthritis re­
ceived drugs orally in solution or in suspension in tap water by gas­
tric intubation. Control mice received tap water (250 μΐ/mouse). To 
study drug effects on in vivo sulfated GAG synthesis, NA235S0i, was in­
jected intraperitoneally (2 цСі/д) 30 minutes after drug dosage. Four 
hours later mice were killed and the incorporated amount of 35S-GAG in 
their patellae was assessed (10,11). For in vivo degradation studies, 
groups of mice were first injected with 3bS-sulfate followed, 24 hours 
later, by drug administration. Two hours after drug application unila­
teral zymosan arthritis was induced. At this time point the amount of 
incorporated S in the patella was accepted as 100 units. Then, drugs 
were given 4 hours later and, at the next day, 22 hours later (i.e. day 
1 arthritis). In one experiment, drug dosing was continued with a 
fourth and fifth dosage, 28 and 46 hours after induction of arthritis 
(i.e. day 2 arthritis), respectively. Mice were killed two hours after 
the last drug application. The remaining 3 5 S amount in the healthy and 
arhritic patellae was subsequently quantified. 
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Statistical analysis. Differences between means were considered statis-
tically significant when p<0.05 according to Student's t test for un-
paired data. Since the standard deviation was less than 20 or, in some 
experiments, 25 35S-radioactivity units, the control values (mean ±SD) 
were not always stated apart, but accepted as e.g. 100 ± 25 units. 
RESULTS 
In vitro effect of various drugs on normal anatomically intact carti-
lage. The effect of a number of drugs on chondrocyte S-GAG synthesis 
was studied in a short-term in vitro culture. Murine patellae were pre-
incubated in drug-containing medium for 2 h followed by a 2 h S-sul-
fate labeling period in the presence of the drug. As described earlier 
(7) SodSal caused a dose dependent suppression of S-GAG synthesis in 
the concentration of 1-5 mM. The highest dose was routinely used as a 
positive control for drug screening in our cartilage assay system. At 
therapeutic antiinflammatory concentrations and higher ones, neither 
TA, PX nor Pred caused a significant change in S-GAG synthesis (Table 
1). A number of other drugs listed in Table 1 were tested once. Only 
aspirin and at a very high concentration, pirprofen seem to inhibit 
chondrocyte synthetic function. Ethanol, a vehicle commonly used to 
dissolve certain drugs, can safely be used in end concentrations of 
0.04-0.1%, but higher concentrations suppressed chondrocyte GAG 
synthesis. The lowest concentrations of TA, PX and Pirprofen (Table 1) 
occur as free (i.e. not plasma-bound) amounts in the synovial fluid of 
therapeutically treated patients. Around these low concentrations we 
never observed adverse effects on patellar GAG synthesis. SodSal, PX, 
TA and Pirprofen were also tested at several concentrations, including 
those of Table 1, in S-pulse chase experiments (2 h pulse and 6 h 
chase) to examine their potential effect on the basal PG breakdown. 
Neither retardation nor acceleration of PG catabolism was observed. In 
further in vitro experiments, to be described here, the effects 
of SodSal, TA, PX and Pred were investigated only at the highest 
concentration shown in Table 1. 
Exaiination of potential changes in drug susceptibility of damaged car-
tilage in vitro. Joint inflammation is accompanied by proteoglycan de-
lie 
Table 1. Effect of various NSAIDs on basal sulfated GAG synthesis in 
mouse patellar cartilage in vitro. 
Drug 
Sodiun salicylate 
(SodSal) 
Tiaprofenic acid 
(TA) 
Piroxicam 
(PX) 
Prednisolone sodi­
um phosphate (Pred) 
Concentration 
mM 
5.0 
3.Θ χ 
7.7 χ 
6.0 χ 
1.2 χ 
3.0 χ 
10-ц 
ю-
2 
ю-
4 
ю-
1 
ю-
1 
цд/ті 
800 
0.1 
20 
0.2 
40 
145 
S incorporation 
units* 
62 
98 ± 16 
99 
102 ± 23 
97 
98 
± 13* 
/121 ± 24 
± 20 
/ 90 ± 14 
± 12 
± 7 
N 0 
10 
2 
6 
2 
6 
4 
Acetylsalicylic acid 4.4 800 
(Аьрігіп) 
Paracetamol 
Indomethacin 
Naproxen, sodium salt 
Sulindac sulfoxide 
Ibuprofen 
Pirprofen 
Ethanol 
5.3 
1.4 χ IO"3 
1.6 χ Ю- 1 
5.6 χ IO"3 
1.9 χ IO"1 
4.0 χ IO"3 
1.5 χ Ю- 1 
0.04 % 
0.1 % 
0.4 % 
800 
0.5 
40 
2 
40 
1 
40 
40 
100 
400 
74 
103 
95 ± 28 
105 
118 
95 
102 
72 
101 
104 
73 
+ 
+ 
1В* 
14 
/119 ± 15 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
28 
29 
12 
18 
8* 
18 
21 
17* 
2 
# Results represent the mean ± SD of incorporated radioactivity units/ 
patella (see materials and methods), calculated from data of one or 
more experiments, each consisted of patellae from 6 mice. If more 
than two experiments were done the mean of the average incorporation 
values per experiment is presented. Mean control value is accepted 
as 100 ± 20 units. 
* Significantly different from control. 
0
 Number of experiments. 
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pietion of the cartilage matrix, and a suppressed chondrocyte synthetic 
activitity (9). To investigate whether chondrocytes in a proteoglycan 
(PG) depleted matrix per se are more susceptible to adverse drug ef­
fects, murine patellae were artificially depleted of PGs using short-
term trypsin treatment. This resulted in loss of 40-50% of the PGs and 
the subsequent chondrocyte synthetic activity was reduced to 32-43S of 
synthesis in normal cartilage. Nevertheless we did not observe any in­
crease in suppressive effects of the drugs tested. Compared to normal 
cartilage, SodSal caused a similar or even a reduced suppression of 
sulfated GAG synthesis in trypsin treated patellae. Of interest, Pred 
Table 2. In vitro effect of drugs on sulfated GAG synthesis by PG de­
pleted cartilage. 
Drug 
35 S incorporation units* 
Normal Trypsin 
Control 
Sodsal 
TA 
PX 
Pred 
100 ± 17 
100 ± 17 
100 ± 19 
46 ± 9* 
51 ± Θ* 
83 + 18 
108 ± 27 
79 + 18 
96 ± 16 
100 ± 10 
100 ± 12 
100 ± 18 
63 ± 11* 
56 ± 8* 
102 ± 27 
90 ± 20 
87 ± 21 
114 ± B* 
Relative S content 
in absence of drug: 100ÜÍ 38% 
# Radioactivity units per patella (see materials and methods). Values 
represent the mean ± SD of patellae from 6 mice. Mean control value 
accepted as 100 units. 
* Significantly different from control. 
0
 Experiment number. 
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appeared to stimulate slightly the suppressed rate of synthesis in the 
affected cartilage. TA and PX were still without effect (Table 2). 
To mimic more closely the in vivo situation of an inflamed joint, 
patellae were taken from arthritic joints at day 1 and day 28 after 
induction of zymosan arthritis. At day 1 chondrocyte sulfated GAG syn-
thesis was reduced to b'\°í. Again, on the average, no aggravation of the 
SodSal mediated suppression was found and, of the other drugs tested, 
Pred even significantly enhanced the synthetic activity in the arthri-
tic cartilage (= «relief of inhibition), (Table 3). At day 2B, zymosan 
induced arthritis has waned (9) and the chondrocyte tries to restore 
its depleted matrix, reflected by enhanced synthesis (lAT'o). Also this 
condition of the cartilage did not result in enhanced susceptibility to 
adverse drug effects (Table 3). 
In vivo effects of drugs on healthy and arthritic cartilage. Unilateral 
arthritis was induced with zymosan to enable investigations of in vivo 
drug effects on sulfated GAG turnover in both normal and arhntic car-
tilage. In vivo, antirheumatic drugs may potentially exert adverse ef-
fects on already damaged cartilage but, on the other hand, may cause 
antiinflammatory effects, with concomitant reduction of inflammation 
mediated cartilage damage. Thirty minutes after oral administration of 
drugs, chondrocyte sulfated GAG synthesis was assessed m vivo by iso-
lation of patellae 4 h after S-sulfate injection. In healthy cartila-
ge significant suppression of sulfated GAG synthesis was found after 
SodSal treatment, but not with the other drugs (Table 4). In arthritic 
cartilage, taken at day 1, S-GAG synthesis is already reduced to 63% 
compared to synthesis in contralateral healthy cartilage. SodSal media-
ted suppression of sulfated GAG synthesis was also found in this arthr-
itic cartilage and appeared to be in the same order of magnitude (Table 
4). Again the other drugs (TA, PX, Paracetamol) showed no significant 
effect. At day 28 of zymosan arthritis the 35S-GAG synthesis was enhan-
ced to 160% in the postarthntic cartilage compared to healthy cartila-
ge. Again, although not as high as usual, SodSal mediated suppression 
of synthesis was found in the healthy cartilage. However, in the postar-
thntic cartilage the SodSal suppressive effect seemed slightly higher, 
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Table 3. In vitro effects of drugs on sulfated GAG synthesis by healthy 
and (post)arthritic articular cartilage. 
3 5 dk 
S incorporation units* 
Drug 
Day 1 Day 28 
healthy arthritic healthy postarthritic 
Control 1 100 ± 14 100 ±7 100 ± 20 100 ± 25 
2 100+15 100 ± 2Θ 100 ± 19 100 ± 21 
SodSal 1 56 + 4 * 67 ± 7 * 61+10* 53+11* 
2 69 ± 12* 46 ± 21* 86 + 12* 68 ± 10* 
TA 
PX 
Pred 
Relative 
content : 
senee of 
1 
2 
1 
2 
1 
2 
3 5S 
in ab-
drug: 
83 ± 18 
121 ± 13* 
99 ± 16 
94 + 19 
95 + 11 
109 ± 19 
100 % 
102 ± 
127 + 
96 ± 
101 ± 
118 ± 
148 + 
51 
20 
42 
12 
27 
12* 
14* 
% 
77 ± 14* 
122 + 25 
86 ± 21 
119 ± 27 
92 ± 17 
102 ± 20 
100 % 
92 ± 19 
125 ± 23 
80 ± 28 
99 + 28 
96 ± 12 
120 + IB 
147 % 
* Values represent the mean ± SD of patellae derived from 6 mice with 
unilateral zymosan induced arthritis. Mean control values accepted as 
100 units (see materials and methods). 
* Significantly different from control. 
0
 Experiment number. 
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Table A. In vivo effects of drugs on sulfated GAG synthesis by healthy 
and (post)arthritic articular cartilage. 
Drug 
(| 
Control· 
SodSal 
TA 
PX 
Parace­
tamol 
Relative 
content 
sence of 
Dose 
Tig/kg) 
_ 
200 
16 
10 
200 
3 5 S 
in ab-
drug: 
Day 
healthy 
100 ± 25 
62 ± 14* 
86 ± 22 
ΘΘ + 24 
119 ± 30 
100 % 
1 
Ï5S 
arthritic 
100 ± 
5Θ ± 
82 ± 
88 ± 
113 ± 
63 
25 
14* 
24 
24 
21 
% 
incorporation units* 
(n) 
(10) 
(10) 
(10) 
(10) 
(8) 
Day 
healthy 
100 ± 25 
72 + Θ* 
95 ± 24 
110 ± 17 
nd 
100 % 
• 28 
postarthritic 
100 ± 25 
54 ± 5* 
73 ± 22 
57 ± 7* 
nd 
160 % 
(n) 
(6) 
(6) 
(6) 
(6) 
* Data represent the mean ± SD of patellae derived from (n) mice with 
unilateral zymosan induced arthritis; nd = not done. 
* Separate control experiments were performed for each drug tested. The 
mean ± SD of control values were accepted as 100 ± 25 units (see ma­
terials and methods). 
* Significantly different from control values. 
and PX and TA also caused inhibition, albeit the latter not signifi­
cant, indicating that this cartilage is more drug susceptible. In fact, 
the drugs inhibit the attempt at repair of the cartilage by reducing 
the enhanced synthetic function (aimed to restore the PG depleted ma­
trix). 
Effect on in vivo breakdown of articular GAGs. Using unilateral zymosan 
induced arthritis the effect of drugs was tested on both basal and 
accelerated degradation in the healthy and arthritic joint, respective-
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ly. Table 5 shows that 26-393Í and 47% of the 3 5S label was lost from 
the healthy patellae after 24 h and 48 h respectively, reflecting a 
rapid turnover. In the arthritic joint these figures were 49%-64й and 
67% respectively, pointing to enhanced degradation. From the drugs 
tested TA, Tribenoside and CG 5391B significantly suppressed the basal 
breakdown over 24 h, as found in mice treated with water alone. 
However, compared to the original S content (24 h before) Pred and PX 
(once) stopped significant breakdown in healthy cartilage. TA, CG 5391В 
and Pred (once) also had a significant reducing effect on enhanced de­
gradation in the arthritic joint (Table 5). 
Surprisingly, none of the drugs modulated the natural or accelerated 
breakdown in the 2-days drug experiment. In this particular experiment 
the antiinflammatory effect of the drugs was determined prior to the 
sacrifice of the mice. Therefore, joint inflammation was quantitated at 
day 2 arthritis by performing mTc-uptake measurements (9). Only 
Pred showed a significant antiphlogistic effect (Table 6). 
9 9 
Table 6. Drug effect on joint inflammation: mTc-uptake measurements. 
Drug Day 2 zymosan-induced arthritis 
treatment R/L-ratio* 
Control 1.57 ± 0.09 
SodSal 1.83 ± 0.29 
ТА 1.64 ± 0.19 
PX 1.52 ± 0.22 
Pred 1.24 ± 0.22* 
# Results depict the mean ± SD of R/L-ratios, calculated from the 
mTc-uptake (see ref 9) measured alternately on the right (R) knee 
joint (arthritis) and the left (L) kee joint (normal) of 6 mice. 
* Significantly different from control (p<0.01) by the one-tailed Mann-
Whitney U test. 
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Table 5. In vivo degradation of sulfated GAGs: S content left in рге-
1abeled patellae. 
Remaining S content (units)* 
Drug 
( s i n g l e N ° Day 1 N ° Day 2 
dose/kg) 
h e a l t h y a r t h r i t i c h e a l t h y a r t h r i t i c 
Tap water 1 67 ± H 44 ± 15 1 53 ± 12 33 ± 9 
(10 ml) 2 6 1 + 1 5 36 ± 8 
3 74 + 14 51 ± 9 
SodSal 1 64 ± 3 45 ± 5 1 6 3 + 9 3 3 + 3 
(200 mg) 3 76 ± 11 4 4 + 8 
TA 1 80 ± 20 7 0 + 2 4 * 1 64 ± 18 32 ± 7 
(16 mg) 2 101 ± 30* 54 ± 16* 
3 101 ± 22* 67 + 20 
PX 1 52 ± 14 32 ± 8 1 64 + 7 3 1 + 1 0 
(10 mg) 3 95 + 29 58 + 16 
Pred 2 82 ± 26 5 8 + 1 3 * 1 6 2 + 8 4 0 + 8 
(1 mg) 3 8 9 + 4 0 58 ± 21 
Tribenoside 2 99 ± 35* 55 ± 24 nd nd 
(200 mg) 
CG 5391В 2 94 ± 15* 53 ± 16* nd nd 
(25 mg) 
* Results represent the mean + SD of patellae obtained from 6 monoar-
thritic mice; S content at time of arthritis induction accepted as 
100 ±20 units; nd = not done. 
* Significantly different from tap water treated mice. 
0
 Experiment number. 
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DISCUSSION 
Our data indicate that, of the NSAIDs tested, only salicylate exerted 
harmful side effects towards articular cartilage, whereas tiaprofenic 
acid (TA), Piroxicam (PX) and Prednisolon (Pred) did not. Furthermore, 
arthritic cartilage with a depleted matrix and changed chondrocyte syn­
thetic activity did not merely show a higher susceptibility to adverse 
drug effects. 
Earlier work from our laboratory revealed that salicylate mediated 
suppression of in vivo S-GAG synthesis was probably related to a lo­
wering of endogenous sulfate. Sulfated GAG synthesis is highly depen­
dent on the sulfate concentration (7,8) and salicylate caused a deep 
fall in the serum sulfate level early after administration (Θ). Some of 
the other drugs tested in vivo in the present study, showed a variable, 
but ignorable effect on endogenous sulfate (data not shown). 
Recent studies of Palmoski and Brandt demonstrated that suppression 
of GAG synthesis by salicylate and indomethacin was higher in arthrotic 
compared to normal cartilage (12). Not the PG depletion of the carti­
lage per se, with concomitantly higher drug accessibility to the chon­
drocytes (12), appeared to be resposible for this phenomenon but the 
apparent condition of the chondrocyte. Increased susceptibility was 
found in arthrotic depleted cartilage with highly enhanced chondrocyte 
synthetic activity (13). Our data lend further support to this. Mere 
enzymatic PG depletion of the cartilage matrix did not result in higher 
drug effects, and higher susceptibility was also not found in arthritic 
cartilage with a depleted matrix and already suppressed S-GAG syn­
thesis. However, our data in postarthritic cartilage do suggest that 
the phenomenon of enhanced drug susceptibility only occurs when the 
chondrocyte synthetic function is stimulated. Of interest, since this 
phenomenon was seen in vivo, and not in vitro, modulation of systemic 
factors by the drugs in question must be involved in the suppression of 
the augmented chondrocyte anabolic activity. It remains a matter of de­
bate whether suppression of enhanced synthesis to nearly normal synthe­
tic levels (Table 4) must be termed a harmful side effect. A final jud­
gement seems related to the fact whether enhanced synthesis should be 
considered as a necessary attempt at repair or may be an unwanted over­
shoot phenomenon. 
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The maintenance of an intact cartilage matrix depends on the 
delicate balance of chondrocyte mediated synthesis and degradation of 
matrix components. Of the drugs tested in this study only salicylate 
appeared to inhibit synthesis. S-pulse chase studies revealed that 
the present NSAIDs did not affect in vitro proteoglycan degradation in 
normal cartilage. However, in vivo some of the drugs like TA, 
Tnbenoside and CG 5391B, and perhaps Pred clearly inhibited normal 
breakdown. Whether this should be considered as an unwanted side effect 
is at present unclear. In addition, these drugs also seemed to inhibit 
the enhanced degradation in arthritic cartilage in vivo, and this is 
undoubtedly a beneficial effect. Enhanced degradation is probably the 
result of protease activity in the cartilage, originating either from 
inflamed synovium, stimulated leucocytes or interleukin-1 (11-1) acti-
vated chondrocytes (14,15). In vitro studies already demonstrated that 
steroids may interfere with cartilage breakdown by inhibiting 11-1 pro-
duction (16). 
The usefulness of an antirheumatic drug in the treatment of arthr-
itis must be seen in the light of its overall effect. On the one hand 
drugs may be harmful when they further suppress the already decreased 
chondrocyte synthetic activity in arthritic cartilage. On the other 
hand drugs may suppress inflammation, and thereby inflammation mediated 
effects on cartilage such as inhibited chondrocyte PG synthesis and en-
hanced matrix degradation. Although NSAIDs are developed and applied 
for their antiinflammatory action, their effects in suppression of mu-
rine joint inflammation were not evident. In our hands only predmsolo-
9 9 
ne significantly inhibited edema formation as measured by mTc-up-
take by the joint (Table 6). Our findings are in agreement with obser-
vations of Hunneyball in the antigen-induced arthritis model in mice. 
They observed a similar lack of effect of a number of NSAIDs, in either 
inflammation or cartilage damage (17), When clear antiinflammatory 
action is lacking, the effect of NSAID treatment is probably primarily 
analgesic and the drug of first choice should be one without side ef-
fects on cartilage. 
The place of steroids in the treatment of arthritis is still a mat-
ter of considerable debate. In this study prednisolone sodium phosphate 
diminished joint inflammation (Table 6), partly prevented inflammation 
mediated suppression of GAG synthesis in vitro (Table 3) and inhibited 
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enhanced degradation in arthritic cartilage in vivo (Table 5). 
Beneficial steroid effects were also seen in the study of Hunneyball 
(17). Inhibitory effects on chondrocyte synthetic activity as described 
in the literature (18,19) were not evident in the present study. It 
should be mentioned that the described inhibitory effects relate to 
(rather) high steroid doses. In this respect it seems worthwhile to 
extend steroid studies with low doses and to screen in long-term 
studies for unwanted side effects. Especially the observation that very 
low concentrations of steroids already inhibit in vitro 11-1 mediated 
cartilage breakdown (20) warrants further investigation of in vivo 
applicability, since side effects are then hardly expected. 
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CHAPTER 8 
EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON CARTILAGE DESTRUCTION 
IN ANTIGEN INDUCED ARTHRITIS IN MICE 
Bernard J de Vries, Wim В van den Berg, Elly Vitters and Levinus BA van 
de Putte 

EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON CARTILAGE DESTRUCTION 
IN ANTIGEN IMMCED ARTHRITIS IN NICE 
ABSTRACT 
The nonsteroidal antiinflammatory drugs, salicylate, piroxicam and tia-
profenic acid and the steroid prednisolone were investigated in a long-
term study for their potential detrimental or benificial effects on 
joint cartilage of mice with antigen induced monoarthritis. Daily drug 
treatment over a period of 4-7.5 weeks did not affect the histological 
characteristics of normal joints at all. Articular chondrocyte synthe-
tic activity was even stimulated after salicylate and tiaprofenic acid 
treatment, but the significance of this finding is not clear yet. Carti-
lage damage, caused by inflammation in the knee joint, was neither 
markedly deteriorated nor attennuated by these drugs. Slight antiin-
flammatory properties (decrease in edema ( mTc-uptake) and in in-
flammatory cells) were only evident with prednisolone, piroxicam and 
salicylate. 
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INTRODUCTION 
Antigen-induced arthritis is an allergic type of joint inflammation, 
elicited by intra-articular injection of antigen into the knee joint of 
pre-immumzed animals. This type of arthritis can be induced in mice 
with positively charged antigens like methylated bovine serum albumin 
(mBSA) (1,2,3). It bears histopathological resemblance to rheumatoid 
arthritis with regards to lymphocytic infiltrate in the synovial tissue 
and progressive cartilage destruction (4,5). One pharmacological study 
in this murine model so far has shown that the arthritis responds to 
steroids and some second line drugs (6,7). The nonbteroidal antiinflam­
matory drugs (NSAIDs), Ibuprofen, flurbiprofen and indomethacin were 
without effect (6). 
NSAIDs are commonly used in the treatment of various forms of arthr­
itis, including rheumatoid arthritis. However, recent experimental stu­
dies have shown that certain NSAIDs are detrimental to articular carti­
lage, especially osteoarthntic cartilage (8,9). On the one hand, drugs 
may theoretically exert beneficial effect in arthritis by suppressing 
joint inflammation, and therefore inflammation mediated cartilage da­
mage (4,5). On the other hand, chondrocytes in already damaged cartila­
ge of an arthritic joint perhaps may be more susceptible to adverse 
drug effects. 
The present study was set up to investigate the overall effect of 
long-term treatment with various NSAIDs in the murine arthritis model. 
Animals were used with unilateral arthritis, which enables us to screen 
the effect of drugs on both normal and arhntic cartilage. 
MATERIALS AND METHODS 
Animals and arthritis induction. Healthy, male C57B110 mice, aged 6-7 
weeks, were used for a 7.5 week drug treatment experiment (salicylate 
and tiaprofenic acid). Unilateral arthritis was induced in mBSA-immu-
nized mice (9-12 weeks of age) as previously decnbed (5) by intraarti­
cular (i.a.) injection of 40 цд mBSA (in 6 μΐ physiological saline) in­
to the right knee joint. These inflammatory monoarthntic mice were 
used to study the effects of oral administered drugs, during a 4 week 
period, on both normal and arthritic cartilage. To assess the seventy 
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of knee joint inflammation, n,Tc-uptake measurementb were done as 
described (10). Mice were fed a standard, pellet diet and tap water or 
drug-containing water (see below) ad libitum. Prior to the start of 
each experiment, mice were weight- and age-matched. 
Drugs. Mice received by oral gavage 250 μΐ of tap water (control) with 
dissolved drugs (prednisolone sodium phosphate, sodium salicylate) or 
with homogemcally suspended drugs (piroxicam, tiaprofenic acid). In 
another experiment drugs weie added to the drinking water. The drugs 
were dissolved in tap water or first in a negligible volume (less than 
0.5% of the ultimate volume of drug water) of 0.15 N NaOH. All drug-wa­
ters had pH 8, identical to the pH of tap water at that time. Drink 
containers were protected from light; contents (70 -150 ml) were routi­
nely renewed every 2A h. 
Histology »id autoradiography. Mice were killed by ether anaesthesia. 
The joints were dissected and processed for histology. Total knee sec­
tions (7 μπι) were prepared, mounted on gelatin-coated slides and stain­
ed with haematoxylin and eosin (H 4 E) or with Saframn 0. When chon­
drocyte function was studied, mice were injected intrapentoneally with 
2 μΟι Ма23550ц/д 3 h before sacrifice. Paraffin sections of total knee 
were dipped in K5 emulsion (Ilford, Basildon, Essex, England) and expo­
sed for 3 weeks. After this period the slides were developed and stain­
ed with H 4 E. Cellular infiltration, exudation and proteoglycan loss 
(Saframn 0 loss) were scored semi-quantitatively with light microscopy 
on five to seven serial sections. 
In some experiments the patellae of S-sulfate treated mice were 
excised and used to quantitate chondrocyte synthetic activity (11). 
RESULTS AND DISCUSSION 
Effect of NSAIDs on developing arthritis. Unilateral arthritis 'as in­
duced in mBSA immunized mice by i.a. injection of 40 μg mBSA into the 
right knee joint. Drug dosing commenced four hours prior to arthritis 
induction. From that moment, drugs were given twice a day (at 9 h a.m. 
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and 6 h p.m.), seven days a week for four weeks by oral application. At 
days 7, 14 and 21 mTc-uptake measurements were done to assess the 
seventy of knee joint inflammation. Inflammation was expressed as the 
9 9 
ratio of mTc-uptake in the right arthritic versus that in the left 
non-inflamed joint. At day 28 animals were sacrificed and inflammation 
and cartilage destruction were scored on whole joint sections. Table 1 
shows the effects on rnTc-uptake. None of the drug treated groups 
showed a significant suppression compared to the group treated with wa-
ter. However, group 1, i.e. mice not treated with daily gavage with wa-
ter, showed significantly higher inflammation at day seven. 
Histologic assessment of joint inflammation and cartilage damage is 
shown in Table 2. No large differences were seen between the various 
groups with respect to infiltrate, exudate and proteoglycan loss from 
the articular cartilage. The left non-arthritic joints of all groups 
were completely normal in every aspect, indicating that 4 weeks drug 
treatment does not anyhow cause gross cartilage damage. 
The previous experiment suggested that the act of oral administra-
tion, twice a day, on its own may suppress joint inflammation. Group 
one showed higher Tc-uptake at day 7 and cartilage proteoglycan deple-
9 9 
Table 1. mTc-uptake measurements. 
R/L ratio of 99mTc-uptake* 
Group Treatment Dose · Day 7 Day 14 Day 21 
1.47±0.18* 1.1B±0.08 1.17±0.10 
1.29±0.14 1.1B+0.G8 1.11±0.11 
1.32+0.10 1.20±0.08 1.14+0.08 
1.24+0.13 1.14±0.10 1.12±0.11 
1.34±0.19 1.16±0.14 1.17±0.10 
* R/L ratio's exceeding 1.1 indicate joint inflammation; data repre-
sent mean+SD of 12 mice. 
* Dose of one oral application in mg/kg. 
* Significant difference between group 1 and 2: p<0.02. 
1 
2 
3 
4 
5 
-
water 
sodium 
salicylate 
Piroxicam 
tiaprofenic 
acid 
-
-
200 
10 
16 
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Table 2. Histological grading of arthritis. 
Group 
1 
2 
3 
4 
5 
Treatment 
_ 
water 
salicylate 
Piroxicam 
tiaprofenic acid 
Infiltrate 
synovium 
1.1* 
0.8 
1.4 
0.6 
1.2 
in* Exudate 
joint 
0.8 
0.4 
0.5 
0.3 
0.3 
sp 
in* 
lace 
Cartilage PG * 
depletion 
1.8 
1.1 
1.3 
1.0 
1.5 
* Scored on a scale from 0-2. 
* Scored on a scale from 0-4; 4 meaning complete depletion. 
* Values represent the mean calculated from groups of 12 mice. 
tion also tended to be higher pointing to more preceeding inflamma­
tion. The following experiment was set up to repeat this observation 
and to see whether the potential stress of daily oral gavage can be 
avoided by putting the drugs in the drinking water. Prednisolone was 
included as a positive control. Table 3 shows the Tc-uptake values in 
animals treated with drug waters. In one experiment Tc-uptake was only 
measured at day 4, in a second experiment measurements were done at 
days 4, 7 and 14 and animals were sacrificed at day 28 for histology. 
Table 3. Effect of drugs in drinking water on arthritis. 
R/L ratio of 99mTc-uptake* 
Group Treatment Day 4 · Day 4 Day 7 Day 14 
1 oral да адед 1.97±0.32 1.73±0.21 1.33±0.17 1.16+0.07 
2 water 1.86+0.16 1.55±0.25 1.23+0.12 1.14+0.10 
3 salicylate 2.07+0.42 1.39+0.18 1.30±0.11 1.16+0.08 
4 piroxicam 1.41+0.12* 1.27±0.07* 1.16±0.11 1.13±0.06 
5 tiaprofenic acid 1.69+0.37 1.51±0.29 1.29+0.12 1.18+0.09 
6 prednisolone 1.45+0.20* 1.48+0.24 1.16±0.14 1.11±0.10 
* Mean±SD calculated from groups of at least 9 mice. 
* Day 4 measured in a separate experiment. 
Δ Twice a day 250 μΐ tap water/mouse per os. 
* Statistically significant difference compared to group 2. 
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The results clearly indicate that stress induced by daily oral gavage 
does not necessarily cause suppression of joint inflammation (compari­
son of groups 1 and 2). The Tc-uptake measurements in group 1 were even 
higher, although not reaching statistical significance. Furthermore, 
Piroxicam (2 times) and prednisolone (once) showed significant suppres­
sion at day 4 (Table 3). At day seven slightly decreased values were 
still noted for these two drugs, not reaching statistical significance 
anymore. 
To become informed about the average drug intake, the water consump­
tion was measured daily. Average values over the whole 4 week period 
are shown in Table 4. The daily doses (ml) of group 1 (inclusive 500 μΐ 
by oral gavage), tiaprofenic acid and prednisolone group approximated 
the amounts of water intake by control mice (group 2). However, the sa­
licylate and Piroxicam treated mice drunk significantly less than 
those of group 2. Undoubtedly, the taste of these drug waters will be 
the reason for this. The average weight of the mice at the beginning 
(day -1) and at the end (day 28) of the experiment are also given in 
Table 4. Only prednisolone treatment appeared to result in significant 
weight loss. 
Histological grading of the inflammation and cartilage damage is 
Table 4. Average drug dose and water intake during, and weight change 
after, a 4 week period.* 
Group 
1 
2 
3 
4 
5 
6 
Treatment 
oral gavage 
water 
salicylate 
Piroxicam 
tiaprofenic 
acid 
prednisolone 
Cone. 
mg/ml 
-
-
3 
0.2 
0.2 
0.02 
Water intake 
ml/mouse/24h 
2.6±0.5 
3.3+0.4 
2.2+0.4* 
2.7±0.4* 
3.3±0.3 
3.2±0.3 
Dose Mouse 
mg/kg/24h day-1 
-
-
255 
20 
25 
2.5 
26±2 
27+2 
26±2 
28±2 
27+2 
28±2 
weight(mg): 
day 28 
26+2 
29±2 
28±2 
28±2 
28+2 
25±2 * 
* Values depict mean(±S0) obtained from at least 9 mice. 
* Significant decrease in water intake, p<0.01. 
* Significant decrease in weight, p<0.05. 
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shown in Table 5. Of interest, neither drug caused a significant aggra­
vation of the cartilage damage. Antiinflammatory effects in terms of 
decreased values for infiltrate and exudate seem apparent for predniso­
lone and to a lesser extent for salicylate. Piroxicam seemed only to 
suppress exudation. 
Apart from effects on cartilage proteoglycan depletion, we also loo­
ked for potential drug effects on chondrocyte integrity. Scores for 
chondrocyte death were similar for groups 1-5 and tended to be slightly 
lower for group 6 (data not shown). 
Analysis of chondrocyte fwiction. As mentioned above no abnormalities 
were found on gross observation of the articular cartilage of the left 
normal joints of mice treated for 4 weeks with the various drugs. To 
examine in more detail potential effects on chondrocyte synthetic func­
tion, additional groups of normal mice were treated with tiaprofenic 
acid and salicylate for 7.5 weeks. Twenty-four hours after the last 
drug treatment, mice received an intraperitoneal injection of Na2 50ц 
and 3 h later pateallae were isolated. 
Anyway, no suppression of chondrocyte synthetic function was found 
in the drug treated groups (Table 6). In addition to quantitative ana­
lysis of chondrocyte function shown in Table 6, qualitative analysis 
was done by autoradiography. No evidence was obtained for any local 
Table 5. Histological grading of arthritis.§ 
Group 
1 
2 
3 
4 
5 
6 
Treatment* 
oral gavage 
water 
salicylate 
Piroxicam 
tiaprofenic 
prednisolone 
ac id 
Infiltj rate 
in synovium 
1.9 
1.9 
1.2 
1.7 
1.6 
0.7 
Exudat 
joint 
0.6 
0.7 
0.2 
0.2 
1.0 
0.0 
e in 
space 
Cartilage PG 
depletion 
1.0 
0.7 
0.5 
1.3 
1.0 
0.4 
§ See for histologic parameters Table 2. 
* Drugs given in drinking water. 
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Table 6. Weight change of drug treated mice and S-sulfate incorpora­
tion in articular knee cartilage. 
Group 
1 
2 
3 
4 
5 
6 
Drug 
t i a p r o f e n i c a c i d 
11 
t l 
I t 
s a l i c y l a t e 
water 
Dose * 
mg/kg 
32 
16 
θ 
4 
200 
-
w e i g h t 
day 0 
20±2 
20±2 
20±2 
19+2 
19+2 
20+2 
day 52 
25±1 
25±1 
24±2 
25±1 
25±1 
23±2 
3 5 S i n c o r p o i 
p a t e l l a e 
302125 
275±29 
252±27 
349±48 
338+50 
231±25 
r a t i o n * 
(S) 
1 3 1 * 
119 
109 
1 5 1 * 
146* 
100 
* Once a day by oral gavage. 
Δ mgiSD of at least 12 mice. 
* cpm ± SD in the patellar cartilage of groups of 6 mice. 
* p<0.01. 
change in synthetic activity m the patellar cartilage, nor for the 
occurrence of dead chondrocytes. 
Perhaps the increased synthetic activity found in some tiaprofenic 
acid groups and the salicylate group (Table 6) points to an attempt at 
repair after a period of suppressed synthetic activity. For instance, 
if drugs cause short-term suppression followed by a period of enhanced 
synthesis, the overall effect is probably negligible. Such reversibi­
lity was already demonstrated for the salicylate mediated suppression 
of S-GAG synthesis after a single dose. Another aspect, apart from 
the amounts of GAG present in the cartilage, is the quality. If, in the 
phase of suppressed synthesis, molecules of a changed composition are 
made, e.g. undersulfated GAGs, this would disturb cartilage integrity. 
Methods have now been developed to address this issue shortly. 
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CHAPTER 9 
FINAL REMARKS AND DISCUSSION 

FINAL REMARKS AND DISCUSSION 
The study described in this thesis was aimed to elucidate iatrogenic 
effects, mediated by antirheumatic drugs, on (pathological) articular 
cartilage. Many conclusions from the present investigation, which has 
been centered around the cartilage of the mouse patella (kneecap) and 
the effects of nonsteroidal antiinflammatory drugs (NSAIDs) on its me­
tabolism, are mentioned in Chapter 1. In that Chapter an overview is 
given of existing variations in drug test systems, in vitro as well as 
in vivo; some of these, undoubtedly, are the cause of variations in da­
ta obtained. 
Of the NSAIDs examined, sodiun salicylate was studied in detail and 
was furthermore used throughout the whole study as a reference drug. 
Before discussing the effects of several NSAIDs, some remarks are made 
on the cartilage test system, also used throughout the study. 
The nouse patella assay. Since its development in 1982 at our laborato­
ry (1), the mouse patella assay appeared very useful for studying chon­
drocyte metabolic activity in articular cartilage. An extension of this 
assay, merely confined to the metabolism of glycosaminoglycans (GAGs), 
is described in Chapter 2. It appeared that on the one hand S-sulfate 
is a good radiolabeled precursor for quantitative studies on sulfation 
3 3 3 
of GAGs. On the other hand, Η-glucosamine, but not H-acetate or H-
glucose, is a suitable label for quantitating GAG backbone metabolism, 
both in vitro and in vivo. In our cartilage/drug studies this cartilage 
assay is employed which is a peculiar assay for two reasons: 
1_. Use is made of anatomically intact articular cartilage to perform in 
vitro incubation experiments; as distinct from frequently used carti­
lage slices, no artificial disrupted collagen meshwork, in which PGs 
and chondrocytes are entangled, is present. The direct environment of 
the chondrocytes, an intact extracellular matrix, is not changed com­
pared to the in vivo situation. 
2^ . Chondrocyte metabolic activity, defined as the amount of incorporat­
ed radiolabel per time unit (anabolic activity) or the amount lost from 
prelabeled patellae after a particular chase period (catabolic activi­
ty) , is expressed per whole patella which is a well defined anatomical 
structure. In contrast with conventional assays, there is no need to 
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measure contents of cartilage constituents (e.g. DNA, uronic acid, 
hexosamine) or dry/wet weights, parameters against which incorporated 
radio amounts are usually expressed. This absence of an extra parameter 
determination makes the patella assay unique as an assay of mature ar-
ticular cartilage and, probably, is the reason for the relative high 
accuracy of measurements (taken into account the interindividual diffe-
rences between mice, the coefficient of variance is often below 20 %). 
A minor disadvantage might be that in this way only an overall metabo-
lic activity is measured not accounting for differences in very local 
metabolic activities in the patellar cartilage layer. If particular 
chondrocytes or groups of chondrocytes would be more susceptible to 
drugs, autoradiography of whole sections of radiolabeled patellae (e.g. 
with SOiJ might be helpful in picking up such local differences. For 
example, after incubation with sodium salicylate, autoradiography of 
S-labeled patellae revealed that at the marginal (synovial) regions 
of the patellar cartilage a high reduction of radioactivity was found, 
and this was not evident at the central part (Figure 1). Chondrocytes 
in the marginal regions are apparently more susceptible to salicylate 
than chondrocytes lying merely in the central part of the patellar car-
tilage. Of interest, if these synovial sides are regions which are ha-
bitually less loaded than the central cartilage part, then our observa-
tion is in accordance with that of Palmoski and Brandt. They found that 
habitually unloaded canine articular cartilage was susceptible to the 
suppressive action of salicylate, whereas loaded cartilage was not (2). 
Other cartilage assays. Since the patella possesses no epiphyseal car-
tilage, its cartilage is entirely hyaline articular cartilage; follow-
ing radiolabel incorporation the whole patella (freed from surrounding 
tissue) can be processed for measuring cartilage proteoglycan (GAG) me-
tabolism (Figure 1). Searching for other suitable structures with ana-
tomically intact articular cartilage we tried to use whole femoral 
heads. Besides a small interruption in the central part of the articu-
lar cartilage, caused by the attached ligamentum teres femoris, these 
femoral heads furthermore possess epiphyseal cartilage (Figure 2). Stu-
dying strictly articular cartilage metabolism, the epiphysis must be 
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Figure 1. Autoradiograph of a section of a whole mouse patella, pre­
viously exposed to ΊΟ - 2 M salicylate, embedded in the natural surround­
ing tissue and labeled with S-sulfate. Note the reduction of black 
silver granules at the marginal regions of articular cartilage (arrows) 
and the absence of these granules in non-cartilaginous tissue; no epi­
physeal cartilage is present. When used for quantification of the in­
corporated radiosulfate, the patella is punched out of the adjacent 
tissue. Stained with hematoxylin and eosin (H & E); original magnifica­
tion 40x. c=articular cartilage; b=bone; bm=bone marrow. 
Figure 2. Autoradiograph of a section of a whole mouse femoral head, 
labeled with S-sulfate. Radioactivity is seen above the articular 
cartilage layer (c) and, more heavily, above the epiphyseal cartilage 
(ep). The arrow points to the site at which the ligamentum teres femo-
ris had been attached. Stained with H & E; original magnification 40x. 
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removed proceeding to radiolabel incorporation; till now we did not 
succeed in adequate separation of these two cartilage entities. Never-
theless, in vitro studies with sodium salicylate revealed that the 
overall synthetic activity ( S incorporation rate) of femoral head 
chondrocytes (a mixture of both articular and epiphyseal ones) is in-
fluenced to the same extent as patellar chondrocytes, after short-term 
exposure to the drug (Table 1). 
The patella is the largest sesamoid bone of the body and there are 
many more of these structures, which as a rule develop within tendons 
or ligaments (e.g. the fabella). It seems worthwile to examine these 
cartilage specimens for potential suitability in articular cartilage 
assays. 
Susceptibility of patellar cartilage to salicylate in vitro. The poten-
tial effects of NSAIDs on the metabolism of articular cartilage of the 
mouse were started with salicylate. Salicylate is considered as the 
prototype of NSAIDs and is often used as a first choice drug in anti-
rheumatic therapy. Studying the in vitro effects of therapeutic and 
higher drug concentrations on patellar cartilage, an inhibition of GAG 
synthesis was observed (see Figure 1 and Table 1); no disturbance was 
found on basal GAG degradation. This drug mediated suppression was not 
Table 1. Salicylate effect on S incorporation in whole patellae and 
in whole femoral heads: dose-response.* 
Sodium salicylate S content (counts per minute/specimen)* 
(mol/1) 
Patella Femoral head 
0 919 ± 76 (1003!) 2524 ± 491 (lOOÄ) 
10-3 B55 ± 110 ( 93%) 2070 ± 465 ( 82%) 
2 χ ΙΟ"3 6Θ9 ± 69 ( 75%) 20Θ5 ± 316 ( 81%) 
5 χ IO*3 568 ± 80 ( 62%) 1820 ± 486 ( 72%) 
* Four h salicylate (without serum); final two h with S-sulfate. 
* Results represent the mean ± SD of cartilage specimens from 6 mice. 
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only evident in patellar cartilage of young male C57B1 mice (up to 27 
weeks; Chapter 5) but also in patellae of older mice (up to 1 year), 
female mice and mice of other btrains (Swiss and "129")· Of interest, 
no change in magnitude of suppression was noticed, indicating that sex, 
age and strain differences do not effect mouse patellar cartilage's 
susceptibility to salicylate. 
To obtain articular cartilage with higher susceptibility to salicy­
late, we also did some attempts to mimic the experiments performed by 
Palmoski and Brandt (3). They treated articular cartilage slices with 
hyaluronidase to deplete the matrix of proteoglycans (PGs). Subsequent­
ly, upon cultivation of these treated slices for several hours, GAG 
synthetic rate increased as did the chondrocyte susceptibility to sali­
cylate (Chapter 1: Table 6). Decreased PG content, higher GAG synthetic 
rate and (much) higher susceptibility to salicylate was also demon­
strated in osteoarthntic cartilage (4). However, with our mouse patel­
la assay we did not succeed in demonstrating these phenomena. Hyaluro­
nidase treatment did not affect anatomically intact patellar cartilage 
at all; trypsin treatment (Chapter 7) decreased PG content as well as 
the rate of GAG synthesis, but salicylate susceptibility was not en­
hanced. Augmented GAG synthesis was only exhibited by patellar carti­
lage in postarthntic mouse knee joints (day 28 after zymosan-indue ed 
arthritis; Chapter 7). Nevertheless, these affected patellae were not 
convincingly more susceptible to salicylate than normal patellae (in 
vitro); on the other hand there are no clear indications that PG con­
tent in these patellae would be decreased significantly. Perhaps the 
recently published glucose oxidase-induced arthritis model in mice, de­
veloped at our laboratory by Schalkwijk et al (5), is suitable for ar­
ticular cartilage studies in the aforementioned sense. Already after 
one week the GAG synthetic rate in PG-depleted patellar cartilage is 
increased to about 200% (in vitro) and this condition is maintained at 
least for another 7 days (observations made by Drs. H. van Beuningen). 
Cartilage/drug assays with patellae from these arthritic joints is now 
under investigation. 
An important point to make is that in our studies, described above, 
no use was made of serum in the medium in which the patella specimens 
were cultured; thus salicylate was essentially in the free form. In the 
presence of mouse serum, 25й or more, therapeutic concentrations of sa-
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licylate exerted no effect on normal GAG metabolism anymore (Chapter 4 
and 5). This was also found if albumin (2-4Ж) was added to the medium 
(Chapter 5), indicating that the remaining free (not protein bound) 
concentration of salicylate was not able to do any harm to patellar 
chondrocytes; low, free salicylate concentrations (10-10 M) even 
tended to stimulate basal GAG synthesis (Chapter 5)! These latter ob­
servations indicate that a therapeutic dose of salicylate in vivo would 
have no direct suppressive effect on patellar chondrocytes in normal 
joints. 
Susceptibility of patellar cartilage to salicylate in vivo. In Chapter 
4 in vivo studies are described with surprising outcomes. Shortly after 
administration to mice, salicylate (200 mg/kg) induced a sulfate diu­
resis leading to a marked decrease in serum sulfate. Taken into account 
possible changes in specific radioactivity between drug treated animals 
and control ones, labeling studies with S-sulfate and H-glucosamine 
revealed that sulfate incorporation into GAGs of patellar cartilage was 
suppressed (Chapter 4), whereas glucosamine incorporation proceeded un­
altered in vivo (6). The incorporation behaviour of these radiolabels 
in vivo suggests that salicylate treatment induced suppression of GAG 
sulfation without a concomitant disturbance in GAG chain elongation. 
Since salicylate in vivo presumably did not affect normal chondrocyte 
function directly (as stated above), the phenomenon of decreased sulfa­
tion had to occur via an indirect drug effect e.g. the observed, sali­
cylate induced, decrease in availability of endogenous sulfate. This 
was studied in detail in vitro. 
Exposing whole patellae to sulfate concentrations extending from 
physiological (mouse-)levels (about 1.0 mM 50ц) to almost nil, incorpo­
ration of sulfate in patellar GAGs was markedly reduced below a certain 
treshold concentration, i.e. 0.5 mM 50ц (Chapter 4). Of interest, under 
these conditions no significant change in glucosamine incorporation was 
observed (Figure 3), suggesting undersulfation of GAGs. So far, these 
additional in vitro observations might explain the in vivo effects 
caused by salicylate in mice. As far as undersulfation is concerned, 
salicylate demonstrated another interesting aspect in vitro. At high 
drug concentrations, sulfate incorporation was more suppressed than 
glucosamine incorporation, suggesting again undersulfation of GAGs, 
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Figure 3. Sulfate and glucosamine incorporation into patellar glycosa-
minoglycans at various sulfate concentrations. Results are expressed as 
nanomoles of precursors incorporated per patella in 2 h and represent 
the mean ± SD of at least 5 mice. 
(Chapter 5), now by a direct effect of salicylate on the chondrocyte. 
This observation could be related to the observation made by others 
that salicylate, under certain conditions, strongly inhibits sulfate 
transport across cell membranes (7). 
Noteworthy, in this respect, is that incubation experiments perform­
ed with sulfate concentrations below 0.5 mM (without serum) augmented 
the degree of salicylate provoked suppression of sulfated GAG synthesis 
(Chapter 5). 
Undersulfation of GAGs. Because of these, from a fundamental point of 
view, interesting observations we examined if low sulfate availability 
indeed could induce undersulfation of GAGs as suggested by Figure 3. To 
this end H and S labeled GAGs, isolated from patellar cartilage, 
were analysed with cellulose acetate (CA) electrophoresis. No clear 
difference in migration pattern of radiolabeled GAGs could be demon­
strated as would be expected if undersulfated GAGs, possessing a lower 
negative charge density than normal GAGs, were present. Also, prelimi­
nary analysis (performed at the Jan van Breemen Institute, Amsterdam) 
with high performance liquid chromatography (HPLC) of sulfated disac-
149 
charides, obtained after chondroitinase ABC digestion of radiolabeled 
GAGs, did not result in a clear cut answer as to undersulfation or not. 
Experiments done by Sobue (8) and Ito (9) on chick embryo cartilage, 
clearly demonstrated (by means of CA electrophoresis and ion exchange 
chromatography) that low environmental sulfate in vitro caused under­
sulfation of GAGs. This was also observed very recently by Humphries et 
al (10), studying bovine aortic endothelial cells, and Tyree et al 
(11), studying tumor cells. We do not know yet why we could not find 
any change in GAG properties, but this interesting matter is still un­
der investigation. As a final remark to this issue we like to mention 
that also plants demonstrate a sulfate dependence like that described 
here (12). 
Aspirin, the prototype of NSAIDs, is an interesting drug with re­
spect to our studies in mice. Although we have not studied this parti­
cular drug in vivo yet, after absorption in the body it is fastly hy-
drolysed to salicylate, a drug which causes a sulfaturic effect leading 
to a decreased endogenous sulfate availability (Chapter 4). Nowadays 
newly developed derivatives of salicylate are on the market (e.g. di-
flunisal, benorylate, eterylate) and it would be of interest to study 
their actions on sulfate homeostasis in the mouse. 
Sulfate determination. Because a suboptimal availability of inorganic 
sulfate in the circulation may suppress sulfation of GAGs and even 
might, on a chronic basis, deplete articular cartilage of (ester)sul-
fate, it is important to have the disposal of a sensitive sulfate as­
say, to be able to assess potential changes in sulfate levels in small 
experimental animals. Moreover, using S-sulfate in vivo it is of ut­
most importance to be informed about the specific activity (ratio of 
SOij over endogenous 50ц) of this radiolabel in the circulation 
throughout the course of the experiment. For this purpose a simple 
scaled-down inorganic sulfate assay, derived from an existing sensitive 
benzidine method was developed (Chapter 3). This assay will substan­
tially contribute to a reduction in the number of small animals, used 
for studies on inorganic sulfate. Amounts in the range of 1-12 nmol 
sulfate can easily be measured; for that, only 10 μΐ serum or cartilage 
from one mouse patella is needed. 
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Susceptibility of patellar cartilage to other NSAIOs: short-terra and 
long-ten« drug exposure: Short-term in vitro and in vivo studies on 
the effects of tiaprofenic acid, a new developed NSAID, on normal pa-
tellar cartilage are described in Chapter 6. In addition the influence 
of chronic administration (7.5 weeks) of salicylate and tiaprofenic 
acid on the integrity of articular cartilage in normal mice is briefly 
discussed. Tiaprofenic acid exerted no effect on patellar GAG metabo-
lism in vitro; in vivo this drug demonstrated a slight, but not signi-
ficant, suppression of articular GAG synthesis. Chronic administration 
of tiaprofenic acid (and salicylate) to normal mice led to no change 
in histological features of knee joint cartilage. 
Short-term effects of salicylate, tiaprofenic acid and piroxicam 
were further subjected to a detailed investigation in vitro and in vivo 
on healthy as well as arthritic cartilage. The steroid, prednisolone, 
was included in these studies as a highly effective antiinflammatory, 
but potentially harmful agent for articular cartilage. Proteoglycan de-
pleted cartilage, obtained after trypsin treatment or taken from in-
flamed arthritic joints, was not convincingly more susceptible to these 
drugs, in vitro, than normal cartilage; except for salicylate these 
drugs seemed harmless (Chapter 7). In vivo effects were tested in mice 
with unilateral, zymosan-induced arthritis. Except for salicylate, the 
drugs did not affect endogenous serun sulfate levels to a significant 
extent, and in vivo patellar GAG synthesis (quantitated with S-sul-
fate) was not influenced, neither in healthy, nor in arthritic patel-
la. On the other hand, drug studies performed in mice with 28 day-las-
ting monoarthritis, were of particular interest. The affected joints, 
exhibiting augmented patellar GAG synthesis, were susceptible to sup-
pressive actions of the NSAIDs. Again GAG synthesis in patellae of the 
normal, contralateral joints was not affected by tiaprofenic acid and 
piroxicam. In addition, studies were performed on GAG degradation in 
vivo. Under certain conditions only tiaprofenic acid and to a lesser 
extent prednisolone were able to suppress both the basal and enhanced 
(inflammation mediated) breakdown rate. These latter observations indi-
cate that effects of drugs are dependent on the condition of cartilage 
and should stimulate future research on this item. In conclusion, as 
far as in vivo patellar GAG metabolism is concerned, only salicylate 
seems potentially detrimental, piroxicam seems neutral in action and 
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tiaprofenic acid and prednisolone seem to possess beneficial proper­
ties. 
To extend these observations, above findings were put to the proof 
by performing long-term studies in mice with antigen induced arthritis 
(Chapter Θ). Although prednisolone, Piroxicam and salicylate, but not 
tiaprofenic acid, exerted some antiinflammatory effects, daily drug 
treatment, for 4-7.5 weeks, did not result in clear detectable changes, 
neither in normal knee-joint cartilage nor in damaged, arthritic carti­
lage. These latter results are still preliminar, and await completion 
by data from further investigations in this matter. 
All the studies described in this thesis were performed to examine 
the potential role of NSAIDs in the process of articular cartilage des­
truction, occuring in chronic joint diseases. No indications were ob­
tained for any marked deleterious effect, nor for the reverse, amelio­
ration of damaged, arthritic cartilage by the studied NSAIDs. Because 
our studies were performed on mice, the relevance of outcomes should be 
further investigated, preferably in animals which possess more human­
like (patho)physiology, before a definite conclusion can be made regar­
ding iatrogenic cartilage effects of the drugs considered in this the­
sis. 
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CHAPTER 10 
SAMENVATTING 

KRAAKBEEN VAN DE MUIZEPATELLA EN DE GEVOELIGHEID HIERVAN VOOR NIET-
STEROIDALE ONTSTEKINGSREMCNDE MIDDELEN 
Het promotieonderzoek, beschreven in deze dissertatie, heeft zich voor-
namelijk geconcentreerd op het kraakbeen van de muizepatella (knie-
schijf) en de beïnvloeding van metabolische processen hierin door niet-
steroidale ontstekingsremmende middelen (NSAIDs). Vele conclusies zijn 
reeds vermeld in hoofdstuk (HS) 1, waarin een overzicht wordt gegeven 
van bestaande variaties m geneesmiddeltestsystemen, zowel in vitro als 
in vivo, die ongetwijfeld voor een deel verantwoordelijk zijn voor de 
variaties in gegevens afkomstig van diverse onderzoekingen. 
Een uitbreiding van de muizepatella-testmethode, ontwikkeld op ons 
laboratoriLFi in 1982, wordt beschreven in HS 2. De patella wordt ge-
bruikt als een bron van anatomisch intact gewrichtskraakbeen en blijkt 
uitermate geschikt voor de bestudering van effecten van ontstekingsme-
diatoren en NSAIDs op de stofwisseling van proteoglycanen (PGb), reuze 
molekulen die naast collageen en water de hoofdbestanddelen van kraak-
been vormen. Inbouw van S-sulfaat, dat gewoonlijk wordt gebruikt om 
de synthesesnelheid van de hoog gesulfateerde glycosaminoglycanen 
(GAGs), de belangrijkste componenten van PGs, te meten, werd nauwkeurig 
bestudeerd. Ook andere radiolabels ( H-glucosamine, Η-glucose, H-ace­
taat), in gebruik voor de bestudering van de GAG-ketenverlenging, wer­
den op hun geschiktheid onderzocht. 
De ontwikkeling van een eenvoudige analysemethode voor zeer kleine 
hoeveelheden anorganisch sulfaat, afgeleid van een bestaande gevoelige 
benzidinemethode en beschreven m HS 3, zal aanzienlijk minder kleine 
proefdieren vergen, welke worden gebruikt voor studies gericht op het 
sulfaat-metabolisme. Hoeveelheden van 1-12 nmol sulfaat kunnen 
makkelijk gemeten worden; daarvoor is slechts 10 μΐ serin of kraakbeen 
van één muizepatella nodig. 
Studies naar de effecten van NSAIDs op het metabolisme van normaal 
gewrichtskraakbeen van de muis werden begonnen met salicylaat in een 
therapeutische, ontstekingsremmende dosis. Salicylaat wordt wel be-
schouwd als het prototype van NSAIDs en wordt vaak (niet in Nederland) 
als geneesmiddel van eerste keus gebruikt in de medicamenteuze therapie 
van reumapatienten. In HS 4 worden in vivo studies beschreven met ver-
rassende resultaten: 1. Salicylaat veroorzaakt een sulfaatdiurese die 
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een sterke daling van de endogene, anorganische sulfaat-spiegel tot ge­
volg heeft. 2. De verlaagde sulfaat beschikbaarheid, op zich, werd ver­
antwoordelijk gesteld voor de waargenomen onderdrukking van de gesulfa­
teerde GAG-synthese in de muizepatella. Om de in vivo salicylaat effec­
ten beter te kunnen verklaren werden de in vitro effecten van salicy­
laat op het patellaire kraakbeen GAG-metabolisme onderworpen aan een 
nader onderzoek (HS 5). De suppressieve eigenschappen van therapeuti­
sche concentraties salicylaat verdwenen in de aanwezigheid van 25л of 
meer serum in het incubatiemedium, hetgeen doet vermoeden dat salicy­
laat in vivo geen direct effect uitoefent op het metabolisme van de 
kraakbeencel (chondrocyt). 
Kortdurende studies naar in vitro en in vivo effecten van salicylaat 
en tiaprofeenzuur, een nieuw ontwikkeld NSAID, op kraakbeen van gezonde 
muizen worden beschreven in HS 6. Ook wordt de invloed van chronische 
toediening (7,5 week) van deze medicamenten aan normale muizen kort be­
sproken. Geen indicatie werd verkregen voor enig schadelijk effect op 
kniegewrichtskraakbeen na deze (relatief) langdurige behandeling. 
Studies naar de effecten van NSAIDs op pathologisch kraakbeen zijn 
natuurlijk relevanter dan op gezond kraakbeen. HS 7 behandelt kortdu­
rende studies van in vitro en in vivo effecten van diverse NSAIDs, in 
het bijzonder de nieuwe farmaca piroxicam en tiaprofeenzuur, op zowel 
gezond kraakbeen als kraakbeen van ontstoken muizeknietjes. Het ste­
roid Prednisolon werd in deze studies gebruikt om te fungeren als een 
sterk ontstekingsremmend middel en tegelijkertijd als een mogelijk 
schadelijke stof voor gewrichtskraakbeen. Piroxicam leek neutraal in 
werking, terwijl tiaprofeenzuur en Prednisolon zelfs een heilzame wer­
king uitoefenden op kraakbeen. 
Als een logische voortzetting werden de effecten van NSAIDs na chro­
nische toediening (dagelijks, 4 weken lang) aan muizen met antigeen-ge-
ïnduceerde, eenzijdige gewrichtsontsteking, bestudeerd (HS θ). De re­
sultaten zijn nog steeds voorlopig van karakter en het is op dit moment 
niet mogelijk om harde conclusies te trekken over heilzame of nadelige 
effecten van deze medicijnen op gewrichtskraakbeen van ontstoken knie­
tjes. In ieder geval, opvallend schadelijke effecten werden nooit ge­
vonden, noch voor normaal kraakbeen noch voor kraakbeen uit ontstoken 
gewrichten. 
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Ten slotte, naast het breken van een lans voor de patella-testmethode, 
wordt in HS 9 een overzicht gegeven van de behaalde resultaten. Verder 
worden additionele gegevens vermeld, in het bijzonder over relaties 
tussen salicylaat, anorganisch sulfaat en ondersulfatering van glycoaa-
minoglycanen. 
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MURINE PATELLAR CARTILAGE 
AND 
ITS SUSCEPTIBILITY TO 
NON STEROIDAL 
ANTIINFLAMMATORY DRUGS 
Bernard J. de Vries 
STELLINGEN 
1. De vermeende schadeli jkheid van NSAIDs voor gewrichtskraakbeen i s 
geenszins voldoende bewezen. 
(Dit proefschr i f t ) 
2. Radiolabeling van de novo gesynthetiseerde gesulfateerde glycosami-
noglycanen door chondrocyten in cultuurmediun met c a r r i e r - f r e e anorga­
nisch S-sulfaat kan leiden tot ondergesulfateerde produkten. 
(Dit p r o e f s c h r i f t ) 
3. Na toediening van anorganisch S-sulfaat wordt vaak ten onrechte 
aangenomen dat het "gedrag" van anorganisch sulfaat in vivo weerspie­
geld wordt door dat van S. 
(Dit proefschr i f t ) 
4. In v i t r o effecten van antireunatica op kraakbeen dienen i n aanwezig­
heid van serin of synoviaalvocht te worden bestudeerd. 
(Dit p r o e f s c h r i f t ) 
5. Verergering van experimentele o s t e o a r t h r i t i s na chronische toedie­
ning van aspirine zou mogelijk te wi j ten kunnen z i jn aan anorganisch 
sulfaat gebrek. 
(Dit p r o e f s c h r i f t ) 
6. De niet-carcmogene stof 4-amino-4'-chloordifenyl (CAD) l i j k t een 
goede vervanger voor het carcinogene reagens, benzidine, dat gebruikt 
wordt in sulfaatbepalingen. 
7. Aspirine i s een prodrug voor s a l i c y l a a t . 
JR Vane et a l , 2nd World Conference on Inflammation, Monte-Carlo, 19Θ6. 
8. Waarschijnl i jk onderdrukken de n iet -s tero idale ontstekingsremmende 
p i j n s t i l l e r s (NSAIDs) over het algemeen meer de p i j n dan de ontste-
k i ngsak t i v i t e i t . 
9. Het kniegewricht van de muis l i j k t geschikt om de lokale b i jwerk in -
gen van het radiocol loïde Yt t r i i i n -90-s i l i caa t , in gebruik voor bestra-
lings-synovectomie, te bestuderen. 
BJ de Vries et a l . Agents Actions 15: 101-103, 19B4. 
10. Radioactief Y t tnun penetreert mogelijk in het kraakbeen na i n t r a -
a r t i cu la i re toediening van Yt t r i i j n -90-s i l i caa t . 
11. Het gebruik van het monoklonale anticytokeratine anti l ichaan CAM 
5.2 in de tunordiagnostiek dient met gepaste voorzichtigheid te ge-
schieden, aangezien d i t reagens ook glad spierweefsel en spierweefsel-
tunoren (leiomyosarcomas) herkend. 
M Leader et a l , Histopathology 10: 1315-1324, 1986. 
12. Het i s o n b i l l i j k dat de noodzakelijk geachte kortere verlenging van 
' t r i j bew i j s van inval ide personen als consequentie heeft , dat telkens 
weer de normale onkosten moeten worden opgebracht. 
13. Het verkr i jgen van een p i j n s t i l l e r u i t de verpakking i s voor een 
reunapatient soms een p i j n l i j k e aangelegenheid. 
Wouter Klootwi jk, de Volkskrant (27-12-86). 
14. De invoering van de term KLOIO's (klassiek opgeleiden in opleiding) 
voor diegenen die een klassieke akademische opleiding hebben genoten 
maar noodgedwongen op een AlO-plaats worden gestationeerd, dient te 
worden vermeden. 
15. Het f e i t dat steeds meer medische publ ikat ies verschijnen in boule-
vardbladen zal ertoe leiden dat ook voor deze " l i t e ra tuu r " een c i t a t i e -
index wordt vastgesteld. 
16. Na het doctoreren zullen vele doctorandi niet alleen een punt ach-
ter hun wetenschappelijke loopbaan zetten, maar ook achter de afkorting 
van hun nieuwe titel; hoewel dit laatste vaak onbewust gebeurt zijn 
hier geen duidelijke richtlijnen voor (zie van Dale, 11e druk 1984, on-
der de rubriek "Het gebruik van leestekens" en onder het woord "punt"). 
17. De dichte zijkant van een proefschrift blijft het langst m zicht. 
18. Reclame in een proefschrift is iets dat nú nog opvalt. 
19. Promoveren kost vriendschap. 
BJ de Vries. Nijmegen, 20 februari 1987. 


